Intracellular Signalling in Experimental Hypertension by Nixon, Graeme F
 
 
 
 
 
 
 
https://theses.gla.ac.uk/ 
 
 
 
 
Theses Digitisation: 
https://www.gla.ac.uk/myglasgow/research/enlighten/theses/digitisation/ 
This is a digitised version of the original print thesis. 
 
 
 
 
 
 
 
 
Copyright and moral rights for this work are retained by the author 
 
A copy can be downloaded for personal non-commercial research or study, 
without prior permission or charge 
 
This work cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the author 
 
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the author 
 
When referring to this work, full bibliographic details including the author, 
title, awarding institution and date of the thesis must be given 
 
 
 
 
 
 
 
 
 
 
 
 
 
Enlighten: Theses 
https://theses.gla.ac.uk/ 
research-enlighten@glasgow.ac.uk 
INTRACELLULAR SIGNALLING IN EXPERIMENTAL HYPERTENSION
by
Graeme F. N ix o n ©
This being a thesis submitted for the degree of 
Doctor of Philosophy in the Faculty of Medicine 
of the University of Glasgow
Department of Medicine and Therapeutics 
October, 1991
ProQuest Number: 11011399
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 11011399
Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
LIST OF CONTENTS Page N°
ACKNOWLEDGEMENTS (i)
DECLARATION (ii)
LIST OF FIGURES (iii)
LIST OF TABLES (vii)
SUMMARY (ix)
CHAPTER ONE - GENERAL INTRODUCTION 1
1.1. BloodVessels 2
1.1.1 Physiology of the vasculature 2
1.1.2 Structure of blood vessels 3
1.2. Regulation of arterial blood pressure 4
1.2.1 The sympathetic nervous system 4
1.2.2 The renin angiotensin system 5
1.2.3 Endothelin 6
1.3. Vascular smooth muscle 7
1.3.1 Contraction of vascular smooth muscle cells 7
1.3.2 Regulation of intracellular calcium 8
1.4. Control of contraction by second messengers 9
1.4.1 Phosphatidylinositol cycle 9
1.4.2 Phosphatidylinositol lipids 13
1.4.3 Phospholipase C 14
1.4.4 Inositol phosphates 15
1.4.5 1,2-Diacylglycerol and protein kinase C 17
1.4.6 Effect of lithium 18
1.5. Receptor - effector coupling 18
1.5.1 Activation of G-proteins 18
1.5.2 Effect of cholera and pertussis toxin 20
Page N°
1.5.3 Coupling of receptor binding to phospholipase C activation 21
1.6. Hypertension 22
1.6.1 General p athophy siology 22
1.6.2 Characteristics of essential hypertension 23
1.6.3 Thickening of the blood vessel wall 23
1.7. Potential factors involved in the pathogenesis of essential 24
hypertension
1.7.1 Sympathetic nervous system 25
1.7.2 Endothelin-1 26
1.7.3 The heart 28
1.7.4 Ion transport 29
1.7.5 Calcium and second messenger systems 30
1.8. Secondary hypertension 32
1.8.1 General pathophysiology 32
1.8.2 Goldblatt model of renovascular hypertension 32
1.8.3 Perinephritis hypertensive model 33
1.9. Suitability of experimental models of hypertension and 34
normotensive controls
1.10. Aims 36
CHAPTER TWO - INOSITOL PHOSPHATE FORMATION IN 38
AORTIC RINGS FROM SPONTANEOUSLY HYPERTENSIVE 
RATS: EFFECTS OF NORADRENALINE AND ENDOTHELIN-1
2.1. Introduction 39
2.1.1 Alterations in contractions in hypertensive smooth muscle 39
2.1.2 Alterations in inositol phosphate formation in hypertensive 41
smooth muscle
2.1.3 Aims 42
2.2. Methods 43
Page N°
2.2.1 Assay for the measurement of total [% ]-inositol phosphate 43
formation
2.2.2 Statistical analysis 44
2.3. Results 44
2.3.1 Basal [JH]-inositol phosphate formation 44
2.3.2 Agonist stimulated [%]-inositol phosphate formation: SHR 45
versus WKY
2.4. Discussion 45
CHAPTER THREE - INOSITOL PHOSPHATE FORMATION IN 56 
CULTURED AORTIC SMOOTH MUSCLE CELLS FROM 
SPONTANEOUSLY HYPERTENSIVE RATS: EFFECTS OF 
NORADRENALINE AND ENDOTHELIN-1
3.1. Introduction 57
3.1.1 Vascular smooth muscle cells under culture conditions 57
3.1.2 Cultured vascular smooth muscle cells in hypertension 59
3.1.3 Aims 61
3.2. Methods 61
3.2.1 Preparation of primary cultured aortic smooth muscle cells 61
3.2.2 Maintenance of cultured aortic smooth muscle cells 62
3.2.3 Assay for the measurement of total [JH]-inositol phosphate 63
formation
3.2.4 Assay for the measurement of total [JH]-phosphatidylinositol 65
formation
3.2.5 Statistical analysis 65
3.3. Results 66
3.3.1 Basal [^H]-inositol phosphate formation and basal [% ]- 66
phosphatidylinositol formation
Page N°
3.3.2 Agonist stimulated [ H]-inositol phosphate formation 66
3.3.3 Timecourse experiments 69
3.4. Discussion 69
CHAPTER FOUR - INOSITOL PHOSPHATE FORMATION IN 87
AORTIC RINGS AND CULTURED AORTIC SMOOTH MUSCLE 
CELLS FROM PERINEPHRITIS HYPERTENSIVE RABBITS:
EFFECTS OF NORADRENALINE AND ENDOTHELIN -1
4.1. Introduction 88
4.1.1 In vivo responses 88
4.1.2 In vitro responses - noradrenaline 89
4.1.3 In vivo responses - endothelin-1 90
4.1.4 Aims 91
4.2. Methods 92
4.2.1 Surgical procedures 92
o
4.2.2 Assay for the measurement of total r  H]-inositol phosphate 93
formation in aortic rings
4.2.3 Assay for measurement of total [^H]-phosphatidylinositol 93
formation in aortic rings
4.2.4 Preparation of primary cultured aortic smooth muscle cells 94
a
4.2.5 Assay for the measurement of total [H]-inositol phosphate 94
formation in cultured aortic smooth muscle cells
4.2.6 Statistical analysis 95
4.3. Results 95
4.3.1 Blood pressure and tissue weight 95
4.3.2 [^H]-Inositol phosphate formation in aortic rings 95
4.3.3 [%]-Inositol phosphate formation in cultured aortic smooth 97
muscle cells
4.4. Discussion 97
Page N°
CHAPTER FIVE - GTP-BINDING PROTEIN COUPLING TO 115
INOSITOL PHOSPHATE FORMATION IN CULTURED AORTIC 
SMOOTH MUSCLE CELLS FROM SPONTANEOUSLY 
HYPERTENSIVE RAT
5.1. Introduction 116
5.1.1 Regulation of signal transduction pathways 116
5.1.2 G-protein activation of phospholipase C 119
5.1.3 Involvement of G-proteins in noradrenaline and endothelin-1 119
responses
5.1.4 Aims 121
5.2. Methods 123
5.2.1 Preparation of primary cultured aortic smooth muscle cells 123
5.2.2 Assay for the measurement of total [^H]-inositol phosphate 123
formation in the presence of pertussis toxin
5.2.3 Pertussis toxin-dependent ADP-ribosylation with [^P]-N A D  124
5.2.4 Statistical analysis 125
5.3. Results 125
5.3.1 Effects of pertussis toxin preincubation on [JH]-inositol 125
phosphate formation
5.3.2 Effects of zero calcium + O.lmM EGTA on [^H]-inositol 126
phosphate formation
5.3.3 Pertussis toxin-dependent ADP-ribosylation in the presence of 127
endothelin-1
5.4. Discussion 135
Page N°
CHAPTER SIX - INTRACELLULAR CALCIUM 139
CONCENTRATION IN CULTURED AORTIC SMOOTH 
MUSCLE CELLS FROM SPONTANEOUSLY HYPERTENSIVE 
RAT
6.1. Introduction 140
6.1.1 Role of calcium in vascular smooth muscle contraction 140
6.1.2 Methods for measurements of intracellular calcium 140
concentration
6.1.3 Intracellular calcium concentrations in vascular smooth 143
muscle
6.1.4 Intracellular calcium concentration in experimental 143
hypertension
6.1.5 Aims 144
6.2. Methods 145
6.2.1 Preparation of primary cultured aortic smooth muscle cells 145
6.2.2 Growing cultured aortic smooth muscle cells on coverslips 146
6.2.3 Measurement of inracellular calcium using fura 2 146
6.3. Results 148
6.4. Discussion 151
CHAPTER SEVEN - GENERAL DISCUSSION 154
7.1. Summary 155
7.2. Conclusions 158
MATERIALS 161
PRESENTATIONS AND PUBLICATIONS CONTAINING THE 162
WORK UNDERTAKEN FOR THIS THESIS
REFERENCES 163
ACKNOWLEDGEMENTS
There are many people I would like to thank:
Professor J.L. Reid, firstly, for allowing me to study in this department providing me 
with such an excellent training in medical research and, secondly, for his help and 
encouragement with this project.
Carlene Hamilton, for her continual helpfulness and enthusiasm throughout my 
Ph.D. without whom I would never have reached this far.
Roger Wadsworth, whose experience and optimism, no matter how bad things got, 
was a constant tonic. His advice, especially before a presentation, always managed 
to keep me calm (except when we got on the wrong train going to Cambridge, but 
thats another story).
Kate Howie, for advice on statistics and computing.
Nigel Pyne, for giving me the opportunity to learn new techniques in his lab. 
Fabrizio Pasanisi and Christine Pryce, for help with parts of this thesis.
Julie McKenzie, for her technical help and for keeping my feet on the ground. 
Jim McCulloch and the rest of the technical staff who at one point or another always 
seemed to be giving me a hand.
The secretaries in the department,who were always helpful beyond the call of duty. 
To all my friends in the department and those who have moved on who made this 
such a great place to work.
To my friends outside work, whose company (and a small sherry) solved all my 
problems instantly.
To the Paton family, who didn’t mind me marrying there daughter despite being a 
student with no money.
My biggest thank you goes to my family; Maw, Paw, my sister Kim, my Grandma, 
and my wife, Yvonne, who have made my life such a happy one.
My wife, Yvonne, (I wasn’t married when I started this project) deserves a huge 
thanks for putting up with me for the past 7 months and allowing me to pursue my 
dreams, while her own are left behind. I’ll never appreciate how lucky I am.
To my mother and father who have supported and encouraged me throughout my 
life. This is the culmination of a long-term investment for my parents. This thesis is 
dedicated to them but I feel it is little repayment for everything they have given me. 
"Words cannot express ".
And finally to the late John J. Nixon whose philosophies made me appreciate what is 
really important in life. Cheers, Pop.
In this thesis, as a record of my life to date, I would like to say: 
I don’t regret a minute of it
(i)
DECLARATION
I declare that this thesis has been composed by myself and is a record of work 
performed by myself. It has not been submitted previously for a higher degree.
This research was carried out in the Department of Medicine and Therapeutics, 
University of Glasgow under the supervision of Dr. C.A. Hamilton, Dr. R.M. 
Wadsworth and Professor J.L. Reid.
Graeme F. Nixon 
October, 1991
LIST OF FIGURES
CHAPTER ONE
Figure 1.1 - The phosphatidylinositol cycle 
Figure 1.2 - Regulatory system of a G-protein 
CHAPTER TWO
Figure 2.1 - Noradrenaline stimulated inositol phosphate formation in 
aortic rings from 6 week old SHR and WKY rats 
Figure 2.2 - Noradrenaline stimulated inositol phosphate formation in 
aortic rings from 14 week old SHR and WKY rats 
Figure 2.3 - Noradrenaline stimulated inositol phosphate formation in 
aortic rings from 40 week old SHR and WKY rats 
Figure 2.4 - Endothelin-1 stimulated inositol phosphate formation in 
aortic rings from 6 week old SHR and WKY rats 
Figure 2.5 - Endothelin-1 stimulated inositol phosphate formation in 
aortic rings from 14 week old SHR and WKY rats 
Figure 2.6 - Endothelin-1 stimulated inositol phosphate formation in 
aortic rings from 40 week old SHR and WKY rats 
CHAPTER THREE
Figure 3.1- Electronmicrograph of cultured aortic smooth muscle 
cells from 6 week WKY rats 
Figure 3.2 - Electronmicrograph of cultured aortic smooth muscle 
cells from 6 week SHR 
Figure 3.3 - Electronmicrograph of cultured aortic smooth muscle 
cells from 14 week WKY rats 
Figure 3.4 - Electronmicrograph of cultured aortic smooth muscle 
cells from 14 week SHR
(iii)
Page N°
11
19
47
48
49
50
51
52
70
71
72
73
Page N°
Figure 3.5 - Endothelin-1 stimulated inositol phosphate formation in 74
cultured aortic smooth muscle cells from 6 week SHR 
and WKY rats
Figure 3.6 - Noradrenaline stimulated inositol phosphate formation in 75
cultured aortic smooth muscle cells from 6 week SHR 
and WKY rats
Figure 3.7 - Endothelin-1 stimulated inositol phosphate formation in 76
cultured aortic smooth muscle cells from 14 week SHR 
and WKY rats
Figure 3.8 - Noradrenaline stimulated inositol phosphate formation in 77
cultured aortic smooth muscle cells from 14 week SHR 
and WKY rats
Figure 3.9 - Mean basal inositol phosphate formation in cultured 78
aortic smooth muscle cells from 14 week SHR and WKY 
rats after different incubation times with [^H]-myoinositol
Figure 3.10 - Mean basal phosphatidylinositol formation in cultured 79
aortic smooth muscle cells from 14 week SHR and WKY 
rats after different incubation times with [JH]-myoinositol
CHAPTER FOUR
Figure 4.1 - Mean arterial blood pressure in control and hypertensive 101
rabbits 1, 2 and 6 weeks after surgery
Figure 4.2 - Noradrenaline stimulated inositol phosphate formation in 102
aortic rings from hypertensive and control rabbits 1 week 
after surgery
(iv)
Page N°
Figure 4.3 - Noradrenaline (10"6M - 10“4M) stimulated inositol 103
phosphate formation in hypertensive and control rabbits 
2 weeks after surgery 
Figure 4.4 - Noradrenaline (10'^M - 10"^M) stimulated inositol 104
phosphate formation in hypertensive and control rabbits 
2 weeks after surgery 
Figure 4.5 - Noradrenaline stimulated inositol phosphate formation in 105
aortic rings from hypertensive and control rabbits 6 
weeks after surgery
Figure 4.6 - Endothelin-1 stimulated inositol phosphate formation in 106
aortic rings from hypertensive and control rabbits 2 
weeks after surgery
Figure 4.7 - Noradrenaline (10'4M) stimulated inositol phosphate 107
formation in femoral arteries from hypertensive and 
control rabbits 2 weeks after surgery 
Figure 4.8 - Electronmicrograph of cultured aortic smooth muscle 108
cells from perinephritis hypertensive rabbits 2 weeks 
after surgery
Figure 4.9 - Electronmicrograph of cultured aortic smooth muscle 109
cells from uninephrectomized control rabbits 2 weeks 
after surgery
Figure 4.10 - Noradrenaline stimulated inositol phosphate formation in 110 
cultured aortic smooth muscle cells from hypertensive 
and control rabbits 2 weeks after surgery 
Figure 4.11 - Endothelin-1 stimulated inositol phosphate formation in 111
cultured aortic smooth muscle cells from hypertensive 
and control rabbits 2 weeks after surgery
(v)
CHAPTER FIVE
Figure 5.1- Possible sites of independent regulation of noradrenaline 
and endothelin stimulated inositol phosphate formation 
Figure 5.2 - Effect of pertussis toxin preincubation on noradrenaline 
stimulated inositol phosphate formation in cultured aortic 
smooth muscle cells from 14 week SHR and WKY rats 
Figure 5.3 - Effect of pertussis toxin preincubation on endothelin-1
stimulated inositol phosphate formation in cultured aortic 
smooth muscle cells from 14 week SHR and WKY rats 
in 1 mM calcium solution 
Figure 5.4 - Effect of pertussis toxin preincubation on endothelin-1 
stimulated inositol phosphate formation in cultured 
aortic smooth muscle cells from 14 week SHR and WKY 
in zero calcium solution + 0.1 mM EGTA 
Figure 5.5 - Autoradiograph showing the effect of endothelin-1 on 
pertussis toxin dependent ADP-ribosylation in 
membranes prepared from cultured aortic smooth muscle 
cells from 14 week SHR and WKY rats
CHAPTER SIX
Figure 6.1 - Basal intracellular calcium concentration of cultured
aortic smooth muscle cells from 14 week SHR and WKY 
rats
Figure 6.2 - Free intracellular calcium concentration in primary
cultured endothelial cells from bovine aorta stimulated 
with ATP (10'7M)
(vi)
Page N° 
117
131
132
133
134
149
150
LIST OF TABLES Pa£e N°
CHAPTER TWO
Table 2.1 - Basal inositol phosphate formation in aortic rings from 6 46
week, 14 week and 40 weeks old SHR and WKY rats
CHAPTER THREE
Table 3.1 - Basal inositol phosphate formation and basal 80
phosphatidylinositol formation (after incubation with
0.5p.Ci [JH]-myoinositol) for endothelin-1 experiments in 
cultured aortic smooth muscle cells from 6 and 14 week 
SHR and WKY rats
Table 3.2 - Basal inositol phosphate formation and basal 81
phosphatidylinositol formation (after incubation with 
1.0|iCi [^H]-myoinositol) for noradrenaline experiments in 
cultured aortic smooth muscle cells from 6 and 14 week 
SHR and WKY rats
CHAPTER FOUR
Table 4.1 - Mean tissue sample weight of aorta per assay in 98
hypertensive and control rabbits 1, 2 and 6 weeks after 
surgery
Table 4.2 - Basal inositol phosphate formation in aortic rings from 99
hypertensive and control rabbits 1,2 and 6 weeks after 
surgery
Table 4.3 - Basal inositol phosphate formation and basal 100
phosphatidylinositol formation in cultured aortic smooth 
muscle cells from hypertensive and control rabbits 2 
weeks after surgery
(vii)
CHAPTER FIVE
Table 5.1 - Basal inositol phosphate formation (noradrenaline
experiments) ± pertussis toxin preincubation in cultured 
aortic smooth muscle cells from 14 week SHR and WKY 
rats
Table 5.2 - Basal inositol phosphate formation (endothelin-1
experiments) ± pertussis toxin preincubation in (a)l mM 
calcium solution and (b)zero calcium solution + 0.1 mM 
EGTA in cultured aortic smooth muscle cells from 14 
week SHR and WKY rats
Table 5.3 - The effect of preincubation with pertussis toxin (1.0(Xg /  
ml) on endothelin-1 stimulated inositol phosphate 
formation in cultured aortic smooth muscle cells from 14 
week SHR and WKY rats
PaeeN 0
128
129
130
(vlii)
SUMMARY
1. The effects of noradrenaline and endothelin-1 on the phosphatidylinositol cycle 
were investigated in 2 models of experimental hypertension, the spontaneously 
hypertensive rat (SHR) and the perinephritis hypertensive rabbit, at various stages 
during the development of hypertension. In both models freshly isolated aorta and 
cultured aortic smooth muscle cells were examined to ascertain the suitability of 
cultured aortic smooth muscle cells in this aspect of hypertension research. The 
coupling of endothelin-1 and noradrenaline to inositol phosphate formation via GTP- 
binding proteins was also investigated in cultured aortic smooth muscle cells from 
SHR.
2. In aortic rings from 6, 14, and 40 weeks old SHR basal inositol phosphate 
fo rm ation  was unchanged com pared  to W istar K yoto (W KY) ra ts . Both 
noradrenaline and endothelin-1 stim ulated inositol phosphate formation was 
unchanged in aortic rings from 6 week SHR. However at 14 and 40 weeks 
noradrenaline and endothelin-1 stim ulated inositol phosphate formation was 
decreased in aortic rings from SHR compared to WKY.
3. Basal inositol phosphate formation was increased in cultured aortic smooth 
muscle cells from 6 and 14 week SHR com pared to cells from WKY. Both 
noradrenaline and endothelin-1 stim ulated inositol phosphate formation was 
unchanged in cultured aortic smooth muscle cells from 6 week SHR. In cultured 
aortic smooth muscle cells from 14 week SHR noradrenaline stimulated inositol 
phosphate formation was increased while endothelin-1 stimulated inositol phosphate 
was decreased.
(ix)
4. In aortic rings from perinephritis hypertensive rabbits 1, 2 and 6 weeks after 
surgery  basal in osito l phosphate  form ation  was unchanged com pared  to 
uninephrectomized control rabbits. At 1 week after surgery noradrenaline stimulated 
inositol phosphate formation was unchanged in aortic rings from perinephritis 
hypertensive  rabb its . H ow ever, in aortic  rings from 2 w eek perin ep h ritis  
hypertensive rabbits noradrenaline stimulated inositol phosphate formation was 
increased but endothelin-1 stimulated inositol phosphate formation was similar to 
controls. Noradrenaline stimulated inositol phosphate formation was unchanged in 
aortic rings from 6 week perinephritis hypertensive rabbits. Cultured aortic smooth 
muscle cells were prepared from the aorta of perinephritis hypertensive rabbits 2 
weeks after surgery. Both noradrenaline and endothelin-1 stim ulated inositol 
phosphate formation was unchanged in these cells compared to smooth muscle cells 
from control rabbits.
5. The effects of pertussis toxin on noradrenaline and endothelin-1 stimulated 
inositol phosphate formation in cultured aortic smooth muscle cells from 14 week 
SHR and WKY rats was investigated. Noradrenaline stimulated inositol phosphate 
formation was unaffected by pertussis toxin preincubation. However, endothelin-1 
stimulated inositol phosphate formation was decreased by 50% in both SHR and 
WKY cells after preincubation with pertussis toxin. Therefore noradrenaline and 
endothelin-1 appear to be regulated independently at the level of the GTP-binding 
protein. Confirmation of endothelin-l’s ability to activate a pertussis toxin sensitive 
GTP-binding protein was obtained by measuring endothelin-l’s interaction with 
pertussis toxin dependent ADP-ribosylation in membranes prepared from cultured 
aortic smooth muscle cells. In the presence of endothelin-1 the pertussis toxin 
dependent ADP-ribosylation was decreased in both SHR and WKY membranes.
(x)
6. The free intracellular calcium concentration in cultured aortic smooth muscle cells 
from 14 week SHR grown on coverslips was unchanged compared to WKY cells as 
measured using fura 2.
7. A lterations in inosito l phosphate form ation occur in these 2 m odels of 
hypertension. The changes are agonist specific possibly due to independent 
regulation by GTP-binding proteins and are likely to depend on the system (i.e. fresh 
tissue or cultured cells), the model and the species studied.
(xi)
CHAPTER ONE
GENERAL INTRODUCTION
1
1. INTRODUCTION
1.1. Blood Vessels
1.1.1. Physiology of the Vasculature
The systemic and pulmonary circulation supply the tissues of the body with blood. 
The vascular system in each tissue has its own special characteristics but general 
principles of vascular function apply in all parts of the circulation. In the circulation 
their are various types of blood vessels: arteries, arterioles, capillaries, venules and 
veins. The function of these vessels (with the exception of capillaries) is to maintain 
a constant arterial pressure and regulate organ blood flow.
The heart pumps blood continually into the aorta and the pressure in the aorta is high 
fluctuating between a systolic pressure of 120mmHg and a diastolic pressure of 
80mmHg in a young normotensive adult. As the blood flows through the systemic 
circulation its pressure falls progressively. The decrease in arterial pressure in each 
segment of the circulation is directly proportional to the vascular resistance in that 
segment. The function of the arteries is to transport blood under high pressure to all 
the peripheral tissues. For this reason the large arteries have strong vascular walls. 
They are also elastic so that they can stretch and recoil as a pulse of blood enters and 
leaves the artery. The elastic nature of these arteries prevents the blood pressure 
rising extremely high when the blood is pumped into the arterial tree and also 
maintains a sufficient arterial pressure between heart beats.
Muscular arteries distribute blood between the organs. Included in this category are 
the resistance arteries (arteries less than 0.5mm in diameter) and the arterioles
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(which have a single layer of smooth muscle). These 2 types of muscular arteries are 
the main site of peripheral vascular resistance in the arterial system (Mulvany and 
Aalkjaer, 1990). The arterioles are the last small branches of the arterial system and 
they control the blood which is released into the capillaries. The arteriole has a 
strong muscular wall that is capable of closing the vessel completely or allowing it 
to be dilated several fold, thus having the capability of vastly altering the blood flow 
to the capillaries.
The function of the capillaries is to exchange fluid, nutrients, electrolytes, hormones 
and other substances between the blood and the interstitial spaces. The capillary 
walls are of necessity very thin (less than lp m ) and are perm eable to small 
molecular substances. The venules collect blood from the capillaries and gradually 
coalesce into progressively bigger veins. The veins function as conduits for transport 
of the blood from the tissues back to the heart.
1.1.2. Structure of Blood Vessels
Arteries are divided into several different types. The largest arteries such as the aorta 
are elastic in nature whereas other major arteries and small arteries are muscular 
arteries. In all of these vessels the wall can be divided into three major components: 
intima, media and adventitia.
The intima consists of luminal lining of endothelial cells with a basal lamina and a 
subendothelial layer of connective tissue. The endothelial cells are joined by tight 
junctions and, along with the basal lamina, serve as a barrier to the passage of 
substances. However transendothelial transport does occur through several 
mechanisms e.g. pinocytotic vesicles.
The media of arteries is the thickest of the three layers. It consists of layers of
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smooth muscle cells surrounded by collagenous and elastic fibres. These fibres are 
produced by the smooth muscle cells themselves and comprise the extracellular 
matrix.
The adventitia  is a connective tissue layer. The main com ponent o f this is 
collagenous fibres which aid in preventing the expansion of the arterial wall beyond 
physiological limits during systole. The adventitia also contains blood vessels and 
nerves, branches of which enter the media to supply the blood vessel wall. The blood 
vessels supply only the outer part of the arterial wall with the inner part being 
supplied from the lumen of the vessel.
1.2. Regulation of Arterial Blood Pressure
There are two main mechanisms for control of blood pressure; alterations in total 
peripheral resistance and alterations in volume homeostasis. Both these mechanisms 
can be regulated by neural input (predominantly the sympathetic nervous system) 
and by humoral factors such as the vasoconstrictor agents noradrenaline, angiotensin 
II and endothelin.
1.2.1. The Sympathetic Nervous System
The walls of the arteries and arterioles contain smooth muscle, the activity of which 
is controlled by the sympathetic nervous system and by various humoral factors. 
Vascular smooth muscle has a basal tone. Vascular contractility can be controlled by 
excitation or inhibition of the sympathetic nerves. The sympathetic system is not 
regulated by a single mechanism but by several inter-related mechanisms that 
perform different functions. One such system is the baroreceptor reflex. This reflex 
is initiated by stretch receptors located in the walls of large arteries and particularly
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in the aortic arch. If these receptors are stimulated by increased stretch as a result of 
increased blood pressure, they cause a decrease in sympathetic nerve activity 
creating vasodilation throughout the peripheral circulation and consequently a 
decrease in arterial pressure. Conversely, low pressure has the opposite effect 
leading to a rise in arterial pressure back to normal.
The baroreceptors are just one of the pressure control systems which w ill be 
activated within a few seconds of a change in arterial pressure and cause stimulation 
or inhibition of the sympathetic system. The sympathetic nervous system not only 
causes direct neural excitation of the blood vessels but also causes release of 
noradrenaline and adrenaline from the adrenal medullae into the circulating blood. 
These two hormones circulate to all parts of the body and cause essentially the same 
effects in controlling arterial pressure as direct sympathetic stimulation.
1.2.2. The Renin Angiotensin System
Whenever the arterial pressure falls very low blood flow through the kidneys is 
consequently reduced. A decrease in renal blood flow or pressure causes the 
juxtaglomerular cells in the kidney to secrete an enzyme, renin, into the blood. Renin 
brings about the breakdown of a peptide angiotensinogen to angiotensin I which is 
further cleaved by angiotensin converting enzyme to form an active octapeptide, 
angiotensin II. Angiotensin II has a half life of 1 minute and is rapidly inactivated by 
blood and tissue enzymes.
A ng io tensin  II has severa l e ffec ts  w hich can e lev a te  a rte ria l p ressu re  
Vasoconstriction, especially of the arterioles, occurs very rapidly. This increases 
total peripheral resistance and thereby raises blood pressure. Importantly, in the case 
of blood pressure regulation, renin-like activity and angiotensin have been 
demonstrated in the aorta, renal carotid, and mesenteric arteries (Dzau, 1987).
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Angiotensin II produced locally in the vascular smooth muscle cells may induce 
vasoconstriction by activating angiotensin receptors on the cells or enhance 
noradrenaline release from sympathetic nerve endings in blood vessels as suggested 
by Dzau (1987).
The other effects of angiotensin are mainly related to the body fluid mechanisms and 
are important factors in the long-term regulation of arterial pressure. Angiotensin II 
causes the adrenal glands to secrete aldosterone. The most important function of 
aldosterone, with respect to blood pressure control, is to produce a marked increase 
in sodium reabsorption by the kidney tubules, thus increasing the extracellular 
sodium  concen tration . This increases w ater re ten tion  leading  to increased  
extracellular fluid and a long-term elevation of the arterial blood pressure.
1.2.3. Endothelin
Another group of peptides which may be of great physiological importance in 
regulating blood pressure has only recently been isolated (Yanagisawa et al, 1988). 
This is the endothelin family. They are found in at least three distinct isoforms, 
endothelin-1, endothelin-2 and endothelin-3, and all are twenty one amino acid 
peptides with two disulphide bonds (Itoh et al, 1988). All these peptides have a high 
structural similarity with cardiotoxic peptides, the sarafotoxins, which are derived 
from snake venom (Kloog et al, 1988). Endothelin-1 has been shown to be 
synthesized and released by endothelial cells in the vascular tree (Kohno et al, 
1990a) whereas sites for endothelin-2 and endothelin-3 synthesis are uncertain.
Endothelin-1 is one of the most potent vasoconstrictors known to date, particularly 
in the renal, mesenteric and pulmonary vasculature (Miller et al, 1989; Lippton et al, 
1988; King et al, 1989). As endothelin-1 increases renal vascular resistance it
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consequently lowers renal blood flow and increases plasma renin activity (Miller et 
al, 1989).
Despite these effects described, no physiological role has yet been assigned to 
endothelin-1. It has been suggested that endothelin-1 may have a potential role in the 
volume homeostasis and regulation of vascular resistance (Rubanyi, 1989). Because 
of its sustained action endothelin-1 is unlikely to play a direct part in the short term 
regulation of regional blood flow that meet the rapid fluctuation in metabolic activity 
of most tissues. However, the continuous release of small amounts of endothelin-1 
from endothelial cells toward the underlying smooth muscle could contribute to the 
maintenance of vascular tone. Evidence for this is provided by the detection of low 
levels of circulating endothelin-1 in human plasma (Suzuki et al, 1989).
1.3. Vascular Smooth Muscle
1.3.1. Contraction of Vascular Smooth Muscle Cells.
The ultrastructure of the smooth muscle cell is typified by a densely packed array of 
longitudinally orientated thin filaments (consisting of actin and tropomysin) and 
myosin-containing thick filaments. The cell also has a surrounding basement 
membrane and is spindle shaped ranging between 100 - 200 fim in length. Myosin 
thick filaments are composed of two heavy chain subunits and two sets of light chain 
subunits (Hathaway et al, 1991). Myosin is configured as an intertwined coiled tail 
region and two globular head regions that protrude from the thick filaments at 
regular intervals to form cross bridges. These head regions contain distinct sites for 
the binding of actin and for adenosine trisphosphate (ATP) hydrolysis. The 
mechanism of activation of contractile proteins in vascular smooth muscle starts 
with the binding of calcium to the regulator protein calmodulin. This induces a 
conformational change in the calmodulin molecule forming a calcium calmodulin
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complex. This complex interacts with an inactive enzyme, myosin light chain kinase, 
to form an active complex which phosphorylates the myosin light chain of the 
myosin head region. This enables myosin ATPase to activate actin resulting in cross­
bridge formation and contraction. Following sequestration or extrusion of calcium 
(Twort and van Breeman, 1988) the resulting reduction in free calcium concentration 
dissociates calmodulin from myosin light chain kinase regenerating the inactive 
enzyme. Dephosphorylation then occurs and the muscle relaxes (Kamm and Stull, 
1985). Although calcium appears to be the physiological initiator of the contractile 
response (Itoh et al, 1989) phosphorylation of myosin light chain kinase by other 
mechanisms is sufficient to induce contraction and may be particularly important 
during the latter part of a sustained contraction. Evidence is now emerging that part 
of the contraction can be regulated under certain circumstances through calcium - 
independent phosphorylation of myosin light chain kinase by several protein kinase 
enzymes such as protein kinase C (Nishikawa et al, 1985).
1.3.2. Regulation of Intracellular Calcium
The contraction-relaxation cycle in vascular smooth muscle is regulated primarily by 
changes in free calcium concentration. An increase in the cytosolic calcium  
concentration can be produced either by influx of calcium across the smooth muscle 
cell membrane or by a release of calcium from intracellular stores, mainly the 
sarcoplasmic reticulum (Bolton, 1979). There would appear to be three main 
mechanisms by which intracellular calcium can be increased. These are: 
voltage-dependent calcium influx 
receptor-operated calcium influx 
receptor-operated intracellular calcium release.
Voltage-dependent calcium influx occurs during sustained depolarization of the
membrane. Receptor-operated calcium influx is activated by the interaction of agonists 
with specific receptors to directly increase calcium influx through calcium channels. 
Such interaction may also result in an increase in membrane sodium permeability 
resulting in membrane depolarization and an increase in voltage-dependent influx of 
calcium (Bolton, 1979). Receptor-operated intracellular calcium release occurs via 
agonist induced receptor activation which leads via intracellular second messenger 
systems to release of calcium from the sarcoplasmic reticulum (Bolton, 1979).
1.4. Control of Contraction by Second Messengers
Intracellular calcium is released from the sarcoplasmic reticulum of vascular smooth 
muscle cells by the binding of inositol 1,4,5-trisphosphate to specific receptors on 
the membrane of the sarcoplasmic reticulum (Somlyo et al, 1985). Inositol 1,4,5- 
trisphosphate is one of the products generated by receptor activation o f the 
phosphatidylinositol cycle.
1.4.1. Phosphatidylinositol Cycle
Figure 1.1 shows a diagrammatic representation of the phosphatidylinositol cycle. 
The initial event following the binding of agonists to their specific receptors in the 
plasma membrane involves a receptor-mediated activation of a transducing guanine 
nucleotide binding protein (G-protein) (Kobayashi et al, 1988). This G-protein 
induces the activation of a family of phosphodiesterase enzymes, phospholipase C, 
which catalyses the breakdown of the phosphoinositide lipids, most notably 
phosphatidylinositol 4,5-bisphosphate. This produces inositol phosphates, most 
importantly inositol 1,4,5-trisphosphate, and 1,2-diacylglycerol. The inositol 1,4,5- 
trisphosphate can now bind to specific receptors on the sarcoplasmic reticulum 
releasing calcium thereby increasing the free intracellular calcium concentration and
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initiating contraction of the smooth muscle. Inositol 1,4,5-trisphosphate can also be 
further phosphorylated to inositol 1,3,4,5-tetrakisphosphate. Inositol 1,4,5- 
trisphosphate is dephosphorylated in a stepwise manner by a series of phosphatase 
enzymes being broken down first to inositol 1,4-bisphosphate, then to inositol 1- 
phosphate and finally to myo-inositol. The inositol 1,3,4,5-tetrakisphosphate is 
dephosphorylated to inositol 1,3,4-trisphosphate and again in a step wise manner to 
myo-inositol. The free myo-inositol can now re-enter the cycle and facilitate the 
formation of the phosphatidylinositol lipids. As shown in figure 1.1 the myo-inositol 
and phosphatidic acid (formed by the phosphorylation of 1,2-diacylglycerol) can 
resynthesize phosphatidylinosito l via a high energy in term ediate, cytid ine 
d ip h o sp h a te -d iacy lg ly ce ro l. P h o sp h a tid y lin o s ito l 4 -p h o sp h a te  and 
phosphatidylinositol 4,5-bisphosphate are synthesized from phosphatidylinositol by 
specific kinases that phosphorylate the 4- and 5-positions of phosphatidylinositol 
and phosphatidylinositol 4-phosphate respectively. Thus the phospholipids can again 
be broken down by phospholipase C. Phospholipids are continually being broken 
down by phospholipase C in the basal cycling of this system that occurs in the cell. 
Agonist stimulation of the phosphatidylinositol cycle therefore does not activate 
phospholipase C per se but serves to enhance phospholipase C activity and increase 
phospholipid breakdown.
The phosphatidylinositol cycle is a ubiquitous system and many different agonists 
and hormones can activate this cycle via receptors e.g. noradrenaline, angiotensin II, 
serotonin and endothelin to name but a few.
The various parts of this cycle and their function shall now be discussed in greater 
detail.
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FIGURE 1.1: ABBREVIATIONS
PLC - phospholipase C
PI(1,4,5)P2 - phosphatidylinositol 4,5-bisphosphate
PI(4)P - phosphatidylinositol 4-monophosphate
PI - phosphatidylinositol
I(1,4 ,5)P3 - inositol 1,4,5-trisphosphate
I(1,4)P2 - inositol 1,4-bisphosphate
1(1 )P - inositol 1-monophosphate
I(1,3 ,4 ,5)P4 - inositol 1,3,4,5-tetrakisphosphate
I(1,3,4)P3 - inositol 1,3,4-trisphosphate
DAG - 1,2-diacylglycerol
ATP - adenosine triphosphate
PA - phosphatidic acid
CTP - cytidine triphosphate
CDP-DAG - cytidine diphosphate-diacylglycerol
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1.4.2. Phosphatidylinositol Lipids
Phosphatidylinositol accounts for up to about 10% of membrane phospholipids and 
is widely distributed amongst different cellular membranes. Phosphatidylinositol 4- 
phosphate and phosphatidylinositol 4,5-bisphosphate each account for between 1% 
and 4% of the cellular inositol phospholipid pool. Their precise concentrations in 
cells are determined by the balance between the rates of the kinase reactions and the 
activities of the phosphatases that specifically remove their phosphate groups 
(Irvine, 1982). The occurrence of the polyphosphatidylinositols is distinctly more 
localised than phosphatidylinositol itself. They have generally been considered to be 
plasma membrane constituents (Downes and Michell, 1982). A discrete pool of 
polyphosphatidylinositols in erythrocyte membrane has been observed by King et al 
(1987) however definite subcellular localization data are still lacking.
Phospholipase C has affinity for phosphatidylinositol, phosphatidylinositol 4- 
bisphosphate and phosphatidylinositol 4,5-bisphosphate and can under certain 
conditions hydrolyze all of these lipids (Irvine et al, 1984). Phosphatidylinositol 4,5- 
bisphosphate breakdown occurs rapidly and is usually detectable within about 5 
seconds after the initiation of receptor activation (Michell et al, 1981). In general, 
within about 1 minute the phosphatidylinositol 4,5-bisphosphate concentration will 
have decreased by 50%-80% of the control value. This level, at any one time, 
reflects the relative activities of phospholipase C and the kinase/phosphatase 
activities that determine phosphatidylinositol 4,5-bisphosphate concentration in the 
cell. The rapid breakdown of phosphatidylinositol 4,5-bisphosphate is usually, but 
not always, accompanied by the disappearance of phosphatidylinositol 4-phosphate 
(Creba et al, 1983). No detectable fall in phosphatidylinositol is generally observed 
until a few minutes of exposure to agonist (Kirk et al, 1983).
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1.4.3. Phospholipase C
Phospholipase C enzymes are a heterogenous group of proteins that can be 
distinguished by immunological techniques, by subcellular distribution and by their 
physicochemical properties such as molecular weight (Kamisaka et al, 1986; Rhee et 
al, 1989; Low et al, 1984). This analyses suggests the existence of at least nine 
distinct phospholipase C isoenzymes (Wahl and Carpenter, 1991). It is unlikely that 
all of these isoenzymes are present in vascular smooth muscle though several of 
them may be expressed. A possibility therefore is that distinct classes of agonist 
receptors on the cell membrane in teract only with specific phospholipase C 
isoenzymes.
It is now apparent that both cytosolic and membrane-associated phospholipase C 
isoenzymes occur in cells. In recent years it has also become apparent that it the 
membrane-associated phospholipase C enzymes which are involved in mediating 
receptor regulation of phosphatidylinositol hydrolysis. Membrane phospholipase C 
appears to be a calcium  dependent enzym e in that recep to r stim ulation  of 
phospho lipase  C occurs w ith res tin g  levels of calcium  w ith in  the norm al 
physiological range but is inhibited by chelation of calcium (Cockcroft, 1986). It has 
been suggested by several authors that agonist receptor occupancy or activation of 
G -proteins may convert the membrane phospholipase C from a form that is 
insensitive to resting cytoplasmic calcium to a form that is active at low calcium 
concentrations (Lucas et al, 1985; Smith et al, 1986). Studies of membrane 
phospholipase C activation indicate that the enzyme can also be activated by calcium 
alone and this may act as a positive feedback mechanism (Finch et al, 1991).
Although cytosolic phospholipase C has been detected the role of these isoenzymes 
has yet to be elucidated. It is possible that in situ there are only membrane-associated 
forms of the enzyme and that these are easily dislodged from the membrane upon
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tissue homogenisation (Martin, 1989). However, if there are distinct membrane and 
cytosolic forms of phospholipase C, they may represent different isoenzymes and 
may, as already suggested, serve distinct roles in signal transduction in the cell.
1.4.4. Inositol Phosphates
Upon agonist stimulation inositol 1,4,5-trisphosphate levels increase within 1-5 
seconds (Downes and Wusteman, 1983) reaching a peak a few seconds later. Inositol
1,4,5-trisphosphate binds to a receptor on a non-m itochondrial in tracellu lar 
membrane with the result that a calcium pore opens to release calcium into the 
cytosol. In smooth muscle this membrane is probably the sarcoplasmic reticulum 
(Somlyo et al, 1985). However, Volpe et al (1988) have recently proposed that a 
specific organelle, the calciosome (a small membrane vesicle with some properties 
charac te ris tics  of the sarcoplasm ic re ticu lum ) as a target of inosito l 1,4,5- 
trisphosphate. To release calcium, inositol 1,4,5-trisphosphate must bind to receptors 
that are linked to calcium channels connected with the calcium store. Individual 
inositol 1,4,5-trisphosphate sensitive calcium channel conductances have been 
recorded from membrane vesicles isolated from the sarcoplasmic reticulum of aortic 
sm ooth m uscle (E hrlich  and W atras, 1988). The action  o f ino sito l 1,4,5- 
trisphosphate seems highly co-operative as 3 molecules are required to open the 
calcium channel (Meyer et al, 1988) which may explain the latencies that exist when 
cells are stimulated with calcium mobilizing agonists (Berridge et al, 1988).
Of the other inositol phosphates produced by the phosphatidylinositol cycle two 
have been implicated as having possible second messenger functions, inositol 1,3,4- 
trisphosphate and inositol 1,3,4,5-tetrakisphosphate.
Inosito l 1 ,3 ,4-trisphosphate  has slow rates of form ation and rem oval after
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stimulation which suggests that if it has a function as a second messenger it would 
have to be over a comparatively long time scale. Such a function has not yet been 
ascribed to this molecule.
Rapid synthesis and degradation of inositol 1,3,4,5-tetrakisphosphate in stimulated 
tissues and the specificity of its kinase and phosphatase enzymes (Irvine et al, 1986; 
Batty et al, 1985) has led to the proposal that inositol 1,3,4,5-tetrakisphosphate may 
have a role as an intracellular second messenger. However, microinjections or direct 
applications to cell preparations have produced little effect (Irvine and Moor, 1986). 
Irvine and Moor (1986) have suggested that inositol 1,3,4,5-tetrakisphosphate may 
stimulate calcium entry from the extracellular medium.
Intracellular calcium mobilization is a short lived phenomenon (usually less than 1 
minute) because the intracellular stores are limited. After the initial calcium increase 
there is a prolonged stimulated influx (Merrit and Rink, 1987). Suzuki et al (1985) 
have shown that a diffusible second messenger is involved in calcium entry and, as 
this does not appear to be calcium itself, the most likely candidates are the inositol 
phosphates. It has been suggested by Putney (1986) that there is a calcium pool 
mobilized by inositol 1,4,5-trisphosphate that can be refilled directly from outside 
the cell without increasing cytosolic calcium during the refilling process. It has been 
proposed that inositol 1,3,4,5-tetrakisphosphate may function primarily to control 
the influx of calcium and therefore control the calcium content of the store that 
inositol 1,4,5-trisphosphate mobilizes. Another possibility is that inositol 1,4,5- 
trisphosphate only mobilizes calcium from a discrete organelle, e.g. the calciosome, 
and that inositol 1,3,4,5-tetrakisphosphate controls transfer of calcium to this 
organelle from the sarcoplasmic reticulum (Irvine, 1989).
One inositol phosphate not yet mentioned is the cyclic molecule, inositol (l:2-cyclic)
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4,5-trisphosphate. This inositol phosphate is produced in vitro by phospholipase C 
(Majerus et al, 1986). It appears to have calcium mobilizing properties and is 
metabolized slowly. It may therefore act as a more stable form of inositol 1,4,5- 
trisphosphate for longer term effects. Other authors believe that cyclic inositol 
phosphates may be an artifact of isolation.
1.4.5. 1,2-Diacyl glycerol and Protein Kinase C
1.2-D iacylglycerol is one of the products o f the phospholipase C associated 
hydrolysis of the phosphatidylinositols and its main property is to stimulate protein 
kinase C (Nishizuka, 1986). Protein kinase C is a family of proteins and recent work 
has identified at least 3 distinct genes encoding for protein kinase C isoenzymes 
(Housey et al, 1987). Stimulation of protein kinase C by phorbol esters (which 
mimic the effect of 1,2-diacylglycerol on protein kinase C) has been shown to 
trigger contraction in vascular smooth muscle (Rasm ussen et al, 1984). The 
contractions have been shown to be characteristically slow and delayed. Danthuluri 
and Deth (1986) suggested that 1,2-diacylglycerol is essential for maintaining the 
sustained, tonic phase of vascular contractions since agonists that produce phasic, 
transient contractions in some vessels typically evoke a transient rise in 1,2 - 
diacylglycerol within the cell, while agonists that produce a sustained increase in
1.2-diacylglycerol similarly evoke a sustained development of tension.
Although the importance of protein kinase C in vascular smooth muscle contraction 
has been demonstrated, i.e. the phosphorylation of myosin light chain kinase, other 
cellular substrates for this enzyme have not yet been identified.
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1.4.6. Effect of Lithium
Lithium has been shown to prevent the breakdown of inositol 1-phosphate to free 
myo-inositol by inhibition of the enzyme inositol monophosphatase (Naccarato et al, 
1974). The usefulness of lithium as a pharmacological tool was demonstrated by 
Berridge et al (1983) who produced a relatively simple method for the study of the 
phosphatidylinosito l cycle. They used ^H -m yoinosito l to label the inosito l 
phosphates, all of which are confined to this cycle, and lithium to prevent the 
degradation of the inositol phosphates. The water soluble inositol phosphates and 
the chloroform soluble inositol phospholipids can then be separated by solvent 
partition and the inositol phosphates isolated by use of an anion-exchange resin. 
Therefore it is possible to stimulate a tissue with an agonist and measure the amount 
of inositol phosphates produced in that tissue.
1.5. Receptor-Effector Coupling
1.5.1. Activation of G-proteins
Guanine nucleotide binding proteins (G-proteins) are a family of proteins that serve 
as m em brane-bound transducers of recep to r -effec to r coupling. They are 
heterotrimers consisting of a , p and T subunits in decreasing order of mass. The a  
subunits differ among different G-proteins and are responsible for their specificity of 
action. Different a  subunits associate with a common pool of PT dimers. Many 
hormones and neurotransmitters that regulate intracellular interactions elicit cellular 
responses by combining with specific receptors that are coupled to effector functions 
by G-proteins. The cycle of activation and deactivation of G-proteins is shown in 
figure 1.2 .
It is now accepted that the role of the receptor (in the case of G-protein linked 
receptors) is merely to catalyse the activation of the G-protein. It causes the a
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FIGURE 1.2: Regulatory system of a G-protein
Squares represent inactive conformations and circles 
and semicircles represent active forms of the G-protein.
Adapted from Bimbaumer and Brown (1990)
19
subunit of the intact ocp7 trimer to bind guanosine triphosphate (GTP). Activation is 
both GTP and magnesium dependent. Upon binding GTP the G-protein changes 
conformation which gives the a subunit low affinity for the P7 subunit and this leads 
to dissociation of the a from the P7 subunit. The a  subunit may then interact with 
the effector mechanism. The GTP on the a subunit is then hydrolyzed by the 
G TPase activ ity  of this subunit w hich leads to ano ther change in p ro te in  
conformation. This change increases the affinity of the a subunit for the p7 subunits 
and a re-association of the ap7 heterotrimer occurs to give an inactive G-protein 
bound to guanosine diphosphate. Re-initiation of the system by receptors requires 
the release of guanosine diphosphate and renewed binding of GTP. Thus, an effector 
interacts only with the monomeric a-GTP complex and the receptor interacts only 
with the trimeric ap7 form (Bimbaumer and Brown, 1990).
1.5.2. Effect of Cholera and Pertussis Toxin
Many G-proteins are the targets of 2 bacterial toxins: cholera toxin and pertussis 
toxin. These toxins are enzymes that covalently modify specific a  subunits by 
transferring the adenosine diphosphate (ADP)-ribose moiety from nicotinamide 
adenine dinucleotide (NAD) onto an arginine (in the case of cholera toxin) or 
cysteine (in the case of pertussis toxin) residue on the a  subunit (Shere et al, 1987). 
Cholera toxin ADP-ribosylates specific G-proteins and inhibits the GTPase activity 
of the a  subunit. This prevents hydrolysis of GTP leaving the G-protein irreversibly 
activated. Pertussis toxin ADP-ribosylates the a  subunit and prevents the binding of 
GTP. The a  subunit therefore remains inactivated and a blockade of the receptor- 
effector coupling occurs. Pertussis toxin ADP-ribosylates a wider spectrum of G- 
proteins than cholera toxin. These include Gj (involved in adenylate cyclase 
inhibition), GD (activator of phospholipase C), G^ (stimulates potassium channels)
r
and several others. Because of their specificity and effect on G-protein function 
pertussis and cholera toxin are powerful tools to investigate the involvement of G-
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proteins in cellular responses. G-protein function can also be altered by a fluoro- 
aluminate complex [AIF4 ]". This complex is thought to activate G-proteins by 
causing dissociation of the a  subunit from the |5Ysubunits.
1.5.3. Coupling of Receptor Binding to Phospholipase C activation 
The finding that non-hydrolyzable GTP analogues stimulated basal phospholipase C 
activity (Cockcroft and Gomperts, 1985) and promoted agonist activation of 
phospholipase C in membranes (Litosch et al, 1985) implicated the involvement of 
G-proteins in the phosphatidylinositol cycle. In particular, in smooth muscle a non- 
hydrolyzable GTP analogue has been shown to stimulate phosphatidylinositol 4,5- 
bisphosphate breakdown (Sasaguri et al, 1985) and to release calcium and trigger 
contraction (Kobayashi et al, 1988). Also [AIF4]" can cause contraction (Kobayashi 
et al, 1988) and phosphatidylinositol hydrolysis (Blackmore et al, 1985) implicating 
further the involvement of G-proteins. Subsequent studies have shown that at least 2 
distinct phospholipase C associated G-proteins exist, a pertussis toxin sensitive and a 
pertussis toxin insensitive G-protein. The characteristics of these G-proteins appears 
to differ depending on the cell type and receptor type studied. Even within vascular 
smooth muscle differences in G-proteins are observed. In rat tail artery segments a 
non-hydrolyzable GTP analogue and [AIF4]" stim ulated inositol phosphate 
formation as did noradrenaline. However noradrenaline responses were insensitive 
to pertussis toxin (LaBelle and Murray, 1990). In contrast, Reynolds et al (1989) 
have shown that endothelin -1 - stim ulated inositol phosphate formation was 
partially inhibited by pertussis toxin in cultured vascular smooth cells from renal 
artery. However, in a neonatal rat vascular smooth muscle cell line (Mitsuhashi et al, 
1989) and in A10 cells (rat aortic smooth muscle cell line)(Takuwa et al, 1990) 
endothelin stimulated inositol phosphate formation was unaffected by pertussis 
toxin. Thus, although the identity of the phospholipase C associated G-proteins
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remain to be established, data suggest that at least 2 different G-proteins may be 
involved in a cell- and/or receptor-specific manner.
1.6. Hypertension
Abnormalities in the phosphatidylinositol cycle have been implicated in a number of 
disease states, such as depressive illnesses (Berridge, 1989) and recently alterations 
in phosphatidylinositol metabolism have been proposed to occur in cardiovascular 
diseases, particularly hypertension.
1.6.1. General Pathophysiology
Hypertension is a disease state where the mean arterial pressure is considered to be 
greater than normal. This can range from mild hypertension where blood pressure is 
only slightly elevated (diastolic pressure of 90mmHg) to severe hypertension 
(diastolic pressure of above 130mmHg). The effect of this sustained blood pressure 
increase is to increase the work load on the heart. This can lead to ischemia of the 
left ventricle. Ischaemia, angina and atherosclerosis are greatly exacerbated by 
hypertension. Hypertension causes cardiac and vascular hypertrophy although these 
are long term effects. Ischaem ia and haem orrhaging may be produced by 
hypertension but this is rare now because blood pressure can norm ally be 
pharmacologically controlled. The incidence of hypertension in Britain is high, 
especially in the West of Scotland. In a study of a town in the West of Scotland 21% 
of subjects (ages 45 - 64) had at some time been considered to have hypertension 
(Hawthorne et al, 1974)
There are two main types of this disease: essential hypertension and secondary 
hypertension. Both of these are characterized by an increase in peripheral vascular 
resistance however the cause of this varies with the type of hypertension.
22
1.6.2. Characteristics of Essential Hypertension
Essential hypertension is the most common form of hypertension in man. However 
the causes of this disease are not known though it is becoming clear that essential 
hypertension is a condition of multifactorial aetiology. Factors such as genetic 
predisposition and various environmental circumstances, such as salt intake, are all 
likely to be involved. How these factors lead to a sustained rise in blood pressure, 
however has not been elucidated. There is a large body of evidence indicating that in 
established essential hypertension, despite an increased work load on the heart, 
cardiac output is normal. Also humoral factors such as plasma renin and plasma 
noradrenaline are unaltered in the majority of patients with established essential 
hypertension.
Several genetic animal models of essential hypertension have now been developed 
for use in hypertension research. The most widely used of these models is the 
spontaneously hypertensive rat (SHR) (Yamori, 1984) although others such as stroke 
prone SHR, Lyon hypertensive rat and the Milan hypertensive rat have also been 
examined to a lesser extent. In the SHR, as in most forms of hypertension both 
essential and secondary, there are 2 distinct phases. The first relates to the initial 
underlying disorder, unknown in essential hypertension, which would lead to an 
increased total peripheral resistance. The second established phase is due to an 
increase in the size of the medial layer of arteries. This results in a decrease in the 
internal diameter of the vessel and leads to a stable elevated pressure.
1.6.3. Thickening of the Blood Vessel Wall
The increase in the medial layer thickness is thought to be due to hypertrophy and 
hyperplasia of the smooth muscle cells. Hypertrophy is an increase in smooth muscle 
cell size and hyperplasia is an increase in cell number. Hyperploidy, which is an
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increase in the DNA content of cells due to a failure of cells that have completed 
mitosis to divide, has also been observed. Measurements of the pressures in vessels 
from aorta through to the capillaries in SHR suggest that these abnormalities is 
found mainly in the small arteries as well as the arterioles (Zweiflach et al, 1981). As 
already mentioned the small arteries and arterioles contribute most to the total 
peripheral resistance of the vasculature under normal conditions and so a small 
reduction in the internal diameter of these vessels could have a greater effect on 
blood pressure as a whole. In essential hypertensive patients evidence for a structural 
alteration in the resistance vessels is provided by experim ents indicating an 
increased resistance of the hypertensive vasculature to blood flow (Folkow, 1956). 
Also small arteries from essential hypertensive patients obtained from subcutaneous 
biopsies displayed an increase in thickness of the media to lumen diameter (Aalkjaer 
et al, 1987). Mulvany et al (1980) demonstrated that medial hypertrophy occurred in 
arteries from SHR at 12 weeks and 24 weeks old but not at 6 weeks old though 
blood pressure was already elevated at this early stage. Thus the medial hypertrophy 
would appear to be the result of the increased pressure but did not precede blood 
pressure elevation. It is believed that in essential hypertension an initiating factor 
increases blood pressure before any structural alteration in the blood vessels occurs.
1.7. Potential Factors Involved in the Pathogenesis of Essential Hypertension
Many factors have been identified as having a potential role in the pathogenesis of 
hypertension. However, whether a particular factor is important in the hypertensive 
process or is merely a secondary change occurring as a result of primary alterations 
is hard to establish, and most published studies do not distinguish between cause and 
effect.
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1.7.1. Sympathetic Nervous System
Some authors have suggested that increased sympathetic nerve activity may be a 
feature of essential hypertension. There are indications that sympathetic activity is 
increased in SHR (Judy et al, 1979). In some vascular beds of SHR an enhanced 
noradrenaline content has been demonstrated as well as an increased nerve density. 
This increased innervation of vascular tissue in SHR was evident between 2 and 5 
weeks of age before the rise in blood pressure (Donohue et al, 1988). Westfall et al 
(1987) has shown a greater release of JH-noradrenaline in SHR perfused mesenteric 
arteries after nerve stim ulation. Based on results of studies conducted with 
normotensive animals, in which it was demonstrated that sympathetic nerve function 
may regulate blood vessel medial change (Bevan, 1975), it has been proposed that 
altered sympathetic activity or hyperinnervation in the SHR may induce an increased 
rate of vascular smooth muscle cell proliferation (Lee, 1985). If this is the case, an 
increased sympathetic nervous activity could firstly increase blood pressure by 
increasing total peripheral resistance and secondly initiate the second stage of 
hypertension, thickening of the blood vessel wall.
Two possible mechanisms for this alteration in the sympathetic nervous system are 
adaptive changes in the arterial baroreceptors or neurochemical changes in the 
central nervous system ’s sympathetic centre. In vitro studies have shown that 
baroreceptors in the SHR are reset to a higher pressure threshold allowing blood 
pressure to increase to greater levels before displaying an inhibitory control (Sapru 
and Wang, 1976). If the initial alteration was a decrease in baroreceptor reflex 
control then the inhibitory effect on the sympathetic nervous system would be 
prevented allowing an increase in sympathetic activity. Judy and Farrel (1979) 
demonstrated that a functional loss of baroreceptor reflex does occur in the SHR but 
not until after the phase of rapid blood pressure development. Thus, baroreceptor
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dysfunction cannot be the causative factor for the development of hypertension, 
although it may one of the factors responsible for the maintenance of elevated blood 
pressure in the SHR. Judy and Farrel concluded that the central sympathetic centre 
was the causative factor in the increased sympathetic activity of the SHR.
Alterations in sympathetic nerve activity in human essential hypertension have not 
been as easy to detect. A commonly used indicator of sympathetic activity is the 
plasma noradrenaline concentration. However, since many pathophysiological 
factors can influence plasma noradrenaline levels (Goldstein, 1983), the validity of 
these observations as reflecting sympathetic nerve activity remains an open question. 
Of the many studies of this aspect of essential hypertension it appears that there are 2 
distinct subgroups of hypertensive patients. One subgroup (between 30%-50% of the 
hypertensive population) have significantly elevated plasma noradrenaline levels 
with the other subgroup having normal noradrenaline levels ( de Champlain et al, 
1977; Reid et al, 1977). Further evidence for increased sympathetic activity was 
provided by A alkjaer et al (1989). They dem onstrated that the blockade of 
noradrenaline uptake by cocaine led to an increased arterial responsiveness to 
noradrenaline in subcutaneous small arteries from essential hypertensive patients. 
This would be consistent with increased innervation and an increased uptake in 
essential hypertension. It would appear that the sympathetic nervous system is 
altered in SHR and at least in some cases of essential hypertension.
1.7.2. Endothelin-1
Vasoconstrictor agents have a role in controlling blood pressure. If there is an 
alteration in the level of one of these agents this could affect overall blood pressure. 
Authors have attempted to ascribe a physiological role for the recently discovered 
vasoconstrictor, endothelin-1. However, even more emphasis has been placed on its 
potential role in cardiovascular diseases. In 2 studies the mean level of plasma
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immunoreactive endothelin-1 as measured by radioimmunoassay was increased in 
patients with essential hypertension compared to normotensive controls (Saito et al, 
1990; Kohno et al, 1990b). Miyauchi et al (1989b), however, failed to show any 
change in plasma endothelin-1 concentration in either young adult or middle aged 
hypertensives. The same group have also examined 15 week SHR and demonstrated 
a significant decrease in plasma endothelin concentration compared to controls 
(Suzuki et al, 1990). Kohno et al (1991) observed no change in plasma endothelin-1 
concentration in either 6 week old or 18 week old SHR compared to WKY.
If endothelin-1 was an initiating factor in the development of essential hypertension 
it should be able to increase total peripheral resistance. It has been demonstrated by 
Mortensen et al (1990) that an infusion of endothelin-1 into normotensive rats 
produced a maintained hypertension and this blood pressure increase was due to 
elevations in total peripheral resistance. Evidence that increased endothelin-1 levels 
can lead to an increase in blood pressure and a sustained hypertension has come 
from studying patients with endothelin secreting tumours. Yokokawa et al (1991) 
have reported patients with haemangioendothelioma, a condition characterized by 
intravascular proliferation of endothelial cells. The tumours of this condition 
manifest clinically as scalp nodules which were shown to have 8 times higher 
concentrations of endothelin-1 than normal scalp tissue. The patients had both 
hypertension and increased levels of plasma endothelin-1. Surgical resection of the 
tumours resulted in decreased endothelin-1 levels and decreased blood pressure. In 
one patient a recurrence of the original tumour was associated with a rise in both 
blood pressure and plasma endothelin. This serves to demonstrate that, as shown in 
rats, abnorm ally high concentrations of endothelin -1 can lead to sustained 
hypertension in man.
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In addition to vasoconstrictor properties it has been demonstrated that endothelin-1 
can stimulate proliferation of vascular smooth muscle cells (Dubin et al, 1989). 
E ndothelin  may therefore  be capable of inducing  both stages o f essen tia l 
hypertension, the initial vasoconstriction and then hypertrophy of the blood vessel 
wall.
1.7.3. The Heart
The effects of hypertension on the heart is to increase the work load. This leads to an 
increase in heart size, more specifically left ventricular hypertrophy, which is a 
common occurrence in chronic hypertension. A study by Adams et al (1989) in SHR 
led them to propose that the left ventricular hypertrophy was important in the 
initiation and maintenance of the raised blood pressure. They found at 4 weeks of 
age that blood pressure was the same in SHR and normotensive W istar Kyoto 
(WKY) rats but vascular resistance was already significantly higher in SHR. Thus in 
this case the increased medial thickness did not result in increased blood pressure. 
However at 4 weeks the degree of left ventricular hypertrophy was small but by 14 
weeks of age (when the blood pressure rise was established) the left ventricular 
hypertrophy had developed in parallel to the hypertension. They suggested that the 
delay in the rise in blood pressure until after 4 weeks (despite the hypertrophy of the 
vessel w all) appeared to be re la ted  to the developm ent o f le ft ven tricu lar 
hypertrophy and that this was of critical im portance in the pathogenesis of 
hypertension.
The contribution of left ventricular hypertrophy to the increasing blood pressure in 
essential hypertension is not known. Generally in established essential hypertension 
the cardiac output is normal though several investigators have found cardiac output 
to be elevated in young patients with borderline hypertension (Safar et al, 1975).
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1.7.4. Ion Transport
Many authors now believe that in hypertension there is a generalized membrane 
defect in vascular smooth muscle. That such a defect should occur in hypertension is 
not surprising as so many membrane constituents are determinants of vascular 
smooth muscle contraction and therefore control total peripheral resistance. Most of 
these theories which examine essential hypertension at a molecular level involve 
calcium which is a major component of contraction in smooth muscle.
Blaustein (1977) and Haddy and Overbeck (1976) have proposed that ion transport 
defects in the cell membrane may have a role in hypertension. They suggested that 
essential hypertension is due to the production of circulating sodium transport 
inhibitors by the kidney. Evidence for this was provided by Dahl and Heine (1975) 
who observed that hypertension in rats could be transferred by renal transplantation. 
It has been suggested that this circulating inhibitor may act on the sodium/potassium 
ATPase pump on vascular smooth muscle membranes. This would lead to increased 
intracellular sodium which would in turn act on the membrane sodium/calcium 
exchange mechanism. Intracellular calcium would therefore be increased producing 
co n trac tio n  of the sm ooth m uscle cell and in c reased  resp o n siv en ess  to 
vasoconstrictors.This would result in increased total peripheral resistance. However, 
studies in both human and experim ental hypertension have failed to show a 
consistent correlation between sodium/potassium ATPase activity and blood 
pressure and, although circulating inhibitors have been found (Hamlyn et al, 1989), 
whether they can cause hypertension is still unclear.
It has been proposed that another sodium transport mechanism, sodium/hydrogen 
antiport system, may increase intracellular sodium and therefore be involved in the 
pathogenesis of hypertension. Berk et al (1989) observed that cultured vascular
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smooth muscle cells from SHR had significantly higher sodium/hydrogen antiport 
activity than WKY cells. Also intact vessels from 5 week SHR were demonstrated to 
be m ore a lkaline  than vesse ls  from  W KY, p o ssib ly  due to in c reased  
sodium /hydrogen exchange in SHR (Izzard and Heagerty, 1989). However, 
Alexander et al (1990) have shown that, although sodium/hydrogen antiport activity 
is increased in vascular smooth muscle cells from SHR compared to WKY, the 
sodium/hydrogen antiport activity of normotensive Wistar rats was, in fact, higher 
than that of SHR. Therefore increased sodium/hydrogen antiport activity cannot 
explain the hypertensive process in SHR. Also, Izzard and H eagerty (1990) 
examined the intracellular pH of isolated human resistance arteries from essential 
hypertensives and controls and , unlike in rat arteries, there was no change in pH in 
arteries from hypertensives. On this evidence it would seem unlikely that the 
sodium/hydrogen antiport system is directly involved in hypertension.
Even if there is a primary defect involving sodium transport mechanisms it is not 
clear that physiological changes in intracellular sodium are sufficient to alter cell 
calcium significantly via the sodium/calcium exchange system in vascular smooth 
muscle to produce an increase in total peripheral resistance.
1.7.5. Calcium and Second Messengers System
Other theories of a generalized defect in hypertension also involve calcium. Bohr 
and Webb (1984) have suggested that the major abnormality in hypertension appears 
to be in the relationship of calcium ions and the stability of the cell membrane. They 
proposed that in vascular smooth muscle an increase in extracellular calcium makes 
the membrane less permeable to all ions and that this stabilization effect of calcium 
is less effective in hypertension (Holloway and Bohr, 1973) and could lead to an 
increased vascular reactivity. Alterations in the contractile reactivity of hypertensive 
vascular smooth muscle to several vasoconstrictor agonists has been demonstrated
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by many authors. However, conflicting results have been reported depending on the 
agonist and the blood vessel studied. For example, Aqel et al (1986) observed an 
increased maximum tension developed by caudal artery rings from SHR in response 
to noradrenaline whereas Aoki et al (1981) found that noradrenaline induced tension 
development was actually less in aorta from SHR compared to WKY.
If there is an alteration in the responsiveness of hypertensive vascular smooth 
muscle (even though this alteration may not occur uniformly throughout the 
vasculature) it is likely to be the result of, or at least involve, an alteration in calcium 
handling. In order for a vasoconstrictor agonist, such as noradrenaline, to produce an 
altered calcium response, as in hypertensive smooth muscle, a change in the events 
linking the receptor activation to the calcium release would have occurred. The 
events linking receptor activation to intracellular calcium release in vascular smooth 
muscle have already been described. However, in relation to alterations in essential 
hypertension there are several possibilities where changes could occur which would 
affect intracellular calcium release and contraction. Some of these are: an alteration 
in receptor number, a change in the number or activity of G -proteins in the 
membrane, a change in phospholipase C activity to increase or decrease formation of 
inositol phosphates, a change in the size of the phosphatidylinositol pools, an 
alteration in the metabolism of the inositol phosphates by the various kinase and 
phosphatase enzymes or a change in the sensitivity of the sarcoplasmic reticulum to 
inositol 1,4,5-trisphosphate molecules. A decrease in calcium extrusion has also 
been implicated. An alteration in any of these individual components of this signal 
transduction system could alter intracellular calcium levels and directly affect total 
peripheral resistance.
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1.8. Secondary Hypertension
1.8.1. General Pathophysiology
Secondary hypertension has many different causes initiating the rise in blood 
pressure. Aldosteronism is caused by a tumour in the adrenal glands which secretes 
large quantities of aldosterone leading to an increase in sodium and fluid retention 
by the kidneys which produces increased blood volume and therefore increased 
blood pressure. Hypertension originating from a phaeochromocytoma is caused by a 
tum our in the adrenal m edulla re leasing  large am ounts of adrenaline and 
noradrenaline. As both these agonists are vasoconstrictors they will produce an 
increase in peripheral vascular resistance.
1.8.2. Goldblatt Model of Renovascular Hypertension
A common type of secondary hypertension is renovascular hypertension. This is due 
to unilateral or bilateral renal artery stenosis generally caused by an atherosclerotic 
lesion. However the aetiology of this disease is not well understood and the 
p h y sio log ica l basis for the increase  in blood p ressu re  e levation  rem ains 
controversial. Goldblatt developed animal models of this form of hypertension by 
using a clip on the renal artery to cause a partial occlusion (Goldblatt et al, 1934). 
Two techniques were developed; one renal artery clipped with the contralateral 
kidney removed (one kidney one clip model) and the other has one renal artery 
clipped with the contralateral kidney left intact (two kidney one clip model). 
Although there is increased activity of the renin angiotensin system in experimental 
renovascular hypertension this increase is only short term and cannot explain the 
su sta in ed  rise  in b lood p ressu re . The ren in  ang io ten sin  system  can be 
pharmacologically blocked at a number of different sites, e.g. angiotensin converting 
enzyme inhibitors such as captopril or angiotensin II receptor antagonists such as 
saralasin. In the one kidney one clip rat model Helchen et al (1972) found a
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significant rise in plasma renin activity 20 minutes after the application of the clip but 
this rise peaked at 45 minutes and gradually declined to baseline. However blood 
p ressu re  showed only a sm all rise  afte r 45 m inutes. One k idney  one clip  
hypertension can be blocked by captopril but the effect lasts only 4 days and despite 
continous blockade blood pressure rises rapidly (Seymour et al, 1981). In contrast, 
this study also showed that rats on a low sodium diet did not display a rise in blood 
pressure during captopril treatment. Therefore in one kidney one clip hypertension 
combined sodium restriction and blockade of the renin angiotensin system is 
effective in preventing the rise in blood pressure whereas independently these have 
little effect.
1.8.3. Perinephritis Hypertensive Model
Another experimental model of renovascular hypertension was developed by Page 
(1939). He showed that wrapping the kidney would cause hypertension. This 
perinephritis hypertension has been studied in rabbits and dogs with bilateral 
wrapping or unilateral wrapping with contralateral nephrectomy. Ferrario et al 
(1970) wrapped one dog kidney in cellophane and left the contralateral kidney 
untouched. Cardiac output increased but arterial pressure did not. W hen the 
contralateral kidney was subsequently removed a marked hypertension developed 
but cardiac output remained unchanged. In bilateral kidney wrapped rabbits blood 
pressure was unchanged at 10 days but significantly increased at 28 days (Denton et 
al, 1983). Takata et al (1988) have shown a decrease in renal vascular conductance 
in bilateral wrapped rabbits at 28 days. They suggested that wrapping promotes the 
growth of a capsule of scar-like tissue around the kidney which will cause renal 
constriction. The decrease in renal vascular conductance may lead to the initiation of 
hypertension. However these authors demonstrated that the decrease in renal 
conductance could only account for 10% of the increased total peripheral resistance
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at 28 days after surgery suggesting that other mechanisms are involved. Denton et al 
(1983) have shown that plasma renin activity is unchanged in this model at 10, 28, 
and 56 days but in another study the same group (Denton et al, 1985) demonstrated 
that enalapril, a converting enzyme inhibitor, reduced blood pressure by 50% in 
rabbits 28 and 56 days after surgery. The renin angiotensin system may therefore 
play a role in this form of hypertension but other factors must also be involved.
H am ilton and Reid (1983) have studied the one kidney wrap m odel with 
contralateral nephrectomy. They found that blood pressure was significantly 
increased at 1 week after surgery and continued to rise till 4-6 weeks when the 
increase became established. Cardiac output remained unchanged throughout this 
period. They also demonstrated an increased vasopressor response to noradrenaline 
but not angiotensin II at all times examined. Plasma renin levels were unaltered. The 
increased response was apparent in some hypertensive rabbits before blood pressure 
was significantly elevated. This increase was not due to altered plasma levels of 
adrenaline and noradrenaline, alterations in a  adrenoreceptor number or affinity or a 
decrease in baroreceptor sensitivity. However, the possibility  that vascular 
hypertrophy contributed to this increased response at later time points could not be 
excluded. Hamilton and Reid concluded that there must be some alteration in the 
postreceptor mechanisms of noradrenaline which may involve an alteration in the 
phosphatidylinositol cycle.
1.9. Suitability of Experimental Models of Hypertension and Normotensive 
Controls
Models for both essential and secondary hypertension have been described. The 
SHR which displays genetically inherited hypertension is a model for essential 
hypertension, although the initiating processes are not known. Several models for
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secondary hypertension have been described, such as the Goldblatt one kidney one 
clip model and the perinephritis hypertensive rabbit, where the initiating cause is 
known but how this relates to a rise in blood pressure is still not clear. However, 
both types of hypertension exhibit similar properties such as an increased total 
peripheral resistance and at a later stage a thickening of the blood vessel wall.
In cardiovascular research the advantage of the SHR is that it is a genetic form of 
hypertension, like essential hypertension, which is the condition from which the 
majority of hypertensive patients suffer. However, the problem is selecting the 
appropriate type of control animals for highly inbred strains such as the SHR. The 
most commonly used control animal is the Wistar Kyoto (WKY) rat strain. The 
problem of control animals has already been m entioned as dem onstrated by 
Alexander et al (1990) on their comparison of sodium/hydrogen antiport activity in 
SHR, WKY and Wistar rats. Since the inheritance of spontaneous hypertension is 
not compatible with simple Mendelian genetics and favours a polygenic mechanism, 
the development of one genetic trait such as high blood pressure is likely to be 
associated with the development of other genetically linked characteristics. It is 
therefore difficult to relate a given biochemical observation to only one genetic 
characteristic such as increased blood pressure.
In contrast to the SHR, models of secondary hypertension such as the perinephritis 
hypertensive rabbit do not have this problem as control animals are of the same 
strain. Therefore any biochemical differences observed can be ascribed to the 
hypertensive process, although whether this difference is a causal or a consequential 
one would still have to be established.
Animal models cannot claim to be perfect models of human hypertension and as
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already described in the introduction there are differences between experimental and 
hum an hypertension. T herefore, in term s of the pathogenesis of essen tia l 
hypertension models of both genetic and secondary hypertension each have a role to 
enable a particular alteration to be directly associated with the rise in blood pressure.
1.10. Aims
There are many possible causes of hypertension. Evidence for the involvement of 
the sym pathetic  nervous system  and n o rad ren a lin e  has been observed . 
Vasoconstrictor agonists such as endothelin-1 and angiotensin II are involved in the 
control of total peripheral resistance and are likely to have a role at some stage in the 
development and/or maintenance of hypertension. Changes in volume homeostasis 
and ion transport may also have a role. The properties of arteries are changed during 
hypertension and in many cases show altered responses to vasoconstrictor agonists. 
These changes could be due to alterations in the contractile process and as the 
primary mediator of contraction is calcium then it may be involved. The intracellular 
calcium concentration is controlled in part by the phosphatidylinositol cycle and 
therefore alterations in this second messenger system may have a causal role in the 
alterations observed in contractile responses.
The aim of this work was to examine the effects of 2 vasoconstrictor agonists, 
noradrenaline and endothelin, on the phosphatidylinositol cycle and coupling to G- 
proteins in vascular smooth muscle from a genetic model of hypertension, the SHR, 
and a model of secondary hypertension, the perinephritis hypertensive rabbit, at 
various stages during their development. For practical reasons the blood vessel 
chosen for study was the aorta because of its size.
Different experimental models of hypertension can give different results and may
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not always have suitable controls, depending on the origin of the hypertension. For 
this reason in this study 2 models of hypertension were studied.
Aortic smooth muscle cells cultured from the aortae of these 2 models were also 
examined to evaluate the suitability of a cultured system for the study of signal 
transduction mechanisms in hypertension. If cultured aortic smooth muscle cells 
reflect alterations that occur in the hypertensive blood vessel this system could be 
used in further molecular studies which are technically difficult to carry out in whole 
tissue. Many previous studies of cultured vascular smooth muscle in hypertension 
have not ascertained whether the cells retain the characteristics of whole tissue. 
Therefore the aim of the present study was to compare the properties of cultured 
cells and freshly isolated tissue.
A problem in hypertension research is identifying whether an observed response 
which is altered in hypertension is a primary effect or merely a consequential, 
secondary effect. To surm ount this d ifficu lty  the experim ental m odels of 
hypertension used here were studied at various stages during the development of 
hypertension. Studies were undertaken both in the early stages of this disease and in 
the established phase of hypertension. If the signal transduction system has a role in 
the pathogenesis of hypertension in these models, alterations may be observed at a 
time early in their development. However, if alterations are observed at a later stage 
when blood pressure is established this may suggest that the signal transduction 
system may be involved only in the maintenance of the raised blood pressure.
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CHAPTER TWO
INOSITOL PHOSPHATE FORMATION IN AORTIC RINGS FROM 
SPONTANEOUSLY HYPERTENSIVE RATS: EFFECTS OF 
NORADRENALINE AND ENDOTHELIN-1
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2.1 INTRODUCTION
A ltera tions in the con trac tile  responsiveness o f the vascu la tu re  to m any 
vasoconstrictor agonists have now been reported in various models of experimental 
hypertension. However several of these studies have given rise to conflicting reports 
and it is becoming apparent that the changes observed in hypertension are dependent 
on the agonist, the vessel and on the model of hypertension examined.
2.1.1 Alterations in Contraction in Hypertensive Smooth Muscle 
In isolated aorta from SHR with established hypertension (12 - 14 weeks old) 
several authors have demonstrated a decrease to noradrenaline in the maximum 
response and sensitivity compared to age-matched WKY control rats (Cargnelli et al, 
1990; Ek et al, 1989; Bolger et al, 1990; Sharifi et al, 1990). However, other authors 
studying the same vessel from SHR have found no change in sensitivity to 
noradrenaline (Clozel, 1989; Criscione et al, 1990). Fortes et al (1990) also found no 
alteration to noradrenaline stimulation in aorta from SHR. Huzoor-Akbar et al 
(1989) have observed an increase in contractile sensitivity with serotonin in aorta 
from SHR demonstrating that within the same vessel and model of hypertension the 
changes in contractile responsiveness appear to be agonist specific. In small arteries 
from 12 week SHR contractility is increased with noradrenaline (Mulvany et al, 
1980) showing that the alterations observed may depend on the vessel studied. 
Mulvany et al (1980) also observed an increase in small arteries from 6 week SHR at 
a stage when hypertension is developing.
Responses to noradrenaline may also vary in other models of hypertension. For 
example, noradrenaline contractile responses have been reported to be increased in 
aorta (Jones et al, 1988) and in mesenteric artery (Takata et al, 1989) from DOCA-
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salt hypertensive rats. In contrast, in pulmonary artery from pulmonary hypertensive 
rats a 40% decrease in noradrenaline responsiveness was observed (Wanstall and 
O ’Donnell, 1990)
Recently, much research has concentrated on the possible role of endothelin-1 in 
hypertension and on the alterations in contractility which may occur in smooth 
muscle from hypertensive subjects or animals. Again, differences observed were 
dependent on the vessel and model studied. Bolger et al (1990), Martel et al (1990) 
and Clozel (1989) have shown in aorta from SHR that sensitivity to endothelin-1 
was increased whereas the maximum contractility was significantly decreased. 
However other authors who com pleted sim ilar experim ents also observed a 
decreased maximal response but there was no change in endothelin-1 sensitivity 
(Cargnelli et al, 1990; Criscione et al, 1990). In a different blood vessel, the 
mesenteric artery, Miyuachi et al (1989a) have shown that endothelin-1 sensitivity 
and maximal tension was unchanged in 6 week SHR whereas in 14 week SHR 
although maximum tension remained unchanged sensitivity was increased.
In other models of hypertension responses to endothelin-1 in isolated aorta were 
unchanged. In aorta from Goldblatt hypertensive (Fortes et al, 1990) and DOCA- 
salt hypertensive rats (de Carvalho et al, 1990) no changes in either endothelin-1 
sensitivity or maximal contraction was observed. However, in pulmonary artery in 
pulmonary hypertensive rats W anstall and O ’Donnell (1989) demonstrated a 
decreased maximum contraction with endothelin-1. From the studies mentioned 
endothelin-1 sensitivity is either unchanged or increased and maximal contraction is 
unchanged or reduced depending on the model and vessel examined.
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2.1.2 Alterations in Inositol Phosphate Formation in Hypertensive Smooth Muscle 
It is well established that hypertension is associated with an increased peripheral 
resistance (Pfeffer et al, 1974). However it is unclear how these different changes in 
contractile responses in hypertension are associated with this increased vascular 
resistance. In an effort to understand the mechanisms behind the alterations in 
agonist responsiveness researchers have examined the signal transduction systems 
that control vascular contractility. As already described a major mechanism for 
producing contraction in smooth muscle is the phosphatidylinosito l cycle. 
Investigations into changes in this system in hypertension have, as with data on 
contractility, produced conflicting results.
Several studies have now been completed examining inositol phosphate formation in 
the aorta of SHR. Sharifi et al (1990) have observed a decrease in noradrenaline 
stim ulated inositol phosphate formation in aorta from SHR with established 
hypertension while no change in basal inositol phosphate formation was detected. Ek 
et al (1989) found that aorta from SHR failed to show any increase in inositol 
phosphate formation after stimulation with noradrenaline but WKY inositol 
phosphate formation was increased by 219%. They interpreted this as a reduction in 
inositol phosphate formation in aorta from SHR. However, Heagerty et al (1986) 
found no change in basal or noradrenaline stimulated inositol phosphate formation in 
aorta from 19 week SHR but observed an increased inositol phosphate formation, 
both basal and with noradrenaline, in aorta from 5 week SHR. Also in aorta from 
SHR several authors have now demonstrated increases in inositol phosphate 
formation with serotonin (Turla and Webb, 1990; Huzoor-Akbar et al, 1989).
In other models of hypertension alterations in inositol phosphate formation have 
been observed. In DOCA-salt hypertensive rats noradrenaline stimulated inositol
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phosphate formation was increased in femoral artery (Eid and de Champlain, 1988), 
aorta (Jones et al, 1988), and mesenteric artery (Takata et al, 1989). De Champlain et 
al (1989) also demonstrated that inositol phosphate formation in mesenteric artery 
from DOCA-salt hypertensive rats was increased with noradrenaline and with 
endothelin-1. The effects of noradrenaline and endothelin-1 stimulation combined 
produced an additive accumulation of inositol phosphate formation suggesting these 
agonists have independent actions on the phosphatidylinositol cycle.
2.1.3 Aims
The aim of these experiments was to determine if inositol phosphate formation was 
altered in a large conduit vessel in a genetic model of hypertension ( SHR ) .  The 
effects of 2 different vasoconstrictor agonists noradrenaline and endothelin-1 were 
studied. Both these agonists act via the phosphatidylinositol cycle in smooth muscle 
and as previously stated they have been implicated as having a possible role in the 
development and maintenance of hypertension. Aortae from SHR has been studied 
at an early stage in the development of hypertension and at stages when the increase 
in blood pressure was established. Previous studies in this area have used only one 
agonist or only examined established hypertension and not an earlier time point. 
Although Heagerty et al (1986) did examine noradrenaline stimulated inositol 
phosphate formation in 6 week SHR, they only looked at one concentration of 
noradrenaline (10'^M ). The experiments in this chapter have studied a range of 
agonist concentrations for both noradrenaline and endothelin-1. In the following 
experiments the noradrenaline and endothelin-1 stimulated total inositol phosphate 
formation was measured in aortic rings from 6 week, 14 week and 40 week SHR and 
WKY rats.
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2.2 METHODS
2.2.1. Assay for the Measurement of Total T^Hl-Inositol Phosphate Formation 
Animals used in this study were 6, 14 or 40 week old SHR and WKY rats. Animals 
were killed by a blow to the head followed by cervical dislocation. The aorta was 
dissected and placed in ice cold Krebs ringer bicarbonate buffer (NaCl 118.3mM, 
KC1 4.7mM, CaCl2 0.5mM, M gS04 1.2mM, KH2P 0 4 1.2mM, NaHC03 25.0mM, 
glucose 1 l.lm M , myoinositol O.lmM, bovine serum albumin 1.5% ; pH 7.4). The 
vessel was cleaned of connective tissue and incubated for 30 minutes at 37°C in 
Krebs buffer continuously bubbled with 5% C 02 :95% 0 2. The buffer was changed 
every 10 minutes. The vessels were incubated for a further 10 minutes in Krebs 
buffer containing 10"^M LiCl and 2xlO“^M imipramine, after which the inside of 
the vessels were rubbed to remove endothelium and chopped into 5mm rings. The 
rings were spread evenly throughout all the samples (2 rings in each sample, except 
blank tubes which contained no tissue). In order to obtain sufficient tissue for both 
agonist concentration response curves 3 aortae were used in each experiment. Each 
sample was weighed and then incubated at 37°C in 0.3ml Krebs buffer containing 
10"^M LiCl, 2xlO"^M imipramine and 0.5|iCi of [^H]-myoinositol for 3.5 hours 
under an atmosphere of 5% C 0 2 :95% 0 2.
After this incubation period either noradrenaline (10'^M - 10'^M) or endothelin-1 
(10"^M - 10"^M) was added to samples except blank and basal values which had an 
equivalent volume of distilled H20  added. Tubes were incubated for a further 30 
m inutes. The reaction was stopped by the addition of 2ml of m ethanol : 
chloroform : hydrochloric acid mixture (40:20:1 v/v) and the samples sonicated for 
45 minutes. Chloroform (0.63ml) and distilled H20  (1.26ml) were added, tubes 
vortexed and centrifuged at 2500g for 10 minutes. 2ml of the upper aqueous phase
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was removed from the tubes for assay of inositol phosphates. Each sample was pH 
adjusted to between 6.9 and 7.2. This aqueous phase containing the inositol 
phosphates was passed through a column of Dowex ion-exchange resin in the 
formate form. Each column was then washed with 15ml of unlabelled myoinositol. 
The total [ H]-inositol phosphates were eluted by washing with 2ml of 0.1M formic 
acid in 1M ammonium formate and collected in scintillation vials. 15ml of scintillant 
were added and samples counted in a liquid scintillation counter.
Noradrenaline and endothelin-1 stimulated [^H]-inositol phosphate formation was 
measured in aorta from 6, 14, 40 week SHR and WKY rats.
2.2.2. Statistical Analysis
a
All results are expressed as mean ± s.e.m. Basal [^H]-inositol phosphate formation is 
calculated as counts / min /  mg of tissue and agonist stim ulated [JH]-inositol 
phosphate formation calculated as a % of basal values. Comparisons between 
hypertensive and control rats were carried out using repeated measure analysis of 
variance for agonist concentration response curves and unpaired t-tests for basal 
responses, p < 0.05 was considered statistically significant.
2.3 RESULTS
2.3.1. Basal f^Hl -Inositol Phosphate Formation
Basal [^H]-inositol phosphate formation in aorta from 6, 14, and 40 week SHR is 
shown in table 2.1. There was no significant difference in aorta from SHR compared 
to WKY at all times examined. Within the SHR group there was a significant 
increase in basal inositol phosphate formation from 6 to 14 weeks. From 14 to 40 
weeks in SHR basal inositol phosphate formation was not significantly different. 
Similarly, in WKY aortic rings there was a significant increase in basal inositol
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phosphate formation from 6 to 14 weeks. However, from 14 to 40 weeks there was a 
significant decrease in aorta from WKY.
2.3.2 Agonist Stimulated T^Hl-Inositol Phosphate Formation: SHR versus WKY 
Figure 2.1 shows the noradrenaline stimulated inositol phosphate formation in aortic 
rings from 6 week SHR and WKY rats. There was no significant difference in SHR 
aortic rings compared to WKY. At 14 weeks (figure 2.2) noradrenaline stimulated 
inositol phosphate formation in SHR was now significantly decreased compared to 
WKY at all concentrations of noradrenaline examined. This was also the case in 
aortic rings from 40 week SHR and WKY rats (figure 2.3).
At 6 weeks the endothelin-1 stimulated inositol phosphate formation was unchanged in 
aorta from SHR compared to WKY (figure 2.4). However in aortic rings from 14 
week SHR (figure 2.5) the endothelin-1 stimulated inositol phosphate formation was 
significantly decreased between 10"^M and 10"^M endothelin-1. At 40 weeks 
endothelin-1 stimulated inositol phosphate formation was also decreased in SHR at 
10’^M and 10“^ M endothelin-1 (figure 2.6).
2.4. DISCUSSION
No alteration in basal inositol phosphate formation was observed in SHR compared 
to WKY aortic rings at any age group suggesting that basal phosphatidylinositol 
turnover is unchanged and therefore does not contribute to any change in peripheral 
vascular resistance under basal conditions at any of the stages of hypertension 
examined. Within SHR and WKY groups basal inositol phosphate formation is 
altered with age. There is a significant increase in basal values from 6 weeks to 14
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Age of Rats
6 WEEKS (n=6) 
14 WEEKS (n=7) 
40 WEEKS (n=7)
Basal Inositol Phosphate Formation 
( cpm /  mg of tissue)
WKY SHR
176 ±44  ■ 
1240 ±220: 
508 ±71 ■
130± 18- 
923 ±65 “ 
780 ±103
TABLE 2.1. Basal inositol phosphate formation in aortic rings from 6 week, 14 
week and 40 week old SHR and WKY rats.
Mean ± s.e.m. * p< 0.05
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FIGURE 2.1 Noradrenaline stimulated inositol phosphate formation in aortic rings 
from 6 week old SHR and WKY rats. Mean ± s.e.m.
•  SHR (n=6)
O WKY (n=6)
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FIGURE 2.2 Noradrenaline stimulated inositol phosphate formation in aortic rings 
from 14 week old SHR and WKY rats. Mean ± s.e.m.
* p< 0.05 SHR compared to WKY response.
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FIGURE 2.3 Noradrenaline stimulated inositol phosphate formation in aortic rings 
from 40 week old SHR and WKY rats. Mean ± s.e.m.
* p< 0.05 SHR compared to WKY response.
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FIGURE 2.4. Endothelin-1 stimulated inositol phosphate formation in 
aortic rings from 6 week old SHR and WKY rats. Mean ± s.e.m.
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FIGURE 2.5. Endothelin-1 stimulated inositol phosphate formation in 
aortic rings from 14 week old SHR and WKY rats. Mean ± s.e.m.
* p< 0.05 SHR compared to WKY response.
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FIGURE 2.6. Endothelin-1 stimulated inositol phosphate formation in 
aortic rings from 40 week old SHR and WKY rats. Mean ± s.e.m.
* p< 0.05 SHR compared to WKY response.
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weeks in SHR and WKY. This increase is probably due to a maturation effect. 
Heagerty et al (1986) also observed increases in basal values from 5 weeks to 19 
weeks in aorta from SHR although these were of a smaller magnitude than those 
demonstrated here. In SHR aorta there was no difference in basal inositol phosphate 
formation between 14 and 40 weeks although in WKY a decrease from 14 to 40 
weeks was observed. The decrease in WKY would be consistent with an ageing 
effect and lower basal tone. The reason why this was not observed in the SHR may 
be due to the effects of hyperplasia or hypertrophy of the blood vessel wall which is 
apparent at 40 week but not at 6 or 14 weeks.
Both noradrenaline and endothelin-1 stimulated inositol phosphate formation were 
unchanged in aorta from 6 week SHR compared to WKY indicating that neither of 
these agonists con tribu te  to the developm ent o f hypertension  through the 
phosphatidylinositol cycle in this model. However, at 14 and 40 weeks SHR 
responses were significantly decreased with noradrenaline and endothelin-1. These 
decreases agree with the findings of other authors examining inositol phosphate 
formation in aorta from SHR who also observed decreases with noradrenaline (Ek et 
al, 1989, Sharifi et al, 1990). De Champlain et al (1989) found increased inositol 
phosphate formation with endothelin-1 but unlike this study they used DOCA-salt 
hypertensive rats which is a possible reason for this difference. In contrast to our 
study, Heagerty et al (1986) reported an increase in inositol phosphate formation 
with 10“^ M noradrenaline in 5 week SHR. However when the increased SHR basal 
inositol phosphate formation is taken into account the noradrenaline stimulation in 
SHR and WKY (expressed as a % of basal values) would not be significantly 
different. The decreases in inositol phosphate formation observed with noradrenaline 
and endothelin-1 in the aortae of 14 and 40 week SHR are in agreement with data
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from other authors on contractility in this vessel and model of hypertension (Bolger 
et al, 1990; Criscione et al, 1990; Cargnelli et al, 1990).
From our observations it appears that noradrenaline and endothelin-1 stimulated 
inositol phosphate formation is altered at an established stage of hypertension in this 
model. It is likely that, as this alteration occurs after the rise in blood pressure, the 
change in inositol phosphate formation is a consequential one occurring as a result 
of, rather than initiating, the hypertensive process. This does not exclude the 
possibility that the decreased noradrenaline and endothelin-1 stimulated inositol 
phosphate formation may have a role in the maintenance of hypertension. In view of 
the fact that peripheral vascular resistance is increased in SHR (Folkow, 1982) it 
would seem likely that decreases observed in aorta with respect to inositol phosphate 
formation and contractility are not a universal finding throughout the vascular tree.
In precapillary resistance vessels from 5 week and 12 week SHR noradrenaline 
stimulated inositol trisphosphate levels were increased at both age groups compared 
to WKY (Durkin et al, 1990). Criscione et al (1990) have dem onstrated that 
reactivity to endothelin-1 and noradrenaline was significantly increased in perfused 
mesenteric vascular beds from SHR. Similar findings were reported by Fortes et al 
(1990) using Golblatt hypertensive rats. These observations, along with the results 
observed in this study, suggest that although changes in the sensitivity of the aorta 
do occur in hypertension these are not general changes which occur throughout the 
vasculature and blood vessels in different situations may be affected differently.
In summary, in aorta from SHR both noradrenaline and endothelin-1 stimulated 
inositol phosphate formation is decreased compared to WKY at 14 and 40 weeks 
indicating that inositol phosphate responses to these agonists are not involved in the
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in itia tion  of hypertension  in this model but may have a ro le  in estab lished  
hypertension. The significance of these decreases with respect to hypertension is 
unclear and is further complicated by dissimilar changes in different blood vessels.
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CHAPTER THREE
INOSITOL PHOSPHATE FORMATION IN CULTURED AORTIC SMOOTH 
MUSCLE CELLS FROM SPONTANEOUSLY HYPERTENSIVE RATS: 
EFFECTS OF NORADRENALINE AND ENDOTHELIN-1
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3.1. INTRODUCTION
3.1.1. Vascular Smooth Muscle Cell under Culture Conditions 
For many years cell culture systems have been used to study various disease states. 
A major advantage of these systems is that a single effect can be studied on a 
homogeneous cell population in a controlled environment without the intervention of 
the complex hormonal and neural influences that exist in vivo. From a technical 
viewpoint cultured cells have also allowed more detailed investigations of the 
intracellular domain that is not possible in an intact organ or blood vessel and are 
usually easy to grow and maintain.
A large number of studies have used cultured vascular smooth muscle cells to 
investigate changes that occur in various disease states such as hypertension. 
However, it has now been dem onstrated that arterial smooth muscle that has 
undergone the culturing process will experience a change in phenotype (Chamley- 
Campbell et al, 1979). In vivo in the arterial media differentiated smooth muscle 
cells are arranged in concentric layers (Somlyo, 1980) and they contract in response 
to stimuli. This is known as the contractile phenotype and is characterized by the 
presence of myofilament bundles. When arterial smooth muscle cells are isolated by 
enzymatic digestion and sub-cultured in culture dishes a change in the phenotype 
occurs from a contractile state to a synthetic state (Chamley-Campbell et al, 1979). 
Cells in this state have a fibroblast-like appearance and their main functions are to 
proliferate . There is also a reduction in myofilament bundles (Palmberg et al, 
1985). Stadler et al (1989) have measured the volume fraction of myofilaments 
(compared to total cytoplasmic volume) in vascular smooth muscle cells after 5 days 
in culture on a plastic surface. After this period a 75% decrease in myofilaments was 
observed compared to freshly isolated smooth muscle cells. The reason for this loss
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of myofilaments and resulting phenotypic change is now known to be due to the lack 
of an extracellular matrix in culture. The extracellular matrix is produced by, and 
surrounds, vascular smooth muscle cells in vivo and consists of glycoproteins, 
collagen, elastin and glycosoaminoglycans. The important contribution of the 
extracellular matrix in controlling smooth muscle cell function has recently been 
recognized (Couchman, 1988). In vivo it is responsible for structural and functional 
characteristics of the vessel wall, including growth, development, remodelling and 
repair of the artery. Therefore as freshly isolated smooth muscle cells lack an 
extracellular matrix they are unable to maintain their differentiation a contractile 
state and in culture gradually change to a synthetic state. The importance of the 
extracellular matrix in maintaining a contractile phenotype was further demonstrated 
in a study by Stadler et al (1989) who demonstrated that the volume fraction of 
myofilaments was not reduced by the same extent in smooth muscle cells in culture 
if these cells were seeded within matrices of collagen type I or type IV (the major 
collagen types in the ex tracellu lar m atrix). They suggest that these m atrices 
encourage the smooth muscle cells to synthesize and secrete matrix components 
similar to an in vivo situation and thereby retain their contractile phenotype. The 
ability of vascular smooth muscle cells to proliferate in culture conditions,however, 
means that they are a good subject for cell culture as without this capability they 
would not grow under these conditions. It has been suggested that this alteration in 
phenotype is a de-differentiation of the vascular smooth muscle cell which reverts to 
the original morphology of the cell during the early development of the organism. 
This change may, therefore, not be an artificial change but merely a reversal of the 
differentiation process.
In experimental conditions cultured smooth muscle cells are often starved of serum 
24 hours before use. It has been suggested that this step may reduce the proliferation 
of the cells as no external protein is now available and the cell will concentrate its
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protein synthesis on other processes such as receptor production and contractile 
proteins. In normal culture conditions smooth muscle cells lose the ability to 
contract. However this does not mean that the processes which lead to contraction 
are also altered. Indeed many authors have shown that these signal transduction 
systems remain intact and functional in cultured smooth muscle cells. Numerous 
agonists have been shown to produce inositol phosphate formation and consequently 
in tracellu lar calcium  release e.g. noradrenaline, neuropeptide Y (Erne and 
Hermsmeyer, 1988), angiotensin II (Alexander et al, 1985), endothelin-1 (Araki et 
al, 1989; B ialecki et al, 1989), bradykinin (Paquet et al, 1989) and serotonin 
(Millanvoye et al, 1988).
3.1.2. Cultured Vascular Smooth Muscle Cells in Hypertension 
Several authors have extended the study of culture vascular smooth muscle cells to 
disease states such as hypertension using primary cultures prepared from the blood 
vessels of experimental hypertensive animals and compared with cultures from 
normotensive control animals. Authors examining various aspects of hypertension 
which could not be studied in vivo or in whole tissue have utilised cell culture 
systems to demonstrate changes that occur in smooth muscle cells in hypertension. It 
is now well established that the proliferation, in culture, of vascular smooth muscle 
cells from SHR is increased compared to WKY cells. This has been observed as an 
increased cell number in SHR cultures over a period of time (Resink et al, 1987; 
Scott-Burden et al, 1989a) and as an increase in DNA synthesis measured by the 
incorporation of [^H]-thymidine (Yamori et al, 1981; Hadrava et al, 1989; Paquet et 
al, 1989). A possible reason for this increased growth rate in cultured vascular 
smooth muscle cells has been proposed by Scott-Burden et al (1989b) who examined 
the contribution of the extracellular matrix to this proliferation effect. They found 
that the difference between cultured vascular smooth muscle cells from SHR and
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WKY may be due to differences in the extracellular matrices generated by these cells. 
Further evidence for this was that the observed difference became more exaggerated 
4 to 5 days after plating at which time both cell types would have begun to produce 
their extracellular matrices. Other differences have been demonstrated in cultured 
vascular smooth muscle cells from SHR compared to WKY e.g. Jazayeri and Meyer 
(1989) observed a decrease in low affinity (3-adrenoceptors.
As with whole arteries (chapter 2) authors have examined the pathways which 
m ediate  co n trac tio n  in sm ooth m uscle cells  as this m ay lead to a g rea ter 
understand ing  o f the increased  periphera l vascu lar resistance  observed  in 
hypertension (Folkow, 1982). The main mechanism of contraction, as previously 
described, is the activation of the phosphatidylinositol cycle leading to an increase in 
intracellular calcium. Levels of intracellular calcium in hypertensive smooth muscle 
have been measured and this is discussed in chapter 6. Using smooth muscle cells 
from SHR and WKY rats Paquet et al (1989) observed that, while basal inositol 
phosphate form ation was unchanged in SHR, angiotensin II stim ulated and 
bradykinin stimulated inositol phosphate formation was increased compared to 
WKY cultures. As cells from SHR also proliferated faster than WKY in the presence 
of these agonists they suggested that this agonist increased inositol phosphate 
formation may be involved in the enhanced proliferating activity of SHR cultured 
sm ooth m uscle cells. M illanvoye et al (1988) also dem onstrated  the same 
concomitant increase in inositol phosphate formation and proliferation to stimulation 
with angiotensin II. However Socorro et al (1990) using cultured smooth muscle 
cells  p rep ared  from  M ilan hypertensive  rats dem onstrated  tha t, although 
hypertensive cells exhibited an increased growth rate, angiotensin II stimulated 
inositol phosphate formation was actually decreased. This demonstrates that within 
culture systems from hypertensive animals there is there is a variation in response in 
different models as was observed in whole tissue.
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3.1.3. Aims
In most cases when studying this aspect of hypertension research cultured vascular 
smooth muscle cells have been used because of their technical advantages. In the 
above studies authors have examined alterations in the phosphatidylinositol cycle 
with various agonists and their effect on cell growth - experiments which can not be 
carried out in whole artery. It has been assumed generally that these signal 
transduction pathways are not altered by the culturing process. However, to date no 
studies have been completed comparing changes in the phosphatidylinositol cycle in 
hypertension in whole artery and cultured smooth muscle cells. The aim of this study 
was to determine if changes in inositol phosphate formation do occur when vascular 
smooth m uscle cells are subjected to culture conditions. N oradrenaline and 
endothelin-1 stimulated inositol phosphate formation was measured in cultured 
vascular smooth muscle cells from aorta of 6 week (early in the development of 
hypertension) and 14 weeks (when hypertension is established) SHR and WKY rats. 
The time points and agonists studied in this chapter are the same as those studied in 
freshly isolated aorta from SHR and WKY in the previous chapter. Comparison of 
results from this study and the study in whole tissue (chapter 2) will be discussed. If 
similar alterations are observed in cultured smooth muscle cells compared to fresh 
tissue this would m erit further study in these cells in other aspects of signal 
transduction in hypertension.
3.2. METHODS
3.2.1. Preparation of Primary Cultured Aortic Smooth Muscle Cells
Isolated aortic smooth muscle cells were prepared by enzymatic digestion of the
aortae from 6 week and 14 week old SHR and WKY rats. Rats were killed by a
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blow to the head followed by cervical dislocation. The aorta was dissected quickly 
and removed to ice-cold growth medium (Dulbecco’s modified Eagle medium 
containing 8% foetal calf serum, 8% horse serum, 2mM glutam ine and 1% 
commercially prepared antibiotic - antimycotic solution comprising 100 units /  ml 
penicillin G, 100 units / ml streptomycin and 0.35 units /  ml amphotericin B). For 
the preparation of each primary culture 3 aortae were used (3 primary cultures were 
prepared for each group). The vessels were cleaned of connective tissue and the 
inside rubbed with forceps to remove the endothelium . The aortae were incubated in 
fresh growth medium containing 2.5 mg/ml collagenase type II, 0.5mg/ml elastase 
type IV and 0.1 mg/ml trypsin inhibitor at 37°C in a shaking water bath. After 15 
minutes incubation the vessel was removed, cleaned again and cut into small 
segm ents. These segm ents were incubated  in grow th m edium  contain ing  
collagenase, elastase and trypsin inhibitor as above at 37°C in a shaking water bath. 
Every 20 minutes the segments were agitated vigorously with a pasteur pipette until 
a turbid solution was obtained. The resulting suspension was centrifuged at lOOOg 
for 5 minutes at 4°C, the medium removed and the pellet resuspended in fresh 
growth medium. This washing process was repeated, the pellet of cells suspended in 
5 ml of growth medium and poured into a 25cm tissue culture flask. The flask was 
kept in an incubator at 37°C in an atmosphere of 5% carbon dioxide. Growth 
medium was changed every 48 hours until the cells had form ed a confluent 
monolayer in the flask. These cells were then stripped from this flask by the addition 
of 3 ml of 0.25% trypsin-EDTA solution for 30 seconds and passed to a 75cm'J 
tissue culture flask containing growth medium.
3.2.2. Maintenance of Cultured Aortic Smooth Muscle Cells 
Growth medium was changed every 48 hours in all flasks. Once a confluent 
monolayer of smooth muscle cells had been formed cells were passed by stripping 
from the flask with 6ml of 0.25% trypsin-EDTA solution for 30 seconds and
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placing the cell suspension into 2x75cm3 flasks in equal proportions. Some flasks of 
confluent cells were frozen in liquid nitrogen for periods of no longer than 6 months. 
This cryogenic process was carried out as follows. A single cell suspension was 
obtained by treatment of a confluent flask with trypsin-EDTA as above. The cells 
were suspended in cold growth medium and centrifuged at lOOOg for 5 minutes at 
4°C. The medium was removed and the pellet resuspended in 3 ml of Dulbecco’s 
modified eagle medium containing 10% foetal calf serum and 10% distilled DMSO. 
1.5ml of this suspension (approxim ately 5x10^ cells) was placed in a plastic 
cryogenic vial and sealed securely. Vials were placed in a polystyrene container and 
stored at -70°C producing an approximate cooling rate of 1°C /  minute. After 2 
hours vials were removed and stored in liquid nitrogen until use.
Frozen cells were recovered by placing in a water bath at 37°C and shaking 
vigorously until the suspension had defrosted. It was then poured into a tissue 
culture flask containing growth medium preheated to 37°C and stored in an 
incubator as before. Defrosted cells showed similar responses in all experiments 
compared to cells which had not undergone the freezing process.
Cultured aortic smooth muscle cells used in all experiments were between passages 
3 and 10.
3.2.3. Assay for the Measurement of Total r3Hl-Inositol phosphate Formation 
Confluent aortic smooth muscle cells were harvested with 0.25% trypsin-EDTA 
solution, resuspended in 10ml of growth medium and the cell number counted on a 
haemocytometer slide. Cells were plated in a 24 multiwell (1cm well diameter) at a 
density of 105 cells / well (volume 1ml). These were incubated at 37°C in 5% 
carbon dioxide for 24 hours. After this time the growth medium was replaced by 1ml
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of serum free and inositol free medium (medium 199 containing 1% antibiotic / 
antimycotic solution) and incubated for a further 24 hours. [% ] -myoinositol was 
added (0.5|iCi for assays with endothelin-1, l.OjiCi for assays with noradrenaline) 
and cells incubated for 18 hours. Following this incubation the labelled medium was 
aspirated and the cells washed with 1ml of buffer (sodium chloride 133mM, 
potassium chloride 3.6mM, magnesium chloride 0.4mM, calcium chloride ImM, D- 
glucose 16mM, HEPES buffer 3mM, pH 7.4) at 37°C. Samples were incubated for 
10 minutes in 1ml buffer containing 10 M lithium chloride and for a further 30 
minutes with either endothelin-1 (10" - 10'^M) or noradrenaline (10“7M -
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10 M) in buffer and 10 M lithium chloride. The stimulation was stopped by the 
addition of lOOp.1 of 10% perchloric acid. Cells were scraped and aspirated from the 
well and placed in an eppendorf vial. 500|il of distilled H2O was added and the 
samples centrifuged at 13000g for 5 minutes. 550jil of the supernatant was removed 
to a tube containing 130fil of lOmM EDTA (pH 7.0) for measurement of total 
inositol phosphates (the remainder of the sample in the eppendorf vial was stored for 
total phosphatidylinositol analysis). 360|il of 1:1 v/v freon : tri-n-octylamine was 
added, samples vortexed and centrifuged at lOOOg for 4 minutes. 500|il of the upper 
aqueous phase was carefully removed to a tube containing 1 ml of 5mM sodium 
tetraborate in 0.5mM EDTA (pH 6.7). The samples were run through columns 
comprising of Dowex ion exchange resin in the formate form. Columns were 
washed with 15ml of 5mM unlabelled myoinositol. Finally 2ml of ImM ammonium 
formate in O.lmM formic acid (pH 4.0) was run through each column and the 
eluate, containing the total [^H ]-inositol phosphates, was collected in a glass 
scintilla tion vial. Scintillant was added and the samples counted on a liquid 
scintillation counter.
1 0
Total [3H]-inositol phosphate formation was measured with endothelin-1 (10" M - 
10"6M) and with noradrenaline (10"7M - 10"4M) in cultured aortic smooth muscle
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cells from 6 week and 14 week old SHR and WKY rats. Different concentrations of 
[J H]-myoinositol were used noradrenaline and for endothelin-1. This is because 
endothelin-1 produced a much greater maximal increase in inositol phosphate 
formation than noradrenaline and so greater [% ]-m yoinositol was needed with 
noradrenaline samples to produce a sufficient level of [% ]-inositol phosphate for 
measurement. Therefore, each agonist concentration response curve has individual 
basal values. In experiments to examine uptake of [^H]-myoinositol, basal inositol 
phosphate and basal phosphatidylinositol formation were measured after different 
incubation times with pH]-myoinositol.
3.2.4. Assay for Measurement of Total T HI-Phosphatidylinositol Formation 
Following the procedure described above, to each tube was added 470fxl chloroform 
: m ethanol: hydrochloric acid (40:80:1 v/v/v) and then samples vortexed. 310jil of 
chloroform : distilled H2O (1; 1 v/v) was then added and samples centrifuged for 10 
minutes at lOOOg. 250|il of the chloroform phase was removed to a scintillation vial 
and left to evaporate. Scintillation was added and samples counted in a liquid 
scintillation counter.
3.2.5. Statistical Analysis
All results are expressed as a mean ± s.e.m. Basal [ H]-inositol phosphate formation 
is calculated as counts / minute / 10^ cells and stimulated [^H]-inositol phosphate 
formation calculated as a % of basal values. Comparisons between hypertensive and 
control samples were carried out, as for aortic rings, using repeated measurement 
analysis of variance for agonist responses and unpaired M ests for basal value 
comparisons. P<0.05 was considered statistically significant.
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3.3. RESULTS
The presence of vascular smooth muscle cells in culture from 6 week WKY (figure 
3.1), 6 week SHR (figure 3.2), 14 week WKY (figure 3.3) and 14 week SHR (figure 
3.4) was confirmed by the detection of myofilaments using electron microscopy.
3 .3 .1 . B asal T^H I-Inosito l P hosphate  F orm ation  and B asal T^Hl- 
Phosphatidylinositol Formation
The basal [H ]-inositol phosphate formation in cultured aortic smooth muscle cells 
from 6 week and 14 week SHR and WKY rats is shown in table 3.1 (endothelin-1 
experiments) and table 3.2 (noradrenaline experiments). In the cells from both 6 and 
14 week rats basal inositol phosphate formation is significantly increased in SHR 
compared to WKY. An increase was also observed in the basal phosphatidylinositol 
formation, with cells from SHR significantly increased compared to WKY cells in 
all cases except that of noradrenaline in cells from 6 week SHR which just failed to 
reach significance (p<0.06).
3.3.2. Agonist Stimulated I^Hl-Inositol Phosphate Formation
Both endothelin-1 and noradrenaline caused a concentration dependent increase in 
total [^H ]-inositol phosphate formation in SHR and WKY aortic cells. In the 
cultured smooth muscle cells from 6 week rats the SHR cells showed similar 
responses to those of WKY for both agonists examined (figure.3.5 and 3.6). In cells 
from 14 week SHR the endothelin-1 stimulated inositol phosphate formation was 
significantly decreased compared to WKY cells between the concentrations 10 
to 10"6M (figure 3.7). In contrast the noradrenaline stimulated inositol phosphate
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formation in cells from 14 week SHR was significantly increased compared to WKY 
between the concentrations 3xlO"7M and 10"4M (figure 3.8).
The agonist stimulated inositol phosphate formation in these experiments has been 
expressed as a % of the basal inosito l phosphate form ation to allow a direct 
comparison with the results obtained in aortic rings from SHR and WKY rats 
(chapter 2). However, unlike in the rings, in cultured cells from SHR the basal 
inositol phosphate formation was increased and the uptake of [^H]-myoinositol is 
also increased as reflected in the increased basal [^H ]-phosphatidylinositol 
formation. Expressing the results as a % of the basal inositol phosphate formation 
takes account of the different basal levels in SHR and WKY cells and calculates the 
fold increase from basal levels upon agonist stimulation. This allows agonist 
stimulated inositol phosphate formation to be compared directly between SHR and 
WKY samples without the complicating factor of a difference in basal inositol 
phosphate formation. A possible criticism of this method of expressing the data is 
that it does not take into account the increase in the uptake of [JH]-myoinositol (and 
consequent increase in [^H]-phosphatidylinositol formation) observed in smooth 
muscle cells from SHR. Alternative ways of calculating results are as total counts 
per minute (as measured directly in these experiments) or expressing the agonist 
stimulated inositol phosphate formation as a proportion of the [^H]-myoinositol 
incorporated into the lipid phase (i.e. the basal [^H]-phosphatidylinositol) released 
calculated as follows:
stimulated inositol phosphates - basal inositol phosphates 
_________________________    x 100
basal phosphatidylinositol 
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As expressing the data as total counts per minute neither accounts for the difference 
in basal inositol phosphate formation or phosphatidylinositol formation this method 
was not considered appropriate. Results were calculated as a proportion of the basal 
rH ]-phosphatidylinosito l released (total labelled phosphatidylinositol equal to 
100%). Similar differences between SHR and WKY were observed when calculating 
results by this m ethod com pared to expressing data as a % of basal inositol 
phosphate formation. An example is shown in the following table with noradrenaline 
stimulation in cultured aortic smooth muscle cells from 6 and 14 week old rats 
expressed as a proportion of the [JH]-phosphatidylinositol released:
Noradrenaline 
Concentration (M)
6 Week Rats 14 Week Rats
WKY SHR WKY SHR
(n=6) (n=7) (n=6) (n=7)
10'4 9.5 ±1.4 10.6 ±2.9 5.5 ±1.3 14.8 ± 8.9 *
3 x 10"5 9.4 ±1.7 9.3 ± 2.4 5.1 ± 1.0 8.2 ± 0 .5 *
10'5 3.4 ±0.5 3.9 ±1.4 0.8 ±0.3 6.1 ± 1 .2 *
3 x 10'6 2.5 ±0.6 2.6 ±1.0 0.6 ±0.3 4.9 ± 1 .1 *
10'6 0.6 ±0.3 1.6 ±0.8 0.4 ±0.3 3.0 ± 1 .4 *
3 x 10"7 1.1 ±0.5 0.7 ± 0.4 0.1 ±0.1 1.4 ± 0 .4 *
io -7 1.4 ±0.6 0.5 ±0.2 0.1 ±0.1 1.1 ± 0 .2 *
All results are mean ± s.e.m. * p< 0.05 for SHR versus WKY.
Endothelin-1 stimulated inositol phosphate formation calculated using this method 
also gave the same results to those obtained by expressing stimulation as a % of 
basal inositol phosphate formation i.e. no change at 6 weeks and a decrease in SHR 
cells at 14 weeks.
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3.3.3. Time Course Experiments
The time course experiments measuring basal inositol phosphate formation (fig.3.9) 
showed no difference between SHR and WKY after 3 or 6 hours incubation with 
rH ]-m yoinositol. This was reflected in the basal phosphatidylinositol formation 
where no difference was observed at 3, 6 or 9 hours incubation (figure 3.10). 
However, at 9 hours and at all subsequent times measured SHR inositol phosphate 
formation was significantly increased compared to that of WKY aortic smooth 
muscle cells. Basal phosphatidylinositol formation was also increased in SHR cells 
at 18 hours incubation and thereafter.
3.4.DISCUSSION
In these experiments smooth muscle cells cultured from the aorta of both 6 week and 
14 week SHR showed an increased basal inositol phosphate formation compared to 
WKY cells. Basal phosphatidylinositol formation was also increased in these 
hypertensive cells. A sim ilar increase in basal inositol phosphate and basal 
phosphatidylinositol formation was also observed by Resink et al (1987) in cultured 
aortic smooth muscle cells from 20 week old SHR. Uehara et al (1988) have 
demonstrated that vascular phospholipase C basal activity (quantified by direct 
measurement of the enzyme activity) in the aortic wall of SHR at 4 weeks and 14 
weeks was increased and enzymatic activities were positively correlated with blood 
pressure. These increases presumably reflect increased basal turnover of the 
phosp h atid y lin o sito l cycle and could therefore contribute to an increased  
vasoconstriction under basal conditions in hypertension. As the observed increase in 
this study were apparent in cultured smooth muscle cells from 6 week SHR they 
may play a role in the development of hypertension in this model. This increased
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Arrows denote myofilaments
FIGURE 3.1 : Electronmicrograph of cultured aortic smooth muscle cells from 6
week WKY rats
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FIGURE 3.2 : Electronmicrograph of cultured aortic smooth muscle cells from 6
week SHR
Arrows denote myofilaments
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Arrows denote myofilaments
FIGURE 3.3 : Electronmicrograph of cultured aortic smooth muscle cells from 14
week WKY rats
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VArrows denote myofilaments
FIGURE 3.4 : Electronmicrograph of cultured aortic smooth muscle cells from 14 
week SHR
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FIGURE 3.5: Endothelin-1 stimulated %-inositol phosphate foimation in 
cultured aortic smooth muscle cells from 6 week SHR and WKY rats. Mean ±  
s.e.m.
O WKY ( n=7)
•  SHR ( n=6)
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FIGURE 3.6: Noradrenaline stimulated ^H-inositol phosphate formation in 
cultured aortic smooth muscle cells from 6 week SHR and WKY rats. Mean ±  
s.e.m.
O WKY ( n=6)
•  SHR ( n=7)
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FIGURE 3.7: Endothelin-1 stimulated ^H-inositol phosphate formation in 
cultured aortic smooth muscle cells from 14 week SHR and WKY rats. Mean ±  
s.e.m.
O WKY ( n=8 )
•  SHR ( n=8)
* p< 0.05 SHR versus WKY
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FIGURE 3.8: Noradrenaline stimulated ^H-inositol phosphate formation in 
cultured aortic smooth muscle cells from 14 week SHR and WKY rats. Mean ± 
s.e.m.
O W K Y (n = 6)
•  SHR ( n=7 )
* p< 0.05 SHR versus WKY
77
BA
SA
L 
IP 
FO
RM
AT
IO
N 
(c
pm
/K
ft
tt
ls
)
6000 -1
5000 -
4000 -
3000 -
2000 -
1000 -
INCUBATION TIME (HOURS)
FIGURE 3.9: Mean basal ^H-inositol phosphate formation in aortic smooth 
muscle cells cultured from 14 week SHR and WKY rats after different incubation 
times with ^H-myoinositol. Mean ± s.e.m.
O W K Y (n=6)
•  SHR ( n=6)
*p<0.05 SHR versus WKY
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FIGURE 3.10: Mean basal ^H-phosphatidylinositol formation in aortic smooth 
muscle cells cultured from 14 week SHR and WKY rats after different incubation 
times with ^H-myoinositol. Mean ± s.e.m.
O WKY ( n=6)
•  SHR ( n=6 )
* p< 0.05 SHR versus WKY
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Age of rats
basal inositol phosphate 
formation 
(cpm per Krcells)
WKY SHR
basal phosphatidylinositol 
formation _
(cpm per l ( r  cells)
WKY SHR
6 week 312+64 671+122
(n=7) (n=6)
9921+1121 16570+1971' 
(n=7) (n=6)
14 week 342+88 870+148'
(n=8) (n=8)
5452+413 16961+3080
(n=8) (n=8)
TABLE 3.1. Basal [%]-inositol phosphate and basal [^H]- phosphatidylinositol 
formation (after incubation with 0.5jiCi [^Hj-m yoinositol) for endothelin-1 
experiments in cultured aortic smooth muscle cells from 6 and 14 week SHR and 
WKY rats. Mean ± s.e.m.
* p< 0.05 SHR compared to WKY response.
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basal inositol phosphate 
formation 
(cpm per 105 cells)
Age of rats
WKY SHR
basal phosphatidylinositol 
formation 
(cpm per H r  cells)
WKY SHR
6 week 942+89 1539+194* 11519+871 18919+3678
(n=6) (n=7) (n=6) (n=7)
14 week 478+94 1300+202* 4330±686 16100+3080*
(n=6) (n=7) (n=6) (n=7)
TABLE 3.2. Basal [^HJ-inositol phosphate and basal PH]-phosphatidylinositol
■3
formation (after incubation with l.OjiCi rH ]-m yoinosito l) for noradrenaline 
experiments in cultured aortic smooth muscle cells from 6 and 14 week SHR and 
WKY rats. Mean ± s.e.m.
* p< 0.05 SHR compared to WKY response.
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basal phosphatidylinositol turnover may have other effects other than those on 
vasoconstriction. The increased phosphatidylinositol turnover and presumably 
increased 1,2-diacylglycerol may lead to an increased activation of protein kinase C. 
This enzyme is involved in smooth muscle proliferation (Ohmi et al, 1990) and 
increased activation may produce increased proliferation of smooth muscle cells 
leading to blood vessel thickening observed in hypertension.
In the parallel study in the previous chapter using freshly isolated aortic rings from 6
and 14 week SHR and WKY rats no change in basal inosito l phosphate or
phosphatidylinositol formation was observed at either time. However a possible
explanation for this difference between cultured cells and aortic rings may lie in the
variation in experimental conditions. Aortic rings were incubated for 4 hours with
[^H]-myoinositol whereas cultured smooth muscle cells were incubated for 18
. . .  ^hours. This shorter labelling time together with a decreased accessibility of the [ H]- 
myoinositol into smooth muscle cells in aorta due to connective tissue could lead to 
less uptake of the [^H]-myoinositol in aortic rings compared to a monolayer of 
cultured smooth muscle cells. Evidence for this explanation is provided by the 
timecourse experiments (figures 3.9 and 3.10). Using cultured smooth muscle cells 
from 14 week SHR and WKY the basal inositol phosphate formation was unchanged 
at 3 and 6 hours in the hypertensive cells whereas at 9 hours and all times measured 
thereafter basal inositol phosphate formation was significantly increased. Basal 
phosphatidylinosito l form ation was increased at 18 hours and thereafter but 
unchanged at 3, 6 , and 9 hours. If the cultured smooth muscle cells had been 
incubated with [% ]-myoinositol for the same length of time as the aortic rings, i.e. 4 
hours, no difference in basal inositol phosphate formation would have been detected.
In aortic smooth muscle cells cultured from 6 week SHR both noradrenaline and
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endothelin-1 - stimulated inositol phosphate formation was unchanged compared to 
WKY smooth muscle cells. Inositol phosphate formation induced by these agonists 
does not appear, in this system, to be involved at an early stage of hypertension. 
Similar results with endothelin-1 and noradrenaline were obtained using aortic rings 
from 6 week old SHR suggesting that culturing of these cells at this stage has not 
altered the phosphatidylinositol hydrolysis observed in fresh tissue.
Endothelin stimulated inositol phosphate formation in cultured smooth muscle cells 
from aortae of 14 week SHR was decreased compared to WKY smooth muscle cells. 
This was maximal at 10~^M endothelin-1 with the SHR response reduced by 60%. 
Clozel (1989) demonstrated that in cultured aortic smooth muscle cells from 14 
week SHR the density of endothelin-1 binding sites is reduced by 57% compared to 
WKY which would account for the decrease observed here in inositol phosphate 
formation with endothelin-1. Decreases in the density of endothelin-1 binding sites of a 
sim ilar magnitude were also reported by Rossi et al (1991) in cultured smooth 
muscle cells from 11 week and 44 week SHR. However, Resink et al (1990) did not 
observe any change in endothelin-1 binding sites in the same cell type from 20 week 
SHR. They also found that endothelin-1 - stimulated inositol phosphate formation 
was increased in SHR aortic smooth muscle cells. This is the opposite effect from 
that which is reported here though the reason for this discrepancy is unclear. In our 
parallel study in aortic rings from SHR we have found that endothelin-1 stimulated 
inositol phosphate formation is also reduced though this reduction is not as great as 
that observed in the cultured hypertensive smooth muscle cells. Therefore in this 
aspect of hypertension the cultured aortic smooth muscle cells from SHR have 
retained the changes observed in freshly isolated aorta from SHR.
Although the hypertensive responses are similar in the cultured cells compared to the 
aortic rings, the sensitivity and maximum responses to endothelin-1 are altered.
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When comparing figure 3.7 (endothelin-1 stimulated inositol phosphate formation in 
cells from 14 week SHR and WKY) and figure 2.5 of the previous chapter 
(endothelin-1 stimulated inositol phosphate formation in aortic rings from 14 week 
SHR and WKY) an increase in the maximum response of cultured cells from both 
SHR and WKY is clearly seen e.g. WKY, 10'^M endothelin-1, cultured smooth 
muscle cells 1683±362% of basal, aortic rings 264±39% of b a sa l; SHR 10'^M  
endothelin-1, cultured smooth muscle cells 575±83% of basal, aortic rings 191±26% 
of basal. Sensitivity is also increased in the cultured cells by approximately 100 fold 
compared to inositol phosphate formation in aortic rings of both SHR and WKY 
rats. These increases in maximal response and sensitivity to endothelin-1 in cultured 
smooth muscle cells are also observed at 6 weeks. The reason for these increases is 
not known though it is possible that desensitization to endothelin-1 in aortic rings 
may be involved (Miasiro and Piava, 1991). The aorta in vivo is exposed to the low 
levels of circulating endothelin-1 that are present in plasma. This sustained exposure 
of the blood vessels to these low concentrations may lead to a permanent down 
regulation of receptors and when the isolated aorta is challenged with endothelin-1 a 
functional response which is decreased due to this down regulation  may be 
measured. Cultured smooth muscle cells are grown in medium with no endothelin-1 
present for up to several weeks which may allow the receptor population to recover 
from any effects of in vivo down regulation. Hence when these cells are challenged 
with endothelin-1 a larger functional response is observed as a result of a larger 
receptor population. Hirata et al (1988) have demonstrated that pretreatment of 
cultured vascular smooth muscle cells with endothelin-1 for 24 hours resulted in a 
decrease in endothelin-1 receptor number. This decrease was reflected in a decreased 
ability of subsequent additions of endothelin-1 to increase cytosolic free calcium 
levels. This decreased calcium rise in down regulated smooth m uscle cells is 
probably the result of a decreased phosphatidylinositol turnover which is what has
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been observed in these aortic rings. Therefore the increased responses in smooth 
muscle cells compared to aortic rings may be due to down regulation of endothelin-1 
receptors in aorta in vivo and this is manifested as a decrease in inositol phosphate 
formation.
In aortic smooth muscle cells cultured from 14 week SHR, noradrenaline stimulated 
inositol phosphate formation was increased compared to control cells. The studies in 
aortic rings have demonstrated that nordrenaline stimulated inositol phosphate 
formation is decreased in SHR. It appears that perhaps a phenotypic change has 
occurred in these smooth muscle cells during culture involving increased ocj 
adrenoceptor number or an alteration in the G-proteins. This change would be 
specific to noradrenaline as endothelin-1 responses in cells were not different from 
responses in aortic rings. Alternatively these cells may be expressing a characteristic 
which is evident in isolated smooth muscle cells but is not detected in the whole 
artery due to structural limitations. The increase in noradrenaline stimulated inositol 
phosphate formation is in agreement with changes seen in small arteries. Therefore 
these aortic smooth muscle cells, once removed from the vessel matrix and free from 
influences that act upon the cell in situ, may resume characteristics which reflect 
small muscular artery cells more than cells from a large elastic artery such as the 
aorta. Unlike the endothelin-1 responses in the cultured cells the noradrenaline 
stimulated inositol phosphate formation in the cells does not show any changes in 
sensitivity or maximum response compared to aortic rings. This may be due to 
adrenoreceptors being less susceptible to desensitization than endothelin-1 receptors.
The alterations in inositol phosphate formation in cultured smooth muscle cells with 
endothelin-1 and noradrenaline suggest that, although these agonists act via the same 
second messenger system (phosphatidylinositol cycle), the changes in reactivity 
which occur are agonist specific and that these agonists are regulated independently.
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This reg u la tio n  could  occur at recep to r level, or d iffe ren t isoenzym es o f 
phospholipase C , different pools of phosphatidylinositol or at the level of the G- 
protein. Cultured smooth muscle cells are ideal for investigations of this type. 
Reynolds et al (1989) have shown in cultured vascular smooth muscle cells that 
endothelin-1 stimulates inositol phosphate formation via a G-protein that is partially 
pertussis toxin sensitive. However LaBelle and M urray (1990) observed that 
noradrenaline stimulated increases in inositol phosphate formation were insensitive 
to pertussis toxin in permeabilized vascular smooth muscle. If the independent 
regulation of these agonists is controlled by G-proteins then the alterations in 
inositol phosphate formation observed in hypertensive cells may be due to changes 
in the G-protein(s)(Sharma and Bhalla, 1988).
For the purposes of examining changes in the signal transduction system in vascular 
smooth muscle it is technically easier to use a cultured monolayer of cells. We have 
shown that, in comparison to our earlier study in aortic rings, the cultured aortic 
smooth muscle cells from SHR do retain some of the properties of freshly isolated 
hypertensive aorta (as in the case of endothelin-1). However, it appears that there are 
also some changes in cultured smooth muscle cells which do not reflect those 
occurring fresh tissue e.g. noradrenaline stimulated inositol phosphate formation in 
cultured aortic cells from 14 week SHR.
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CHAPTER FOUR
INOSITOL PHOSPHATE FORMATION IN AORTIC RINGS AND 
CULTURED AORTIC SMOOTH MUSCLE CELLS FROM PERINEPHRITIS 
HYPERTENSIVE RABBITS: EFFECTS OF NORADRENALINE AND
ENDOTHELIN-1
87
4.1. INTRODUCTION
The perinephritis hypertensive rabbit is a model of secondary hypertension where 
one kidney is wrapped in cellophane or other irritants and the contralateral kidney 
removed (Page, 1939). The cellophane wrapped loosely around the kidney results in 
an inflammatory reaction which produces a fibrous scar tissue around the kidney 
(Graef and Page, 1940). This capsule causes compression of the kidney thereby 
directly increasing interstitial pressure. Another similar model of this type is the 
bilateral cellophane wrapped kidney model. However this model has a slower onset 
of hypertension and the maximum blood pressure reached is less severe than the 
perinephritis (one kidney wrap) model (Campbell et al,1973).
4.1.1. In Vivo Responses
Van Boom and Saxena (1980) m easured kidney blood flow in perinephritis  
hypertensive rabbits and found a decrease of 41% 5 weeks after surgery. Fletcher et 
al (1976) have demonstrated in rabbits with bilateral renal cellophane wrapping that 
total peripheral resistance was significantly increased by 76% in hypertensive rabbits 
32 days after surgery compared to controls. In the same model Takata et al (1988) 
have shown that 4 weeks after surgery renal vascular conductance was reduced by 
50%. This decrease, however, could only account for 10% of the fall in total 
peripheral conductance and so 90% of this was due not to direct compression of the 
kidneys but probably caused by other functional changes leading to the development 
of hypertension. They suggested that angiotensin II was responsible for a substantial 
fraction of the decreased peripheral conductance therefore amplifying the effect of 
kidney constriction. This was witnessed by the antihypertensive effect of enalapril, 
an angiotensin converting enzyme inhibitor, in the bilateral kidney wrap rabbits 
(Denton and Anderson, 1985) . However, a previous study by these authors had
shown no change in plasma renin activity (Denton et al, 1983). In perinephritis (one 
kidney wrap) hypertensive rabbits Campbell et al (1973) demonstrated that plasma 
renin was decreased during development of the hypertension but returned to normal 
when the rise in blood pressure was established (30 days after surgery). Hamilton 
and Reid (1983) observed no change in plasma renin activity in perinephritis 
hypertensive rabbits at either 1 week or 6 weeks after surgery and no alteration in 
the pressor response to angiotensin II. Therefore in the perinephritis m odel 
angiotensin II does not appear to contribute to this am plification of the kidney 
constriction and consequently increased total peripheral resistance. They did, 
however, demonstrate that pressor responses were increased to noradrenaline and 
phenylephrine but not o^-adrenoceptor agonists in hypertensive rabbits. This 
increase was apparent 1 week after surgery and was not a result of altered basal 
levels of noradrenaline, changes in noradrenaline clearance, decreased baroreceptor 
sensitivity, or hypertrophy of the arterial wall. It did also not appear to be due to 
alterations in otj-adrenoceptor density or affinity.
4.1.2. In Vitro Responses - Noradrenaline
An increased contractile sensitivity to noradrenaline was also dem onstrated in 
mesenteric arterial rings in this model at a time when hypertension was established 
(4-6 weeks after surgery) (Hall et al, 1990) but not in aortic rings from hypertensive 
rabbits 2-5 months after surgery (Dong and Wadsworth, 1985) reflecting the in vivo 
increase in pressor responses. No increase in contractile response was found to 
potassium chloride in mesenteric arterial rings suggesting that this increase is 
receptor mediated and not membrane potential mediated (Hall et al, 1990).
Studies with ^ C a ^ + have revealed that basal influx of calcium in isolated arteries 
from perinephritis hypertensive rabbits is increased (Dong and Wadsworth, 1987; 
Hall et al, 1990; Tomera and Harakel, 1982) but this was unchanged (Hall et al,
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1990) or decreased (Dong and Wadsworth, 1987) when arteries were stimulated 
with noradrenaline suggesting that differences in contractile sensitivity are not due to 
differences in extracellular calcium influx. These observations with ^ C a ^ + influx 
were also reflected in vivo. Hamilton et al (1987) have also shown that calcium 
antagonists caused a greater fall in mean arterial pressure under basal conditions in 
perinephritis hypertensive rabbits (possibly reflecting the increased dependence of 
basal tone on extracellular calcium as also seen with increased ^ C a ^ + influx). Also 
pressor responses to phenylephrine were attenuated with calcium antagonists by a 
sim ilar extent in hypertensive and control rabbits suggesting a com parable 
dependence on extracellular calcium for stimulation. Therefore differences in 
noradrenaline responses in hypertensive rabbits are not due to an increased influx of 
extracellular calcium (suggested by both in vivo and in vitro experiments) indicating 
a role for intracellular calcium.
4.1.3. In Vivo Responses - Endothelin-1
Increases in agonist responsiveness do not appear to be a general phenomenon in 
this form of hypertension. As already described Hamilton and Reid (1983) found no 
change in responsiveness with angiotensin II and the (^-adrenoceptor agonist, 
guanabenz. Endothelin’s effects on pressor responses in perinephritis hypertensive 
rabbits have been examined by Huang et al (1990). In both 2 week and 6 week 
postoperative rabbits the absolute maximum pressor response was greater in 
hypertensives, however, when examined in relation to starting mean arterial pressure 
this difference did not achieve significance. Also calcium antagonists attenuated 
pressor responses to endothelin-1 in both hypertensive and control rabbits but the 
effect was greater in the hypertensives. This may indicate that an increased pressor 
response to endothelin-1 in hypertensive rabbits is dependent on extracellular 
calcium unlike that of noradrenaline. It has been reported that endothelin-1’s
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contractile action in vascular smooth muscle is partly dependent on the influx of 
extracellular calcium (Wallnofer et al, 1989).
4.1.4. Aims
One pathway by which noradrenaline and endothelin-1 mediate contraction is via the 
phosphatidylinositol cycle which causes an increase in intracellular calcium . 
Therefore if there is an alteration in the levels of intracellular calcium in the smooth 
muscle from hypertensive rabbits, reflected by increased pressor responses, then this 
may be produced by an increased agonist stimulated inositol phosphate formation.
The perinephritis hypertensive rabbit, a model of secondary hypertension, has been 
chosen for comparison to similar studies that have been completed in the SHR, a 
genetic model of hypertension. Also as with the previous study several time points in 
the development of perinephritis hypertension have been chosen. As increased 
pressor responses were observed at 1 week after surgery (Hamilton and Reid, 1983) 
it was decided to study rabbits at 1, 2 and 6 weeks postoperative. Blood pressure is 
significantly increased after 1 week in this model and continues to rise rapidly at 2 
weeks reaching a maximum at 4 - 6 weeks (Hamilton and Reid, 1983). As already 
mentioned the advantages of a secondary hypertensive model such as this are that 
both the controls and the hypertensives are genetically the same whereas this is not 
the case with the SHR. Also as the perinephritis hypertensive rabbit is a larger 
animal model the greater tissue yield per animal means that a more complete study 
can be carried out for agonist responses.
Noradrenaline stimulated inositol phosphate formation in the aorta from 1, 2 and 6 
week postoperative perinephritis hypertensive and control rabbits have been 
m easured  to determ ine if this is a lte red  in h y p ertensive  sm ooth m uscle. 
Noradrenaline stimulated inositol phosphate formation in femoral arteries has also
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been measured to determine if any changes observed are vessel specific to the aorta. 
Endothelin stimulated inositol phosphate formation was also examined in aorta to 
establish if any alterations observed to noradrenaline in the hypertensives were 
general changes or are agonist specific.
As with the previous study in aorta from SHR and WKY rats, primary cultures from 
the aorta of perinephritis  hypertensive  and con tro l rabb its  w ere p repared . 
N oradrenaline and endothelin-1 stim ulated inositol phosphate form ation was 
measured to ascertain whether any alterations in inositol phosphate form ation 
observed in freshly isolated tissue would be retained in the smooth muscle cells 
when subjected to culture conditions.
4.2. METHODS
4.2.1. Surgical Procedures
Male New Zealand white rabbits (2 - 2.5 kg) were used throughout this study. The 
surgery was perform ed as previously described by Hamilton and Reid (1983). 
Rabbits were anaesthetized with sodium pentobarbitone (30 mg /  kg). Both flanks 
were injected subcutaneously with 2 % lignocaine and bilateral incisions made to 
expose the kidneys. A ligature was tied tightly round the renal artery and vein of the 
left kidney and this kidney was then removed using a scalpel. The right kidney was 
loosely wrapped in cellophane and this was secured with surgical silk taking care not 
to constrict the renal artery. Flank incisions were then sutured. Control animals had 
the left kidney removed as for hypertensives but the right kidney was manipulated 
and not wrapped. Rabbits were kept in individual cages and fed a standard diet and 
water ad libitum . Animals were studied at either 1, 2 and 6 weeks after surgery.
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Mean arterial pressure was measured in conscious rabbits, the day before tissues were 
assayed, by insertion of a polypropylene catheter into the central artery in the ear. 
Rabbits were then kept unrestrained in individual cages in a quiet, warm laboratory 
for at least 60 minutes before any blood pressure measurements were taken using a 
transducer and Grass (model 7B) polygraph.
4.2.2. Assay for Measurement of Inositol Phosphate Formation in Aortic Rings 
Animals were killed  by an overdose of sodium pentobarbitone (60 mg /  kg 
intravenously). Blood vessels (aorta and in 2 week rabbits also the femoral arteries) 
were dissected and immediately placed in cold Krebs solution. The assay was carried 
out as described in chapter 2. There were 8 rings in each sample which were 
weighed before assaying. Samples for each agonist concentration were completed in 
duplicate. [3H]-inositol phosphate formation with noradrenaline (10'^M  - 10'^M) 
was measured in the aorta of 1, 2 and 6 week postoperative rabbits. Endothelin-1 
(10"^M, 10'^M ) and noradrenaline (10"^M - ICT^M) stimulated [3H]-inositol 
phosphate formation was measured in the aorta of a separate 2 week postoperative 
group. In this group the femoral arteries were also assayed for [J H ]-inositol 
phosphate formation with 10"^M noradrenaline.
4.2.3. Assay for the Measurement of Total r%l-Phosphatidylinositol Formation in 
Aortic Rings
The lipid layer remaining after the aqueous phase had been removed was used for 
the m easu rem en t o f the [3H ]-p h o sp h a tid y lin o s ito ls . T o ta l basa l 
phosphatidylinositols were measured in 2 week perinephritis hypertensives and 
controls.
3ml of chloroform :m ethanol (2:1 v/v) was added to each sam ple, then 2ml 
methanol:KC1 (1M)- myoinositol (0.01M) (1:1 v/v) was added and each sample
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m ixed and cen trifu g ed  at 250g for 5 m inutes. The w ash ing  p rocess w ith 
methanol:KCTmyoinositol was repeated twice. The lipid phase was then removed, 
placed in a scintillation vial and left to evaporate overnight. Scintillant was added 
and the samples counted on a liquid scintillation counter.
4.2.4. Preparation of Primary Cultured Aortic Smooth Muscle Cells
Aortic smooth muscle cells were prepared from 2 week perinephritis hypertensive 
and control rabbits by enzymatic digestion as previously described in chapter 3 with 
the exception that 1 aorta was digested for each primary culture. 3 primary cultures 
were prepared for each group and all cells used in assays were between passages 3 
and 10. Some stocks were frozen as described in chapter 3 and stored in liquid 
nitrogen for not more than 3 months. Defrosted cells showed similar responses to 
non-frozen cells.
4.2.5. Assay for the Measurement of Total I^Hl-Inositol Phosphate Formation in 
Cultured Aortic Smooth Muscle Cells
The assay for total [^H]-inositol phosphate formation in cultured rabbit smooth 
muscle cells was carried out as described in chapter 3. For experiments measuring 
endothelin-1 stimulated inositol phosphate formation cells were preincubated with 
0.5}iCi of [^Hj-myoinositol and for noradrenaline experiments l.OjiCi of [^H]- 
myoinositol. Each agonist concentration was completed in triplicate for each assay.
Total [^H]-inositol phosphate formation was measured with noradrenaline (10"^M - 
10'^M) and with endothelin-1 (1 0 '^ M  - lCT^M) in cultured rabbit aortic smooth 
muscle cells from 2 week perinephritis hypertensive and control rabbits. Total [% ]- 
phosphatidylinositols were also measured in these cells as previously described in 
chapter 3.
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4.2.6. Statistical Analysis
All results are mean ± s.e.m. Basal [^H]-inositol phosphate formation is calculated 
as c.p.m. per mg of tissue for aortic rings and as c.p.m. per 10^ cells for cultured 
aortic smooth muscle cells. Stimulated total [^H]-inositol phosphate formation is 
calculated as a % of basal values. Comparisons between hypertensive and control 
agonist responses were analysed using a repeated measure analysis of variance for 
both aortic  rings and sm ooth m uscle cells. U npaired  t-tests  w ere used fo r 
comparisons between femoral artery responses, basal inositol phosphate formation 
and blood pressure analysis. P < 0.05 was considered statistically significant.
4.3. RESULTS
4.3.1. Blood Pressure and Tissue Weight
Mean arterial pressure was significantly increased in hypertensive animals compared 
to controls at all times examined (figure 4.1).
The mean tissue sample weights (calculated from the mean sample weight per assay) 
for each group of rabbits are shown in table 4.1. There was no difference between 
hypertensive and control rabbits at 1 or 2 weeks. However, at 6 weeks the mean 
tissue sample weight from hypertensive rabbits was significantly  increased 
compared to control rabbits.
4.3.2. r3Hl-Inositol Phosphate Formation in Aortic Rings
The basal values for total [% ]-inositol phosphate formation in the aorta are shown 
in table 4.2. There was no significant difference in the basal values expressed as 
c.p.m. per mg of tissue between hypertensive and control rabbits at 1, 2 or 6 weeks.
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Noradrenaline stimulated total [^H]-inositol phosphate formation at 1 week in the 
hypertensive rabbits was not significantly different from controls at any of the 
concentrations examined (figure 4.2). Two weeks after surgery, the [^H]-inositol 
phosphate formation was significantly increased in the hypertensive group compared 
to controls at all concentrations of noradrenaline examined; 10"^M - 10"^M (figure
4.3) and 10‘^M - 10~^M (figure 4.4). In the 6 week postoperative rabbits (figure 
4.5), the mean noradrenaline stimulated [JH]-inositol phosphate formation was 
elevated in the hypertensive group compared to controls at all concentrations 
examined but this was not statistically significant.
The effect of endothelin-1 in the aorta of 2 week postoperative rabbits is shown in 
figure 4.6. At both concentrations of endothelin-1 examined (10“^ M, 10"^M) there 
was no significant difference between the [ H]-inositol phosphate formation of 
hypertensive or control rabbits.
In the femoral arteries, there was no difference in the basal levels between 2 week 
hypertensive rabbits and controls (control, 221 ± 38 c.p.m. per sample, n=6 ; 
hypertensive, 342 ± 52 c.p.m. per sample, n=7). The limited tissue weight of these 
vessels allowed stimulation with only one concentration of noradrenaline, 10‘^M. At 
this concentration, the stimulated [% ]-inositol phosphate formation in the 2 week 
group was significantly increased in hypertensive rabbits compared to controls 
(figure 4.7).
In the 2 week hypertensive and control rabbits, the phosphatidylinositol formation in 
the aorta was measured. In control rabbits the basal [J H]-phosphatidylinositol 
formation was 9320 ± 1648 c.p.m. per sample compared with 13912 ± 2720 c.p.m.
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per sample in the hypertensive rabbits. This difference was not significant.
4.3.3. r3H l-Inositol Phosphate Formation in Cultured Aortic Smooth Muscle Cells 
E lec tron  m icrographs of cu ltu red  aortic  sm ooth m uscle cells from  2 w eek 
perinephritis hypertensive and control rabbits are shown in figures 4.8 and 4.9 
respectively. The cultures were confirmed as smooth muscle cells by the presence of 
m yofilam ents. Basal total [3H ]-inositol phosphate form ation and basal [3H]- 
phosphatidylinositol was similar in hypertensive and control cultured cells (table
4.3). Both noradrenaline stimulated (figure 4.10) and endothelin-1 stimulated (figure 
4.11) inositol phosphate formation were unchanged in hypertensive smooth muscle 
cells compared to controls at all concentrations examined.
4.4. DISCUSSION
Rabbits with perinephritis hypertension display an increased pressor response to ccj- 
adrenoceptor agonists which is apparent 1 week after surgery and is present 
throughout the development of hypertension (Hamilton and Reid, 1983). The results 
presented here suggest that a generalized increase in [J H ]-inositol phosphate 
formation may not be involved in the initiation of perinephritis hypertension in the 
rabbit. At 1 week after surgery, although blood pressure was significantly increased 
in hypertensives, there was no change in inositol phosphate formation. 2 weeks after 
surgery there was a significant but transient increase in noradrenaline stimulated 
[3H]-inositol phosphate formation in the hypertensive animals which, by 6 weeks, 
had decreased. The phosphatidylinositol formation m easured in the 2 week 
postoperative rabbits, showing no difference between hypertensive and control 
animals, suggests that the increased inositol phosphate formation was not caused by 
an increased uptake of [% ]-myoinositol by hypertensive smooth muscle. This may 
ind icate  that increased  inosito l phosphate form ation  has a ro le  during  the
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Mean tissue sample weight (mg)
Time after surgery (Weeks) control hypertensive
1 35.4 ± 3.7 (n=7) 37.6 ± 6.8 (n=6)
2 40.0 ± 0.6 (n=5) 36.1 ± 6.2 (n=7)
6 40.8 ± 2.0 (n=8) 51.0 ± 6.8 (n=7) *
2(separate group) 32.5 ± 4.4 (n=7) 33.9 ±3.1 (n=8)
TABLE 4.1.: Mean tissue sample weight of aorta per assay in hypertensive and 
control rabbits 1, 2 and 6 weeks after surgery. Mean ± s.e.m.
* p < 0.05 compared to control
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Basal inositol phosphate formation (c.p.m. per mg)
Time after sureerv (Weeks) control hvnertensive
1 30 ± 5 (n=7) 42 ± 8 (n=6)
2 35 ± 9 (n=5) 40 ± 4 (n=7)
6 32 ± 5 (n=8) 26 ± 5 (n=7)
2(separate group) 28 ± 3 (n=7) 36 ± 5 (n=8)
TABLE 4.2.: Basal [^H]-inositol phosphate formation in aortic rings from 
hypertensive and control rabbits 1,2 and 6 weeks after surgery. Mean ± s.e.m.
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c.p.m. per 10^ cells 
control hypertensive
Basal inositol phosphate 549 ± 43 (n=5) 642 ± 124 (n=5)
formation (endothelin)
Basal inositol phosphate 515 ± 47 (n=5) 561 ± 123 (n=5)
formation (noradrenaline)
Basal phosphatidylinositol 5514 ± 1331 (n=5) 6521 ± 2004 (n=5)
(endothelin)
Basal phosphatidylinositol 6726 ± 790 (n=5) 8674 ± 2053 (n=5)
(noradrenaline)
TA B LE 4 .3 . : B asal [^ H ]-in o s ito l p h o sp h a te  fo rm atio n  and b asa l [^H ]- 
phosphatidylinositol formation in cultured aortic smooth muscle cells from 2 week 
hypertensive and control rabbits (endothelin-1 experiments incubated with 0.5|iCi, 
noradrenaline experiments incubated with 1.0[iCi [JH]-myoinositol). Mean ± s.e.m.
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FIGURE 4.3 : Noradrenaline (10"^M - 10"^M )stimulated ^H-inositol phosphate 
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FIGURE 4.6 : Endothelin-1 stimulated %-inositol phosphate formation in aortic 
rings from hypertensive and control rabbits 2 weeks after surgery. Mean ± s.e.m. 
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FIGURE 4.8 : Electronmicrograph of cultured aortic smooth muscle cells from 
perinephritis hypertensive rabbits 2 weeks after surgery
Arrows denote myofilaments
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FIGURE 4.9 : Electronmicrograph of cultured aortic smooth muscle cells from 
uninephrectomized control rabbits 2 weeks after surgery
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FIGURE 4.10 Noradrenaline stimulated ^H-inositol phosphate fonnation in 
cultured aortic smooth muscle cells from hypertensive and control rabbits 2weeks 
after surgery. Mean±s.e.m.
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cultured aortic smooth muscle cells from hypertensive and control rabbits 2 
weeks after surgery. Mean ± s.e.m.
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development of hypertension in this model at a time when the blood pressure is rising 
rapidly. However, we are unable to exclude the possibility that this rise could be due 
to indirect effects. In addition, it may not necessarily reflect changes that are 
occurring at the level of the small arterioles. The increased inositol phosphate 
formation in the 2 week hypertensive rabbits is not specific to the aorta as shown by 
an increased  [^H ]-inosito l phosphate form ation  in the p resence  o f 10 '^M  
noradrenaline in femoral arteries. The fact that this increase has occurred in a small 
artery, where it is suggested that the abnormalities in the hypertensive vasculature 
are to be found (Zweifach et al, 1981) may have important implications for blood 
pressure regulation in the whole animal when hypertension is developing. Although 
an increased pressor responsiveness has been observed in this model at 1 week, this 
does not appear to be caused by an increased inositol phosphate formation. This 
increase could be due to changes in calcium sensitivity or other events occurring 
further down the signal cascade.
In the 6 week hypertensive rabbits, the mean tissue sample weight was significantly 
increased above control tissues, providing evidence of hypertrophy. The increased 
inositol phosphate formation at 2 weeks was probably not due to hypertrophy since 
there was no difference between hypertensive and control tissue sample weights at 
this stage.
The increase in inositol phosphate formation does not appear to be due to any 
generalized membrane change as dem onstrated by the lack o f change with 
endothelin-1. No difference was observed between hypertensive and control rabbits at 
either concentration examined. It appears that the endothelin-1 and noradrenaline 
effects are regulated independently, as suggested by their differential actions in this 
model of hypertension, although both these agonists’ actions are mediated, in part,by
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the phosphatidylinositol cycle. This independent regulation may be via separate 
pools of phosphatidylinositols, different isoenzymes of phospholipase C or different 
G - proteins. Noradrenaline and endothelin-1 were found to be mediated independently 
with regards to their effects on inositol phosphate formation in cultured aortic 
smooth muscle cells from 14 week SHR and WKY rats (chapter 3). This independent 
regulation in the perinephritis hypertensive rabbit may be via a similar mechanism.
Pressor responses to noradrenaline and endothelin-1 may both be increased in 
perinephritis hypertensive rabbits (Hamilton and Reid, 1983; Huang et al,1990). 
However data with calcium antagonists suggests that in the case of noradrenaline 
increased extracellular calcium influx is not important in producing the increased 
response. In contrast the increased pressor responses to endothelin-1 were attenuated 
to a greater extent with calcium antagonists in perinephritis hypertensive rabbits at 2 
and 6 w eeks (H uang et al, 1990) suggesting  an in c reased  dependence  on 
ex tracellu lar calcium . The present in vitro  data is indicative of an increased 
intracellular calcium mobilisation with noradrenaline but this is unchanged with 
endothelin-1. This is compatible with the in vivo data implying that increased 
noradrenaline responses are due to increased intracellular calcium and increased 
endothelin-1 responses may be the result of increased influx of extracellular calcium. 
However this is only speculation as it is difficult to compare in vitro data with in 
vivo responses in the whole animal.
C u ltu red  aortic  sm ooth m uscle cells p repared  from  2 w eek p e rin ep h ritis  
hypertensive rabbits showed similar endothelin-1 and noradrenaline stimulated inositol 
phosphate formation to cultured cells from control rabbits. Therefore the alterations 
observed in noradrenaline stimulated inositol phosphate formation in freshly isolated 
aorta are not retained in the cultured aortic cells. This is not surprising as this model
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of hypertension is not of genetic origin and any alterations that occur to the smooth 
muscle cells in situ are the result of neuronal and humoral changes brought about by 
the kidney wrapping. Once the smooth muscle is removed from these influences and 
the primary cultures prepared it is probable that these altered cell processes would 
revert to normal. As these cultured smooth muscle cells had been passed at least 3 
times and therefore grown for a considerable time under culture conditions away 
from in vivo influences this explanation seems likely. In chapter 3 cultured aortic 
smooth muscle cells from SHR some characteristics of fresh tissue were retained 
unlike here. The SHR, being a genetic model of hypertension means that any 
alteration in the vasculature is intrinsic within each cell and in the present study 
some of these changes appear to be expressed under culture conditions.
a
In summary, although basal [JH]-inositol phosphate formation was unchanged 
throughout the development of perinephritis hypertension in the rabbit, an increase 
in noradrenaline stimulated [^H]-inositol phosphate formation in the aorta and 
femoral artery was observed at 2 weeks. Noradrenaline stimulated [^H]-inositol 
phosphate formation was unchanged in the aorta of hypertensive rabbits at 1 and 6 
weeks. The increase at 2 weeks was not a generalized increase to all agonist 
stimulation as endothelin-1 had similar effects on inositol phosphate formation in 
both hypertensive and control rabbits.
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CHAPTER FIVE
GTP-BINDING PROTEIN COUPLING TO INOSITOL PHOSPHATE 
FORMATION IN CULTURED AORTIC SMOOTH MUSCLE CELLS FROM 
SPONTANEOUSLY HYPERTENSIVE RATS
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5.1. INTRODUCTION
In chapter 3 it was demonstrated that in aortic smooth muscle cells cultured from 14 
week SHR and WKY rats noradrenaline and endothelin-1 are regulated independently 
with regards to their effects on the phosphatidylinositol cycle. Endothelin-1 stimulated 
inositol phosphate formation was decreased in cultured cells from SHR whereas 
noradrenaline stimulated inositol phosphate formation was increased in SHR smooth 
muscle cells compared to WKY. This differential regulation could occur at various 
stages in the signal transduction pathway as shown in figure 5.1.
5.1.1. Regulation of Signal Transduction Pathways
One possibility is that noradrenaline and endothelin-1 stimulate the breakdown of 
phosphatidylinositol-4,5-bisphosphate via different GTP binding-proteins (G- 
proteins) (figure 5.1(a)). Alternatively this regulation may occur further down the 
signal cascade at the level of phospholipase C (figure 5.1(b)). At least 5 distinct 
classes of phospholipase C isoenzymes have now been detected (Rhee et al,1989). 
Complete amino acid sequences of 4 of these isoenzymes has been established. 
However the overall structural similarity of these isoenzymes is surprisingly low 
which suggests that each isoenzyme has a defined function in processing the 
responses in d ifferent cell types and to a variety  of agonists. It is therefore 
conceivable that phosphatidylinositol-4,5-bisphosphate breakdown maybe brought 
about by endothelin-1 and noradrenaline acting via 2 different isoenzymes of 
phospholipase C and that these enzymes may be altered differently in hypertension. 
A third possibility is that regulation of endothelin-1 and noradrenaline occurs at both 
the G-protein and phospholipase C with each agonist acting through different G- 
proteins and different isoenzymes of phospholipase C (figure 5.1(c)).
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( A )
NA -
ET -  
(  B )
NA --------------------- ► R(NA)
ET ---------------------- ► R(ET)
( C )
NA -------------------- ► R(NA) ------------------- ► G(NA)
ET --------------------- R(ET)  --------------------► G(ET)
FIGURE 5.1: Possible sites of independent regulation of noradrenaline and 
endothelin stimulated inositol phosphate formation.
Abbreviations shown overleaf.
P LC (N A)
PL C (E T )
P LC (N A)
P L C (E T )
R(NA)
R(ET)
G(NA)
G(ET)
PLC
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Abbreviations For Figure 5.1;
NA - noradrenaline 
ET - endothelin-1 
R - receptor
R(NA) - receptor selective for noradrenaline 
R(ET) - receptor selective for endothelin-1 
G - GTP-binding protein
G(NA) - GTP-binding protein selective for noradrenaline 
G(ET) - GTP-binding protein selective for endothelin-1 
PLC - phospholipase C
PLC(NA) - isoenzyme of phospholipase C selective for nordrenaline 
PLC(ET) - isoenzyme of phospholipase C selective for endothelin-1 
IP - Inositol phosphate formation
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5.1.2. G-protein Activation of Phospholipase C
One method which can be utilised to investigate the above possibilities is to examine 
the effect of pertussis toxin on endothelin-1 and noradrenaline stimulated inositol 
phosphate formation. Pertussis toxin causes the ADP-ribosylation of the a-subunit 
o f the Gj and GQ classes of G -protein. This pertussis toxin catalysed ADP- 
ribosylation prevents the a-subunit from binding GTP. The effect is therefore to 
uncouple the modified G-protein from receptors thereby preventing otherwise linked 
downstream signalling cascades from being triggered by receptor agonists. If either 
noradrenaline or endothelin- 1 stimulation of inositol phosphate formation is mediated 
by Gj or GQ class of G-proteins then pertussis toxin should produce a blockade of 
inositol phosphate formation.
It has been suggested that at least 2 different phospholipase C associated G-proteins 
(Gp) exist although the identity of these G-proteins remains to be established 
(Harden et al, 1990). Several authors have demonstrated that Gp can either be 
pertussis toxin sensitive, e.g. epidermal growth factor in hepatocytes (Johnson et 
al,1986), angiotensin II in renal mesengial cells (Pfeilschifter and Bauer, 1986) or 
pertussis toxin insensitive, e.g. angiotensin II in hepatocytes (Johnson et al, 1986), 
vasopressin in hepatocytes (Uhing et al, 1986), depending on the receptor and cell 
type examined.
5 .1.3 . Involvement of G-Proteins in Noradrenaline and Endothelin-1 Responses
It is likely that in the cultured aortic smooth muscle cells used in these experiments 
the stimulation of inositol phosphate formation occurs via a G-protein. Labelle and 
Murray (1990) have demonstrated that GTP7S (a non-hydrolyzable GTP analogue) 
and noradrenaline stimulate the breakdown of phosphatidylinositol-4,5-bisphosphate 
in permeabilized rat tail artery and these effects were non-additive. AIF4 '  also
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stimulated inositol phosphate formation however noradrenaline stimulated inositol 
phosphate formation in this tissue preparation was not pertussis toxin sensitive. They 
suggested that noradrenaline stimulated inositol phosphate formation occurred via a 
G-protein which did not appear to be or GQ-like in its characteristics. Tohkin et al 
(1990) observed in rat liver membranes that noradrenaline stim ulated inositol 
phosphate form ation was partially inhibited by pertussis toxin suggesting the 
involvem ent of 2 G-proteins in this system, one of which was pertussis toxin 
sensitive. However, in thyroid cells (Burch et al, 1986) and adipocytes (Schimmel 
and Elliot, 1986) pertussis toxin has been reported as having no effect on a -  
adrenoceptor stimulated inositol phosphate formation.
Endothelin-1 also appears to produce inositol phosphate formation via different G- 
proteins depending on the cell type examined. In rat mesengial cells pertussis toxin 
partially inhibited the stimulation of inositol phosphate formation by endothelin-1 
(Thomas et al, 1991) indicating that some of the endothelin-1 response was via a 
pertussis toxin sensitive G-protein. Endothelin-1 stimulated inositol phosphate 
formation was also partially inhibited by pertussis toxin in C-6 glioma cells (Lin et 
al, 1990). Within similar cell types there are conflicting reports as to the nature of 
the G-protein which couples endothelin-1 to phospholipase C. Reynold et al (1989) 
examined endothelin-1 stimulated inositol phosphate formation in cultured vascular 
smooth muscle cells from rabbit renal artery and found that this response was also 
partially inhibited by pertussis toxin. However, Takuwa et al (1990) studying the 
cultured rat aortic smooth muscle A-10 cell line and Mitsuhashi et al (1989) studying 
a neonatal rat vascular smooth muscle cell line did not detect any inhibition of 
endothelin- 1 stimulated inositol phosphate formation in the presence of pertussis toxin. 
It appears from this data that endothelin-1 may be coupled to the phosphatidylinositol 
cycle by more than one G-protein. As there is such an apparent variability in the G-
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protein subtype expressed in vascular smooth muscle cells, it is possible that disease 
states such as hypertension could result in a change in the subtype of G-protein 
expressed.
5.1.4. Aims
In this chapter the effects of pertussis toxin on endothelin-1 and noradrenaline 
stimulated inositol phosphate formation in cultured aortic smooth muscle cells from 
14 week SHR and WKY rats have been examined. This may give an indication of 
the independent regulation of these agonists and reveal whether this is altered in 
hypertension (Sharma and Bhalla, 1988). If the differences observed in agonist 
stimulated inositol phosphate formation in aortic smooth muscle cells from SHR 
compared to WKY are due to alterations in specific G-proteins and these G-proteins 
are pertussis toxin sensitive then pertussis toxin may abolish this difference between 
SHR and WKY.
ADP-ribosylation of G-proteins can be measured directly. By using radiolabelled 
[32p]-NAD (the substrate with which pertussis toxin A D P-ribosylates the G- 
proteins) the labelled proteins can be separated by gel electrophoresis and the G- 
proteins detected by autoradiography. The intensity of the band of radiolabelled 
proteins is an indication of the amount of ADP-ribosylation. The effect of agonists 
on this can be examined providing an additional means for examining differences 
between SHR and WKY at the level of the G-protein. In this chapter the effects of 
en d o th e lin -1  on p e rtu ssis  tox in  dep en d en t A D P -rib o sy la tio n  u sing  gel 
electrophoresis in membranes prepared from cultured aortic smooth muscle cells 
from 14 week SHR and WKY has been examined. This will indicate if endothelin-1 
has any effects on this ADP-ribosylation and if this is altered in hypertension.
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The differences in agonist stimulated inositol phosphate formation observed in SHR 
compared to WKY in the previous chapter could also be the result of differences in 
the influx of extracellular calcium through receptor or voltage operated channels. 
Although measuring inositol phosphate formation does not, of course, give a direct 
indication of the influx of extracellular calcium it has been suggested that small 
increases in cytosolic calcium induced by agonist stimulated calcium influx across 
the cell membrane may result in direct activation of phospholipase C thereby 
amplifying further the inositol phosphate formation (Eberhard and Holz, 1987; 
Akhtar and Abdel-Latif, 1978). If this positive feedback mechanism occurs in these 
cultured aortic smooth muscle cells then alterations in calcium influx may alter 
inositol phosphate formation. For example, in the case of endothelin-1 if calcium 
influx was decreased in the SHR compared to WKY smooth muscle cells and 
receptor mediated inositol phosphate formation was unchanged this may still lead to 
an observed  decrease in overall inosito l phosphate fo rm ation . The ro le  o f 
extracellular calcium on agonist stimulated inositol phosphate formation in SHR and 
WKY cultured smooth muscle cells has been examined in this chapter by measuring 
endothelin-1 stimulated inositol phosphate formation in the absence of extracellular 
calcium. If this were altered in hypertension the differences in inositol phosphate 
formation between SHR and WKY would be expected to be abolished.
The aim of this study was (1) to establish the molecular coupling mechanism of 
endothelin-1 and noradrenaline to inositol phosphate formation in cultured aortic 
smooth muscle cells using pertussis toxin and the removal of extracellular calcium, 
and (2) comparison of this coupling mechanism in SHR and WKY rats.
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5.2. METHODS
5.2.1. Preparation of Primary Cultured Aortic Smooth Muscle
Cultured aortic smooth muscle cells from 14 week old SHR and WKY were 
prepared as described in chapter 3. Growth medium used was Dulbecco’s minimum 
essen tia l m edium containing 8 % foetal ca lf serum , 8% horse serum , 2mM 
glutamine, 100 units ml"* penicillin G and 100 units ml'* streptomycin. Medium 
was changed every 48 hours. The presence of smooth muscle cells was confirmed by 
electron microscopy. Some cells were frozen in 10% dimethylsulphoxide and stored 
in liquid nitrogen for a period of no longer than 6 months. Defrosted cells showed 
similar responses to non-frozen cells. For experimentation cells used were from 
passages 4 to 10.
5.2.2. Assay for the Measurement of Total f HI-Inositol Phosphate Formation in the 
Presence of Pertussis Toxin
Cultured aortic smooth muscle cells were plated on 24 m ultiw ell plates (well 
diameter 1 cm) at a density of 10^ cells per well in growth medium (total volume 1 
ml) and incubated for 24 hours at 37°C in an atmosphere of 95% 0 2: 5% C 02. Cells 
were incubated for 24 hours in serum free, low inositol concentration Medium 199 
and for a further 18 hours with Medium 199 containing either 0.5|iCi (for assays 
with endothelin-1) or l.OjiCi (for assays with noradrenaline) of [JH]-myoinositol. 
For those assays investigating the effect of pertussis toxin (0.1 jig /  ml) preincubation 
fo r 18 hours was carried  out s im u ltan eo u sly  w ith  the [J H ]-m y o in o sito l 
preincubation. After this incubation cells were washed twice with buffer (NaCl 
133mM, KC1 3 .6mM, MgCl2 0.4mM, CaCl2 ImM, D-glucose 16mM, HEPES 
buffer 3mM, pH 7.4) at 37°C and incubated for 10 minutes in buffer containing 
10"2M lithium chloride. For experiments examining the effect of the removal of 
extracellular calcium the buffer had no CaCl2 present and O.lmM EGTA added.
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After the 10 minute incubation the buffer was replaced by either endothelin-1 or 
noradrenaline in buffer containing 10"^M lithium chloride and incubated for a 
further 30 minutes. Total [^H]-inositol phosphate formation was m easured as 
described in chapter 3 (3.2.).
Total [ H]-inositol phosphate formation was measured in cultured aortic smooth 
muscle cells from 14 week SHR and WKY rats under basal conditions and with 
endothelin-1 (10"^M) and noradrenaline (10"^M) after preincubation with pertussis 
toxin (O.ljig ml-*). In a another set of experiments inositol phosphate formation was 
also measured with endothelin-1 after preincubation with l |ig  /  ml pertussis toxin. 
Endothelin-1 stimulated inositol phosphate formation was also measured in cells 
from SHR and WKY in zero calcium + O.lmM EGTA solution after preincubation 
with pertussis toxin.
5.2.3. Pertussis Toxin - Dependent ADP Ribosvlation with T^Pl - NAD 
Cells were grown to confluency and incubated in serum free medium for 24 hours. 
Membranes were prepared by harvesting the cells with trypsin /  EDTA and washing 
twice with buffer A at 4°C containing 0.25M sucrose, ImM EDTA, lOmM tris base, 
2mM benzamidine, and O.lmM phenylmethylsulphonyl fluoride . Samples were 
homogenized and centrifuged in an ultracentrifuge at 50000g for 20 minutes. The 
membranes were resuspended in buffer A.
ADP-ribosylation was carried out as described by Pyne et al (1989). Pertussis toxin 
was activated by addition of an equivalent volume of 50mM dithiothrietol at room 
temperature for one hour. 12p.1 of membranes (protein 10-15|ig) were incubated with 
25|0,1 of reaction cocktail (0.2M thymidine, 1.5M potassium phosphate, 40mM ATP, 
1M arginine, 2.0|iCi [^P]-N A D ),8|il of preactivated pertussis toxin (0.67|ig ml'*) 
and 5|il of 20mM magnesium chloride for 1 hour at 30°C. Some samples were
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incubated with endothelin-1 (10”^ M) diluted in 20mM magnesium chloride solution. 
Protein was precipitated by addition of 250|il of 24% trichloroacetic acid , 694jil of 
distilled water and 6pl of 2% deoxycholate (total volume 1 ml). Samples were 
centrifuged for 10 minutes at 5000g, the supernatant rem oved and the pellet 
resuspended in 10pl of 1M tris base and 20|il sample buffer (10% sodium dodecyl 
sulphate (SDS), 12.5% glycerol, 3.8% mercaptoethanol, 0.5mM tris base and 
bromophenol blue). Samples were placed in a boiling water bath for 2 minutes and 
run on 10% SDS-polyacrylamide gel electrophoresis. Gels were washed in distilled 
water, placed in 10% trichloroacetic acid for 1 hour (room temperature) and dried 
onto filter paper for 40 minutes at 80°C. The gel was then exposed to photographic 
film at -20°C for 2-5 days.
5.2.4. Statistical Analysis
a
All results are mean ± s.e.m. Basal [JH]-inositol phosphate formation is calculated 
as c.p.m. / 105 cells and stimulated [^H]-inositol phosphate formation calculated as a 
percentage of basal values. Com parisons between hypertensive and control 
experim ents were carried out using unpaired t-tests. P < 0.05 was considered 
statistically significant.
5.3. RESULTS
o
5 .3 .1. Effect of Pertussis Toxin Preincubation on T HI-Inositol Phosphate Formation 
As demonstrated in chapter 3 basal inositol phosphate formation was significantly 
increased in cultured aortic smooth muscle cells from SHR compared to WKY 
(noradrenaline basals - table 5.1, endothelin-1 basals - table 5.2(a)). Preincubation with 
pertussis toxin did not alter basal values compared with nontreated basal inositol 
phosphate formation (tables 5.1 and 5.2).
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Figure 5.2 shows the noradrenaline stimulated inositol phosphate formation in 
cultured smooth muscle cells from SHR and WKY pretreated with pertussis toxin. In 
both the cells from SHR and WKY pertussis toxin had no effect on inosito l 
phosphate formation. Furthermore there was also no difference in the ability of 
noradrenaline to stimulate inositol phosphate formation in SHR and WKY cells.
The effect of pertussis toxin on endothelin-1 stimulated inositol phosphate formation 
in cultured smooth muscle cells from SHR and WKY is shown in figure 5.3. 
Endothelin-1 stimulated inositol phosphate formation is significantly decreased 
compared to WKY and supports the previous observations in chapter 3. After 
preincubation with pertussis toxin the endothelin-1 stimulated inositol phosphate 
formation was significantly decreased in both SHR and WKY cells by a similar 
magnitude (SHR - 54% reduction, WKY - 55% reduction). However, the different 
responsiveness to endothelin-1 in SHR and WKY was still maintained in cells after 
preincubation with pertussis toxin and was similar to the difference observed without 
pertussis toxin.
5.3.2.Effect of Zero Calcium + O.lmM EGTA on I^HI-Inositol Phosphate Formation 
The use of zero calcium buffer with the addition of O.lmM EGTA produced a trend 
towards a decrease in basal inositol phosphate formation (table 5.2(b)) in both SHR 
and WKY but this was not significantly different from basal values in ImM calcium 
solution (table 5.2(a)). Preincubation with pertussis toxin produced no further 
change in inositol phosphate formation in the zero calcium solution. However, the 
significantly increased basal inositol phosphate formation in SHR compared to 
WKY was still apparent under these conditions.
In figure 5.4 the effect of pertussis toxin on endothelin-1 stim ulated inositol 
phosphate formation in zero calcium and O.lmM EGTA solution is shown. All
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responses under these conditions were significantly decreased compared to the 
corresponding inositol phosphate formation in ImM calcium solution (figure 5.3). 
Preincubation with pertussis toxin and the rem oval of ex tracellu lar calcium  
significantly decreased endothelin -1 stim ulated inositol phosphate form ation 
compared to zero calcium alone by a similar magnitude in both SHR and WKY 
smooth muscle cells (SHR - 55% reduction, WKY - 51% reduction). In the absence 
of pertussis toxin endothelin-1 stimulated inositol phosphate formation in zero 
calcium solution was significantly decreased in SHR compared to WKY. This is also 
the case for SHR responses in zero calcium solution after preincubation with 
pertussis toxin.
In the small set of experiments where endothelin-1 stimulated inositol phosphate 
formation was measured after preincubation with lOx the original concentration of 
pertussis toxin (lp.g /  ml) both WKY and SHR responses were reduced by the same 
magnitude as for preincubation with 0. ljLig / ml pertussis toxin (table 5.3). Statistics 
are not shown for these experiments due to the small sample size (n=2 for both SHR 
and WKY).
5.3.3. Pertussis Toxin-Dependent ADP-Ribosvlation in the Presence of 
Endothelin-1
The autoradiograph of pertussis toxin dependent ADP-ribosylation of smooth 
muscle membranes from SHR and WKY aortic smooth muscle cells is shown in 
figure 5.5. Pertussis toxin caused the A D P-ribosylation o f a 41kDa protein 
corresponding to Gj in these membrane preparations. In SHR samples without 
agonist present similar levels of ADP-ribosylation were observed to that in WKY. In 
both groups of samples a decrease in ADP-ribosylation was observed in the presence 
of endothelin-1 (10'^M) which was of a similar magnitude in both SHR and WKY.
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BASAL INOSITOL PHOSPHATE
FORMATION
cpm IQS cells
WKY SHR
NO PREINCUBATION 651 ± 88 (n=7) 2007 ± 205* (n=6)
PREINCUBATION WITH 587 ± 56 (n=7) 1920 ± 201* (n=6)
PERTUSSIS TOXIN
TABLE 5.1: Basal inositol phosphate formation ([JH]-myoinositol l|itCi /  ml, 
noradrenaline experiments ) ± pertussis toxin preincubation in cultured aortic 
smooth muscle cells from 14 week SHR and WKY rats. Mean ± s.e.m.
* p< 0.05 for SHR versus WKY.
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(a) ImM Ca2+
BASAL INOSITOL PHOSPHATE 
FORMATION
( cpm /  10^ cells )
WKY SHR
NO PREINCUBATION
PREINCUBATION WITH 
PERTUSSIS TOXIN
428 ± 38 (n=7) 
402 ± 26  (n=7)
987 ± 85 (n=6) 
1032± 106*(n=6)
(b) 0C a2+ +O.lmM EGTA
NO PREINCUBATION
PREINCUBATION WITH 
PERTUSSIS TOXIN
358 ± 27 (n=8) 
356 + 29 (n=8)
710±130 (n=7) 
761± 133*(n=7)
TABLE 5.2: Basal inositol phosphate formation ([^H]-myoinositol 0.5|J,Ci /  ml, 
endothelin-1 experiments) ± pertussis toxin preincubation in (a) ImM calcium 
solution and (b) zero calcium + O.lmM EGTA solution in cultured aortic smooth 
muscle cells from 14 week SHR and WKY rats. Mean ± s.e.m.
* p< 0.05 for SHR v’s WKY . There are no significant differences in the basal 
values within SHR and WKY groups.
129
% STIMULATION
WKY SHR
( n=2) ( n=2)
ENDOTHELIN ALONE 2020 622
ENDOIHELIN AFTER
PREINCUBATION WITH 840 252
PERTUSSIS TOXIN
(l|!g/ml)
TABLE 5.3: The effect of preincubation with pertussis toxin (1.0|ig/ml) on 
endothelin-1 (10"^M) stimulated inositol phosphate formation in cultured aortic 
smooth muscle cells from 14 week SHR and WKY rats.
Statistics are not shown due to small sample size.
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FIGURE 5.2.: Effect of pertussis toxin preincubation on noradrenaline ( 10"^M) 
stimulated inositol phosphate formation in cultured aortic smooth muscle cells from 
14 week SHR and WKY rats. Mean ± s.e.m.
| | no pertussis toxin (WKY n=7, SHR n=6)
pertussis toxin preincubation (WKY n=7, SHR n=6)
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FIGURE 5.3 : The effect of pertussis toxin on 10‘^M endothelin-1 stimulated
inositol phosphate formation in cultured aortic smooth muscle cells from 14 week 
SHR and WKY rats in ImM calcium solution. Mean ± s.e.m.
* p< 0.05 for responses after preincubation with pertussis toxin compared to 
corresponding responses with no pertussis toxin.
+ p<0.05 for SHR responses compared to corresponding WKY responses.
| |  no pertussis toxin (WKY n=7, SHR n=6)
pertussis toxin preincubation (WKY n=7, SHR n=6)
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FIGURE 5.4: The effect of pertussis toxin on 10'^M endothelin-1 stimulated
inositol phosphate formation in cultured aortic smooth muscle cells from 14 week 
SHR and WKY rats in zero calcium solution + 0. ImM EGTA. Mean ± s.e.m.
* p< 0.05 for responses after preincubation with pertussis toxin compared to 
corresponding responses with no pertussis toxin.
+ p<0.05 for SHR responses compared to corresponding WKY responses.
| | no pertussis toxin (WKY n=8, SHR n=7)
0  pertussis toxin preincubation (WKY n=8, SHR n=7) 
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FIGURE 5.5: Typical autoradiograph showing the effect of endothelin-1 (10'^M) on 
pertussis toxin dependent ADP-ribosylation in membranes prepared from cultured 
smooth muscle cells from SHR and WKY rats.
LANE 1: WKY membranes alone ( n=4)
LANE 2: WKY membranes + endothelin-1 ( n= 4)
LANE 3: SHR membranes alone ( n=3 )
LANE 4: SHR membranes + endothelin-1 ( n=3 )
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5.4. DISCUSSION
In cultured aortic smooth muscle cells from 14 week SHR and WKY rats the basal 
inositol phosphate formation was significantly increased in SHR cells compared to 
WKY as previously demonstrated. Pertussis toxin also had no effect on either SHR 
or WKY basal inositol phosphate formation . Although removal of the extracellular 
calcium reduced the basal values, this was not a significant decrease. As both 
pertussis toxin and removal of the extracellular calcium had no effect on basal 
in o sito l phosphate  form ation  this suggests tha t the basa l tu rn o v e r o f the 
phosphatidylinositol cycle in these cells is not dependent on extracellular calcium 
and does not involve a pertussis toxin sensitive G-protein.
In these cells the noradrenaline stimulated inositol phosphate formation does not 
appear to be mediated via a pertussis toxin sensitive G-protein as demonstrated in 
figu re  5.2. L aB elle  and M urray (1990) have also  d em o n stra ted  in th a t in 
permeabilized rat tail artery noradrenaline stimulates inositol phosphate formation 
via a pertussis toxin insensitive G-protein. SHR and WKY responses were similar in 
both pertussis toxin treated and non-treated cells. In chapter 3 an increased inositol 
phosphate formation with noradrenaline was observed in SHR compared to WKY 
which was not seen in these experiments. A possible explanation for this difference 
could be the SHR basal values which showed a greater increase compared to WKY 
in this study compared to the previous. Stimulation expressed as a % of basal 
inositol phosphate formation would therefore lead to an apparent decrease in SHR 
stim ulation. If the noradrenaline stim ulated inositol phosphate form ation is 
expressed as absolute counts the SHR stimulation (with basal values subtracted) are 
significantly increased compared to WKY stimulation (noradrenaline 10'^M SHR - 
1369+166 cpm/105cells, WKY - 465+88 cpm/105cells).
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The endothelin-1 stimulated inositol phosphate formation was approximately 50% 
inhibited by pertussis toxin in both SHR and WKY smooth muscle cells. This 
suggests that one mechanism in these cells by which endothelin-1 produces an increase 
in inositol phosphates is via a pertussis toxin sensitive G-protein. These findings are 
in agreem ent with the findings of other authors. Thom as et al (1991) have 
demonstrated a partial inhibition of endothelin-1 stimulated inositol phosphate 
formation by pertussis toxin in rat mesengial cells. Reynolds et al (1989) have also 
made similar observations in rabbit cultured aortic smooth muscle cells. However, in 
the A -10 smooth muscle cell line Takuwa et al (1990) have dem onstrated that 
endothelin -1 is coupled to the phosphatidylinositol cycle by a pertussis toxin 
insensitive G-protein. It is possible that endothelin-1 may be linked to inositol 
phosphate formation by different G-proteins in different cell systems.
With respect to hypertension in this model the difference in endothelin-1 stimulated 
inositol phosphate formation between SHR and WKY was still apparent in the 
presence of pertussis toxin. This indicates that the increased response in SHR to 
endothelin-1 is not caused by any alterations in the balance of pertussis toxin sensitive 
and insensitive G-proteins.
As pertussis toxin is capable of only a partial inhibition of endothelin-1 stimulated 
inositol phosphate formation it appears that the endothelin-1 stimulation of this second 
messenger system is mediated by more than one mechanism. One possibility is that 
endothelin-1 could activate calcium channels, either directly or indirectly (Goto et al, 
1989), producing an influx of extracellular calcium and further stimulation of 
phospholipase C. Several authors have now demonstrated that vascular smooth 
muscle contractions to endothelin-1 can be inhibited by calcium channel blockers 
suggesting that endothelin-1 produces an influx of extracellular calcium (Yanagisawaet
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al, 1988; Lougee et al, 1990; Eta and Triggle,1991). M arsault et al (1990) have 
shown that tension development in rat aortic strips in response to endothelin-1 is 
determined by several types of mechanisms, both extracellular calcium dependent 
and extracellular calcium independent. These other mechanisms could be altered in 
hypertension in this model. To examine this possibility the effect of removing 
extracellular calcium on endothelin-1 stimulated inositol phosphate formation and the 
additive effects of pertussis toxin were studied. It was found that the removal of 
extracellular calcium reduced all responses to endothelin-1 in SHR and WKY, but not 
completely, suggesting extracellular calcium may play a role in the stimulation of 
inositol phosphate formation by endothelin-1. These results were confirmed by similar 
experim ents in our laboratory using aortic rings from Sprague D awley rats 
(unpublished data) which demonstrated that the endothelin-1 stimulated inositol 
phosphate formation was partially but significantly inhibited in the absence of 
extracellular calcium. In both SHR and WKY smooth muscle cells the inhibitory 
effects of pertussis toxin and removal of the extracellular calcium were additive. The 
decreased inositol phosphate formation with endothelin-1 in SHR cells compared to 
WKY observed in ImM calcium solution was maintained with the zero calcium 
solution (and with zero calcium and pertussis toxin together) suggesting that the role 
of extracellular calcium in this response is not altered in this hypertensive model.
In this study it has been demonstrated that endothelin-1 causes a partial inhibition of 
the pertussis toxin dependent ADP-ribosylation of a 41kDa protein in membranes 
prepared from SHR and WKY cultured aortic smooth muscle cells. The reason for 
the reduction observed with endothelin-1 in these cells is not known although other 
agonists such as insulin have been shown to produce an inhibition of pertussis toxin 
dependent ADP-ribosylation (Rothenburg and Kahn, 1988). It is possible that this 
reduction is due to a dissociation of the a  subunit from the G-protein heterotrimer, 
caused by endothelin-1. Pertussis toxin preferentially ADP-ribosylates the inactive
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heterotrimer but if endothelin-1 binds tightly to its receptor this will activate more 
inactive G-proteins meaning less substrate for pertussis toxin i.e. endothelin-1 is 
driving the G-proteins towards activation, pertussis toxin towards inhibition but the 
endothelin-1 effect is greater. Thomas et al (1991) using rat mesangial cells also 
observed a decrease in pertussis toxin dependent ADP-ribosylation with endothelin- 
1. They demonstrated that GDPpS, which stabilizes the heterotrimer, prevents the 
decreased pertussis toxin dependent ADP-ribosylation observed with endothelin-1. 
This may be the reason in these smooth muscle cells for the observed decrease in 
pertussis toxin dependent ADP-ribosylation in the presence of endothelin-1. This 
suggestion is in line with the levels of inositol phosphate formation observed with 
endothelin-1 which are much greater than those produced by noradrenaline. This 
may explain the potent constrictor action of endothelin-1 compared to other agonists.
In chapter 3 it was observed in cultured aortic smooth muscle cells from SHR and 
WKY rats that the noradrenaline and endothelin-1 signal transduction systems with 
respect to the phosphatidylinositol cycle are regulated independently and that the 
changes observed in SHR may be the result of alterations in this regulation. In this 
study it has been further demonstrated that endothelin-1 and noradrenaline are 
regulated independently at the level of the G-protein, endothelin-1 partially via a 
pertussis toxin sensitive G-protein while no pertussis toxin sensitive G-protein was 
apparent for noradrenaline. Further evidence for this is provided by endothelin-l’s 
ability to decrease pertussis toxin dependent ADP-ribosylation. It has also been 
demonstrated that endothelin-1 stimulated inositol phosphate formation is partly 
dependent on the presence of extracellular calcium in these cells. However no 
alterations in G-proteins or extracellular calcium mediating the increase in inositol 
phosphate formation by endothelin-1 were observed in SHR smooth muscle cells 
com pared to WKY suggesting  that these are not a lte red  in th is m odel o f 
hypertension.
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CHAPTER SIX
INTRACELLULAR CALCIUM CONCENTRATION IN CULTURED AORTIC 
SMOOTH MUSCLE CELLS FROM SPONTANEOUSLY HYPERTENSIVE
RATS
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6.1. INTRODUCTION
6.1.1. Role of Calcium in Vascular Smooth Muscle Contraction
Calcium has a primary role in the contraction of smooth muscle (Bolton, 1986). 
Contractions are produced by increases in cytosolic calcium. The increased calcium 
binds to calmodulin and this calcium /  calmodulin complex activates a kinase 
enzyme (myosin light chain kinase) which leads to the phosphorylation of myosin 
light chain. This phosphorylation is associated with attachment of cross bridges to 
actin and the subsequent development of force (Stull et al, 1991). The increases in 
cytosolic calcium can result from influxes from the extracellular domain via either 
receptor operated or voltage operated calcium channels or release from intracellular 
stores. Part, but not all (Ghosh et al, 1989), of this intracellular calcium can be 
released by activation of the phosphatidylinositol cycle.
Vascular smooth muscle has an inherent tone, i.e. a cycling of the contraction 
process. This is continually altered by humoral factors and neuronal input which 
increases or decreases the muscle tone depending on the needs of the surrounding 
tissue. Humoral factors such as vasoconstrictor hormones increase cytosolic calcium 
by either influx of extracellular calcium or release of intracellular calcium, but in 
many cases both sources of calcium are utilised to produce contraction. For example 
in the case of endothelin-1 both influx of extracellular calcium (Goto et al, 1988) and 
release of intracellular calcium via inositol-1,4,5-trisphosphate stores (Marsden et al, 
1989) have been shown to have a role in the contractile action of this peptide on 
vascular smooth muscle.
6.1.2. Methods for Measurement of Intracellular Calcium Concentration
As calcium is such an important determinant of contraction in blood vessels the
140
ability to measure this is of great importance. While it has been possible to estimate 
calcium influx relatively easily by measuring the uptake of ^ C a ^ + into smooth 
muscle cells the quantitative measurement of intracellular calcium is technically 
more difficult. Earlier techniques for measuring cytosolic free intracellular calcium 
(Blinks et al, 1982) included using the luminescent photoprotein aequorin and 
calcium  sensitive m icroelectrodes. Both of these techniques involve e ither 
m icroinjection (restricting use to larger cell sizes and makes the use of cell 
populations difficult) or various reversible permeabilisation processes (Cobold and 
Rink, 1987)(which grossly perturbs the membrane and therefore may damage the 
functional integrity of the cells). These techniques are therefore lim ited in their 
usefulness. The largest progression in the range of cell types in which calcium levels 
can be quantified has come from the development of fluorescent indicators that can 
be loaded by using hydrolyzable esters. Currently four fluorescent indicators have 
been developed for use: quin 2, fura 2, indo 1 and fluo 3. Their structures have very 
similar binding sites and are modelled on the calcium chelator EGTA.
Quin 2 was the first of the fluorescent indicators to be developed (Tsien, 1980). It 
has a high specificity and 1:1 stoichiometry for calcium ions similar to EGTA. Quin 
2 is a h y d ro p h ilic  m olecu le  and is ad ap ted  by the ad d itio n  o f fo u r 
acetoxymethylester groups giving the molecule lipophilic properties and allowing it 
to cross the cell m em brane. In the cytoplasm  quin 2 acetoxym ethy lester is 
hydrolysed by endogenous esterases to remove the acetoxym ethylester groups 
leaving the parent molecule which is membrane impermeant and is therefore trapped 
inside the cell. Quin 2 will detect any free calcium ions in the cytoplasm and will 
bind to these ions producing an increase in the fluorescence by about six fold. 
However the brightness of quin 2 fluorescence is not very great so that relatively 
high concentrations are needed to overcome cellular autofluorescence. These high
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levels often buffer fast calcium transients. Quin 2 also has poor photostability. These 
disadvantages make quin 2 unsuitable for single cell microscopy and it has been 
used mainly in suspensions of cells in a cuvette.
Fura 2 is currently the most favoured calcium indicator. It has the advantages of quin 
2 as it still has a non-disruptive loading procedure. However fura 2 has a much 
higher brightness than quin 2 (thirty fold increase in fluorescence). Fura 2 also shifts 
the excitation spectrum about 40nm to shorter wavelengths (from 380nm to 340nm) 
upon binding calcium so that the ratio of intensities for the calcium free and the 
calcium bound species of the molecule gives a good measure of calcium levels 
unperturbed by variable cell thickness or dye content (Grynkiewiez et al, 1985). Fura 
2 is also much more resistant to photodestruction than quin 2. Fura 2 is not without 
its problems though. In some tissues the acetoxymethylester hydrolysis is incomplete 
(Highsmith et al, 1986) and fluorescence can become com partm entalized into 
cellular organelles (Aimers and Neher, 1985).
Indo 1 is sim ilar to fura 2 in that it sh ift its excita tion  spectrum  to shorter 
wavelengths upon binding calcium (Grynkiewiez et al, 1985). It has the unique 
property that its emission spectrum also shifts when the molecule binds calcium . 
Compartmentalisation may be less of a problem with indo 1 than fura 2 though it 
bleaches several fold faster. This dye has been less extensively used compared to 
fura 2 .
Fluo 3 is the newest calcium indicator (M inta et al, 1987). It has a very large 
enhancement in fluorescence intensity, about forty fold upon binding calcium. 
However fluo 3 causes negligible wavelength shifts in either excitation or emission 
spectra and in this respect is similar to quin 2 as dual wavelength cannot be used for 
ratio measurements.
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6.1.3. Intracellular Calcium Concentration in Vascular Smooth Muscle
These fluorescent indicators have now been utilised in many studies examining 
vascular smooth muscle. Initial studies used quin 2 . Brock et al (1985) measured the 
intracellular calcium in a suspension of cultured smooth muscle cells from rat aorta 
preincubated with quin 2 acetoxym ethylester. They obtained resting calcium  
concentrations of 193nM which could be increased six fold by the addition of 
angiotensin II. Capponi et al (1985) examining the same cells except grown on 
coverslips observed a basal calcium of 153nM which was also increased by 
angiotensin II. More recent papers exam ining various aspects of in tracellu lar 
calcium and agonist induced rises in calcium have used fura 2 because of its 
advantages over its predecessor quin 2. Authors examining intracellular calcium 
with fura 2 in vascular smooth muscle have reported basal calcium ranging from 
70nM to 200nM (Marsden et al, 1989; Papageorgiou and M organ, 1991) and 
observed stimulation to a variety of agonists such as noradrenaline, neuropeptide Y 
(Erne and Hermsmeyer, 1988) and endothelin-1 (Simpson and Ashley, 1989).
6.1.4. Intracellular Calcium Concentration in Experimental Hypertension 
The techniques mentioned above have now been utilised in investigations in 
hypertension. In hypertension it has been proposed that there is a general increase in 
the permeability of the vascular smooth muscle cell membrane to calcium and that 
this is an intrinsic defect involved in the pathogenesis of hypertension (Kwan, 1985). 
If this is the case then this defect may be reflected in differences in the basal and /  or 
the agonist stimulated levels of intracellular calcium. These differences may be 
detected by the direct measurement of the intracellular free calcium concentration.
Zidek et al (1982) have measured intracellular calcium using ion selective electrodes
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in cultured aortic smooth muscle cells from SHR and WKY rats and observed that 
this was unchanged. However, the same group measured intracellular calcium by the 
same method in aortic smooth muscle cells freshly isolated by enzymatic digestion 
(Zidek et al, 1983) and now found that intracellular calcium was increased in the 
SHR compared to WKY. They suggested that humoral influences in vivo were 
responsible for the increased calcium (as observed in the freshly isolated cells) but 
this was not observed in the cultured cells due to the absence of humoral factors in 
the culture medium. Nabika et al (1985a, 1985b) using quin 2 showed that there was 
no difference in basal calcium concentration in cultured smooth muscle cells from 
SHR compared to WKY. However, stimulation with [arg]vasopressin caused a 
greater increase in intracellular calcium in SHR smooth muscle cells but stimulation 
with angiotensin II was unchanged (Nabika et al, 1985b). Bukoski (1990) using fura 
2 observed that basal intracellular calcium was not changed in primary and first 
passage cultured smooth muscle cells from SHR but SHR calcium levels were 
increased after further subculturing of the cells. Also stimulation with noradrenaline 
was unchanged but an increase to angiotensin II was demonstrated in SHR cells. 
Using indo 1 with lasermicrofluorospectrometry Sugiyama et al (1986) showed that 
in vascular smooth muscle cells from SHR basal intracellular calcium was increased 
but in cells from Goldblatt hypertensive rats there was no change suggesting that the 
increased calcium concentration in hypertension was of genetic origin.
6.1.5. Aims
The most frequently used methods for measuring intracellular calcium are quin 2 or 
fura 2. As fura 2 has several advantages compared to quin 2 it was decided that the 
best available method for this set of experiments would be to use fura 2. As it is 
technically easier to measure intracellular calcium in cultured vascular smooth 
muscle cells rather than in whole artery strips, it was also decided to study cultured 
aortic smooth muscle cells which have already been studied in several of the
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previous chapters. Cultured vascular smooth muscle cells are adherence - dependent, 
i.e. unless they are adhering to a surface such as the plastic of a tissue culture flask 
the cells will not relax or proliferate. A suspension of smooth muscle cells would 
remain contracted and spherical in appearance. For this reason it was decided to 
study cultured vascular smooth muscle cells grown as m onolayers on glass 
coverslips as this is closer to "physiological" conditions than would be a cell 
suspension.
In the following experiments the basal intracellular calcium concentration was 
measured using fura 2 in cultured aortic smooth muscle cells from 14 week SHR and 
WKY rats grown on glass coverslips. As already observed in chapter 3 basal inositol 
phosphate formation is increased in cells from SHR. This may result in increased 
calcium which would correlate with the increased peripheral vascular resistance 
observed in hypertension. It was also attempted to measure noradrenaline and 
endothelin-1 stimulated calcium levels to discover whether these were altered in 
hypertension and reflected the observed changes in noradrenaline and endothelin-1 
stimulated inositol phosphate formation in cultured aortic smooth muscle cells from 
SHR (in chapter 3).
6.2. METHODS
6.2.1. Preparation of Primary Cultured Aortic Smooth Muscle Cells 
Cultured aortic smooth muscle cells from 14 week old SHR and WKY rats were 
prepared by enzymatic digestion as described in chapter 3. Cells used in these 
experiments were between passages 3 and 10.
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6.2.2. Growing Cultured Aortic Smooth Muscle Cells on Coverslips
Confluent cultured aortic smooth muscle cells from either 14 week SHR or WKY 
rats were harvested from a 75cm^ culture flasks using 0.25% trypsin-EDTA 
solution. 10 ml of growth medium (as described in chapter 3) was added and the 
cells centrifuged at lOOg for 5 minutes. The medium was aspirated, 10 ml of fresh 
growth medium was added and the cells resuspended. The cells were counted in a 
haemocytometer slide and the volume adjusted to give a cell density of 10^ cells per 
ml. 10 ml of the cell suspension was added to a sterile petri dish containing four 
glass coverslips which had previously been cut to fit into a cuvette (width 1cm) and 
had been sterilised in alcohol and exposed to a flame. The petri dish was then placed 
in an incubator at 37°C and 5% CO2 for 24 hours. After this incubation period the 
growth medium was carefully aspirated and replaced with serum free growth 
medium (at 37°C). The petri dish was again placed in the incubator for a further 24 
hours.
6.2.3. Measurement of Intracellular Calcium using Fura 2
The petri dish containing monolayers of smooth muscle cells on glass coverslips was 
removed from the incubator. The medium was carefully aspirated and 10 ml of 
buffer at 37°C added (NaCl 120mM, KC1 5mM, M g C ^  1.5mM, C aC ^  ImM , 
HEPES 25mM, glucose lOmM, 0.1% bovine serum albumin; pH 7.4). The cells 
were incubated for another 10 minutes after which the glass coverslips were 
removed and placed in flat bottomed tubes containing buffer at 37°C and 5|4M fura 2 
acetoxymethylester. Coverslip were incubated for 1 hour at 37°C, washed once in 
buffer and placed in a petri dish containing buffer at room temperature. This was 
then placed in the dark for 20 to 30 minutes.
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The coverslip was carefully removed from the petri dish and fixed in a quartz 
cuvette containing 3 ml of buffer at an angle of approximately 30° to the front side 
of the cuvette by a plastic lid. This lid still allowed for the exogenous addition of 
agents without moving the coverslip. The cuvette was placed in a heated chamber in 
a Perkin-Elmer LS-3 fluorescence spectrometer. The spectrometer was connected to 
an IBM compatible computer which was loaded with the Perkin-Elm er fura 2 
software. This computer programme automatically cycles the excitation wavelength 
between 340nm and 380nm and calculates the ratio of 340/380 approximately every 
6 seconds. Emission wavelength remains constant at 509nm. The programme also 
calculates the calcium concentration, after calibration procedures have been carried 
out, using the formula described by Grynkiewiez et al (1985):
R - Rmin
[Ca2+]: = Kd _________
Rmax - R
where R = fluorescence ratio of the sample
Rmax = maximum fluorescence ratio obtained by permeabilizing the cells and 
allowing all the free fura 2 molecules to bind calcium in the 
extracellular medium.
Rmin = minjmum fluorescence ratio measured by adding a calcium chelator 
which competes with the fura 2 and binds the calcium ions.
Kd for fura 2 = 224nM
The coverslip was kept in the cuvette at 37°C for 5 minutes to equilibriate. The 
buffer was continuously stirred by a magnetic stirrer. After 5 minutes measurements 
of the excitation wavelength ratio commenced using the fura 2 software. After 1 
minute agonist (either noradrenaline or endothelin-1) was added by pipette into the 
cuvette. Measurement was stopped after a further 4 minutes.
For each coverslip a separate calibration was run. A maximum fluorescence was first
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obtained by the addition of the ionophore, ionomycin (10|iM ). Once a maximal 
excitation ratio had been achieved a minimal fluorescence ratio was measured by the 
addition of 1.6mM EGTA.
Autofluorescence at 340nm and 380nm (previously calculated by m easuring 
fluorescence of six coverslips with monolayers of cultured smooth muscle cells not 
loaded with fura 2) was subtracted from fluorescence values and the intracellular 
calcium concentration calculated.
6.3. RESULTS
The autofluorescence that was measured in this system was as follows:
380nm = 4.2 
340nm = 5.8
These values were between 5% and 10% of the total fluorescence measured. The 
basal ratio (340/380) obtained was typically between 2.5 and 3.0. Rmax was 
typ ica lly  betw een 6.0 and 7.0 and Rmin 1.5 and 2.0. The ca lcu la ted  basal 
intracellular calcium concentration of cultured aortic smooth muscle cells from 14 
week SHR and WKY rats is shown in figure 6.1. There was no significant difference 
in intracellular calcium levels from SHR compared WKY.
In these experiments no increases in fluorescence ratio were achieved upon addition 
of either noradrenaline (up to a concentration of 10"^M) or endothelin-1 (up to 
concentrations of 10"^M). Other agonists such as angiotensin II, ATP or high K+ 
concentration also did not produce an increase in the fluorescence ratio in this 
system. Various loading conditions were tried to increase the basal fluorescence of 
the cells as it was possible that the failure to observe any stimulation was due to 
insufficient loading of the dye. Initially cells were incubated with 2.5pM fura 2/AM 
and incubated at either room temperature or at 37°C for various times. 5|iM fura 2/
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Figure 6.1 -
Basal intracellular free calcium concentration of cultured aortic smooth muscle 
cells from 14 week SHR and WKY rats.
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AM at 37°C for 1 hour produced the greatest basal fluorescence signal and 
this was the conditions used in these experiments. Cell suspensions were also 
investigated in this system under these conditions. W ith all of these different 
conditions no stimulation was observed upon addition of agonist.
To test w hether the conditions used were adequate for in tracellu lar calcium  
measurements, endothelial cells (primary cultures from bovine aorta) were grown on 
coverslips and examined in this system. Endothelial cells were stimulated with ATP
n
(10_/M)(figure 6.2). A small initial rise was observed followed by a small transient 
decrease and a larger sustained increase which was maintained for approximately 1 
minute. Although this increase in intracellular calcium was small it may represent an 
agonist stim ulated rise suggesting that the conditions used in this system are 
adequate to record a stimulation of intracellular calcium.
The scan of the spectra for excitation and emission wavelengths showed peaks at 
340nm and 509nm respectively in loaded, unstimulated cells demonstrating that the 
fura 2 acetoxymethylester was in the cells and secondly, that the ester moiety had 
been cleaved to produce the fura 2 free acid.
6.4. DISCUSSION
In chapter 3 it was observed that basal inositol phosphate formation in cultured 
aortic smooth muscle cells from 14 week SHR was significantly increased compared 
to WKY. It is possible that this increased inositol phosphate formation could lead to 
an increased basal tone in blood vessels and therefore contribute to the increased 
peripheral vascular resistance observed in hypertension. If this were the case in these 
smooth muscle cells a possible result of the increased basal inositol phosphate 
formation may be a consequential increase in basal intracellular calcium. However,
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in the experim ents with fura 2 in cu ltu red  cells from  SHR no a lte ra tio n  in 
intracellular calcium was observed. There are possible explanations of this finding in 
view of the increased inositol phosphate formation in SHR.
The increased basal phosphatidylinositol-4,5-bisphosphate breakdown produces 
continually increased inositol -1,4,5-trisphosphate m olecules which leads to 
increased binding at inositol-1,4,5-trisphosphate receptor on the sarcoplasmic 
reticulum. This constant increased binding may lead to a downregulation of the 
inositol-1,4,5-trisphosphate receptor and as a result less calcium is released. The 
intracellular free calcium concentration would then remain essentially unchanged. 
This explanation would mean that the increased inositol phosphate formation does 
not increase peripheral vascular resistance by increasing extracellular calcium 
release. However, peripheral vascular resistance may be increased by other factors 
linked to the phosphatidylinositol cycle such as activation of protein kinase C by 
1 ,2 -d iacy lg ly ce ro l w hich w ould p resu m ab ly  a lso  be in c re a se d  if  
phosphatidylinositol-4,5-bisphosphate breakdown is increased. It has been suggested 
by several authors that protein kinase C can modify contraction of smooth muscle. 
Protein kinase C has been observed to increase calcium sensitivity of intracellular 
processes and therefore influence the characteristics of vascular tone (Nishmura and 
van Breeman, 1989). If 1,2-diacylglycerol is increased as a result o f increased 
phospholipase C activity (Uehara et al, 1988) more protein kinase C will be 
activated leading to an increased sensitivity of contractile machinery to calcium. An 
increase in intracellular calcium concentration would not therefore be necessary to 
produce an increase in smooth muscle tone and consequently increase peripheral 
vascular resistance.
A study of freshly dispersed carotid artery smooth muscle cells from perinephritis
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hypertensive rabbits 4 weeks after surgery demonstrated that with Quin 2 the basal 
intracellular calcium concentration was 127nM compared to 102nM in control cells 
(Nixon et al, 1988). There was no significant difference between hypertensive and 
control. This observation is in agreement with the unaltered basal inositol phosphate 
formation in both aortic rings and in cultured aortic smooth muscle cells from 
perinephritis hypertensive rabbits.
No stimulation was achieved with any of the agonists examined. The reason for this 
lies either in the methodology or with the cultured smooth muscle cells. This method 
gave consistent and sensible results for basal intracellular calcium concentrations 
which were well within the normal range reported in the literature (WKY 112 ± 
6nM, SHR 118 ± 7nM). The spectral scan for excitation and emission wavelengths 
demonstrated that fura 2 free acid was present in the cells. It has already been 
demonstrated in chapter 3 that these smooth muscle cells have functional receptors 
to both noradrenaline and endothelin- 1 as shown by the ability of these agonists to 
stimulate inositol phosphate formation. The failure to obtain stimulation is unlikely 
to be due to a lack of functional receptors. An increase in calcium produced by 
noradrenaline or endothelin- 1 would mostly be elicited from calcium released from 
the sarcoplasmic reticulum by the binding of inositol-1,4,5-trisphosphate. It has also 
been shown in these cells that inositol phosphate formation can be produced by 
agonist stimulation.
It was not possible to demonstrate here whether the stimulated intracellular calcium 
concentrations produced by noradrenaline and endothelin-1 are altered in cultured 
aortic smooth muscle cells from SHR and WKY rats. However, it was possible to 
show that the basal intracellular calcium concentration does not appear to be altered 
in cultured aortic smooth muscle cells from 14 week SHR compared to WKY.
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7. GENERAL DISCUSSION
7.1. Summary
In this study 2 m odels of h y p e rten sio n  have been  stu d ied ; the 
spontaneously  hypertensive ra t (a genetic m odel o f hypertension ) and the 
p e rin e p h ritis  h y p e rten siv e  ra b b it (a m odel o f seco n d ary  h y p e rte n s io n ) . 
In both  these  m odels the s ignal tran sd u c tio n  pa th w ay s o f  n o ra d re n a lin e  
and e n d o th e lin -1 w ere exam ined  in ao rtic  rin g s  and in cu ltu re d  ao rtic  
sm ooth  m uscle  ce lls  at various stages d u ring  the d ev e lo p m en t o f 
hypertension.
The above criteria were chosen to examine various aspects of hypertension such as 
the inter-model variation in experimental models of hypertension and the agonist 
specificity of any alterations observed. The suitability of cultured smooth muscle 
cells from hypertensive animals as a model for whole tissue was also investigated. 
Stages early in the development of hypertension and when the rise in blood pressure 
was established in these models was also exam ined to indicate w hether any 
alterations observed may play a role in the pathogenesis of hypertension or may be 
involved in the maintenance of the raised blood pressure.
In chapter 2 aortic rings from 6 week, 14 week and 40 week SHR were examined. 
No alteration in basal inositol phosphate formation was observed in SHR at any age. 
In aortic rings from 6 week SHR both noradrenaline and endothelin-1 stimulated 
inositol phosphate form ation was unchanged com pared to WKY responses. 
However, at 14 weeks noradrenaline and endothelin-1 stimulated inositol phosphate 
formation in aortic rings from SHR was significantly decreased. This was also the 
case in 40 week old SHR. Alterations in basal, noradrenaline or endothelin-1
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stim ulated inositol phosphate form ation did not appear to be involved in the 
development of genetic hypertension at an early stage but, as changes were observed 
at 14 and 40 weeks, it may contribute to established hypertension in this model.
Cultured aortic smooth muscle cells were prepared from 6 week and 14 week old 
SHR and WKY rats. In contrast to aortic rings, in cells from both 6 and 14 week 
SHR the basal inositol phosphate formation was significantly increased. This 
difference between cultured cells and freshly isolated tissue may be accounted for by 
the longer incubation time of the cells, compared to tissue, with ^H-myoinositol. 
Increased basal inositol phosphate formation observed in these cells may contribute 
to the increased peripheral vascular resistance observed in hypertension. Both 
noradrenaline and endothelin-1 stim ulated inositol phosphate form ation was 
unchanged in cultured aortic smooth muscle cells from 6 week SHR. In cultured 
cells from 14 week SHR noradrenaline stimulated inositol phosphate formation was 
increased compared to WKY whereas endothelin-1 stimulated inositol phosphate 
formation was decreased. In these cultured aortic smooth muscle cells from 14 week 
SHR noradrenaline and endothelin-1 appear to be regulated independently with 
respect to their actions on the phosphatidylinositol cycle.
In perinephritis hypertensive rabbits the mean arterial pressure was already 
significantly increased 1 week after surgery. This continued to rise at 2 weeks and at 
6 weeks (when hypertension is established in this model). In aortic rings from 
perinephritis hypertensive rabbits basal inositol phosphate formation was unchanged 
at all times. In 1 week perinephritis hypertensive rabbits noradrenaline stimulated 
inosito l phosphate form ation was unchanged. In aortic  rings from  2 w eek 
perinephritis hypertensive rabbits noradrenaline stimulated inositol phosphate 
fo rm ation  was s ig n ific an tly  in c reased  com pared  to co n tro ls . H ow ever, 
e n d o th e lin -1 s tim ulated  ino sito l phosphate  fo rm ation  was unchanged  at
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th is tim e. N o rad ren a lin e  s tim u la ted  in o s ito l p h o sp h a te  fo rm atio n  was 
unchanged  in ao rtic  rings from  6 w eek p e rin e p h ritis  h y p e rte n s iv e  
rab b its . In co n tra s t to the a lte ra tio n  in ao rtic  r in g s , in  c u ltu re d  
ao rtic  sm ooth m uscle ce lls  p rep a red  from  2 w eek p e rin e p h ritis  
h y p e rten siv e  rab b its  n o rad ren a lin e  s tim u la ted  in o s ito l p h o sp h a te  
formation was unchanged.
In perinephritis hypertensive rabbits alterations in inositol phosphate formation are 
observed at a time when hypertension is developing. However, this was not seen at 
the earliest stage examined suggesting that noradrenaline stim ulated inositol 
phosphate formation is not involved in the initiation of hypertension in this model. 
With cultured aortic smooth muscle cells prepared from 2 week perinephritis 
hypertensive rabbits no change in noradrenaline stimulated inositol phosphate 
formation was observed indicating that the alterations in aortic rings are not retained 
in cultured cells in this model of hypertension.
As noradrenaline and endothelin-1 stimulated inositol phosphate formation appeared 
to be regulated independently in cultured aortic smooth muscle cells from 14 week 
SHR, the possibility that this regulation may occur at the level of the G-protein was 
investigated.Noradrenaline stimulated inositol phosphate formation was unaffected 
by pertussis toxin pretreatment. However, pertussis toxin preincubation produced a 
significant decrease in endothelin- 1 stimulated inositol phosphate formation by 50% 
in cells from both SHR and WKY. There was still a significant decrease in SHR 
responses after pertussis toxin pretreatment compared to WKY responses after 
pertussis toxin pretreatment. Therefore, noradrenaline and endothelin-1 appear to be 
regulated, in part, by different G-proteins although, in the case of endothelin-1, this 
may be unaltered in cells from SHR.
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The dependence of endothelin-1 stim ulated inositol phosphate form ation on 
extracellular calcium in cultured aortic smooth muscle cells from 14 week SHR and 
WKY was also investigated. Removal of extracellular calcium and the addition of 
O.lmM EGTA reduced SHR and WKY responses significantly and by a similar 
magnitude. Endothelin-1 stimulated inositol phosphate formation in SHR still 
remained significantly decreased compared to WKY. The effect of removal of 
extracellular calcium and pertussis toxin pretreatment reduced further endothelin- 1 
stimulated inositol phosphate formation in both WKY and SHR. The decrease in 
SHR inositol phosphate formation was still maintained suggesting that endothelin-1 
stimulated inositol phosphate formation was partially dependent on extracellular 
calcium but this dependence is similar in SHR and WKY aortic smooth muscle cells.
Pertussis toxin dependent ADP-ribosylation was measured in membranes prepared 
from cultured aortic smooth muscle cells from 14 week SHR and WKY rats in the 
presence of endothelin-1. In both WKY and SHR membranes endothelin-1 caused a 
similar decrease in ADP-ribosylation further indicating that the pertussis toxin 
dependent G-protein activated by endothelin-1 is unchanged in hypertensive aortic 
smooth muscle cells.
The free intracellular calcium concentration measured using the fluorescent 
indicator, fura 2 , was unchanged in cultured aortic smooth muscle cells prepared 
from 14 week SHR compared to WKY.
7.2. Conclusions
The work described has now provided some potential answers to the questions posed 
at the beginning of this chapter. Inositol phosphate formation was altered in a
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genetic model of hypertension although interpretation of these results is complicated 
by control rats being of a different strain. However, alterations in inositol phosphate 
formation were also observed in aorta from perinephritis hypertensive rabbits where 
controls are of the same strain and therefore the change is likely to be the result of 
the hypertension and not, as would be possible in the SHR, a result of strain 
difference. It is probable, on the basis of these results that inositol phosphate 
formation is altered in models of hypertension although these alterations depend on 
the model studied.
Noradrenaline and endothelin-1 were shown to be regulated independently at the 
level of the G-protein. This independent regulation suggests that any alterations in 
inositol phosphate formation would probably not be general changes to all agonists 
but may be agonist specific. Agonist-specificity was observed in aorta from 2 week 
perinephritis hypertensive rabbits and in cultured aortic smooth muscle cells from 14 
week SHR. In the case of endothelin-1 these agonist-specific changes in cells from 
SHR did not, however, appear to be due to alterations in the pertussis toxin sensitive 
G-protein.
In neither of the experim ental models of hypertension exam ined was agonist 
s tim u la ted  in osito l phosphate  fo rm ation  changed  at an early  stage in the 
development of hypertension (at 1 week in perinephritis hypertensive rabbits and at 
6 weeks in SHR). This indicates that noradrenaline and endothelin-1 stimulated 
inosito l phosphate form ation did not appear to have a p rim ary  ro le  in the 
pathogenesis of hypertension. The changes that were observed at 2 weeks in 
perinephritis hypertensive rabbits and at 14 weeks in SHR may be consequential 
changes but they may still contribute to the hypertensive process.
159
Increased basal inositol phosphate formation was observed in cultured aortic smooth 
muscle cells from 6 week SHR. If this result is reflected in vivo then this could 
contribute to an increased peripheral vascular resistance at an early stage in the 
development of hypertension or possibly at the prehypertensive stage.
The parallel studies in freshly isolated aorta and cultured aortic smooth muscle cells 
allowed investigation into the suitability of cultured cells as a model of hypertensive 
vasculature. In the secondary model of hypertension, cells did not retain the 
characteristics of the aorta. This is not surprising as this hypertension is likely to be 
initiated by humoral or neural factor. Once the cells are rem oved from these 
influences they will return to a normotensive state. In SHR some of the changes in 
inositol phosphate formation in aorta were observed in cultured aortic smooth 
muscle cells such as the decrease in endothelin- 1 stimulated inositol phosphate 
form ation in 14 week SHR. However, the noradrenaline stim ulated inosito l 
phosphate formation was increased in cells from SHR, the opposite change to that 
seen in aorta. This difference could be due to alterations in receptor populations 
during the culturing process and serves to demonstrate that cultured cells are not 
always a good model for whole tissue.
In conclusion, inositol phosphate formation is altered in models of hypertension. 
H owever, the alterations observed appear to be dependent on the m odel of 
hypertension, the stage of development of hypertension, the agonist and the system 
(cultured cells or whole tissue) which is examined.
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MATERIALS
The materials used in this thesis were obtained from the following suppliers:
Male New Zealand white rabbits - Cheshire Rabbit Farms, Cheshire, U.K.
SHR and WKY rats - Charles River Laboratories, Cheshire, U.K.
JH-myoinositol and P-NAD - Amersham International, Amersham, U.K. 
Endothelin-1 - Scientific Marketing, Barnet, U.K.
Fura 2/AM - Calbiochem, Cambridge, U.K.
Calcium Chloride - BDH Chemicals Ltd, Poole, U.K.
Freon (1,1,2-trichlorotrifluoroethane) - Aldrich Chemical Company, Dorset, U.K. 
Scintillant (Ecoscint A) - National Diagnostics, New Jersey, U.S.A.
Glass coverslips - Chance Propper Ltd, Warley, U.K.
All tissue culture plasticware was obtained from Sterlin Ltd, Middlesex, U.K.
All tissue culture reagents were obtained from Gibco BRL, Paisley, U.K.
All other chemicals were obtained from Sigma Chemical Company, Dorset, U.K.
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